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Collectively, cardiovascular diseases continue to be the leading cause of death, 
across nations and across decades. Improved diagnostic imaging methods offer promise 
to alleviate the morbidity associated with these diseases. Photoacoustic (PA) imaging is 
one such method, poised to make a significant impact on cardiovascular imaging, both as 
a research tool, as well as a clinical imaging modality. Offering the potential of molecular 
imaging in real-time, PA methods have been demonstrated in proof-of-concept studies 
tracking myocyte calcium dynamics. These results open the door to non-invasive 
longitudinal assessment of cardiac electrophysiological function, with implications for 
drug and contrast agent development. PA image guidance has also been extended to the 
characterization of cardiac radiofrequency ablation lesions. This method has been 
demonstrated to utilize endogenous chromophore changes resulting from ablation for the 
generation of depth-resolved tissue characterization maps, capable of assessing lesion 
extent. The technique has been subsequently validated by assessing high-intensity 
focused ultrasound ablation lesions in myocardium, with the hope for offering 
thermographic capabilities as well. While PA imaging offers such promise in cardiac 
ablation procedures, it is also in the process of clinical translation for image guidance and 
 vi 
characterization in coronary artery disease applications. Research has shown, using 
Monte Carlo optical modeling, that using a simple dual-wavelength PA imaging 
technique has great potential for successful visualization of atherosclerotic plaques across 
multiple tissue types and at clinically relevant multiple millimeters of depth. Collectively 
these results offer a suite of PA imaging tools with the potential for molecular and 
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Chapter 1: Introduction To Photoacoustic Imaging For Cardiovascular 
Applications1 
1.1 INTRODUCTION  
Photoacoustic (PA) imaging (also called optoacoustic imaging) is a hybrid 
optical-ultrasound imaging modality that relies on optical excitation to generate 
ultrasonic waves in tissue. PA signal generation depends upon optical absorption, making 
PA imaging a molecular imaging modality. By observing PA pressure-transients using an 
ultrasound (US) system, and because PA signal generation relies only on absorbed 
photons, PA imaging is able to overcome the imaging depth limitations common to 
optical techniques that rely on ballistic photon propagation. It is also well suited to take 
advantage of the reduced optical absorption of tissues in the near-infrared (NIR), as well 
as to utilize various contrast agents for improved imaging. For these reasons it has 
become a promising medical imaging modality, with applications that include the 
evaluation of coronary heart disease (CHD), stem cell treatment monitoring, cancer 
diagnosis, and treatment guidance, just to name a few. For context, a brief history of PA 
imaging is provided in Appendix A.  
This chapter serves to outline the contents of this dissertation and provide a 
foundation to understand the overall goals of the research presented. It begins with an 
outline of the fundamental physics involved in the production of a PA wave, followed by 
a brief examination of how the physics can be exploited to allow for specific techniques, 
such as molecular or thermographic imaging. The discussion of those techniques will pay 
particular attention to how they can apply to cardiovascular imaging applications and will 
segue into the main theme of this dissertation; PA imaging for cardiovascular image 
                                                 
1 This chapter is adapted in part from a textbook chapter 'Overview of Photoacoustic Imaging' (Dana, 
Dumani, Cook, and Emelianov 2016). Nicholas Dana is the primary author of this textbook chapter. 
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guidance and tissue characterization. The two primary areas of PA cardiovascular 
imaging will be discussed; image guidance for cardiac electrophysiology (EP) studies and 
intravascular photoacoustic (IVPA) imaging for coronary artery disease. An overview of 
the research and goals that comprise Chapters 2, 3, 4 and 5 is provided. The chapter will 
conclude with a summary that will be expanded in Chapter 6 to address the limitations of 
this research, as well as directions of future studies. 
1.2 PHYSICS OF PHOTOACOUSTICS 
Several physical phenomena dictate the manner in which PA signals are generated 
and sensed. Due to photoacoustics being a hybrid imaging modality that relies upon light 
to generate a signal within the tissue, a strong understanding of light transport in tissue is 
necessary. 
1.2.1 Optical Transport in Tissue 
Before we can reliably utilize the photoacoustic effect for imaging, we first must 
have some understanding of light propagation in tissue. The Radiative Transport 
Equation (RTE, also called the Boltzmann Equation) is an analytical model to express the 
fluence (or fluence rate) within a given region or voxel. While this model is 
comprehensive in its treatment of wavelength (λ, [nm]), scattering (μs(r⃗, λ), [cm
-1]), 
absorption (μa(r⃗, λ), [cm
-1]), and anisotropy (g(r⃗), unitless), it is often very difficult to 
solve without considerable simplification. Below we will briefly discuss each term and 
what it represents in terms of optical fluence (F(r⃗, λ) [J/m2]), as well as two common 
methods used to more easily elucidate the light distribution in tissue. 
 
dP = −dPdiv − dPext + dPsca + dPsrc Equation 1 
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In Equation 1, the term dP represents the change in power of the volume element dV 
within the solid angle dΩ (Figure 1). Power loss from beam divergence is accounted for 
by the term dPdiv. The term dPext accounts for losses due to optical extinction, which 
includes absorption and scattering. 
Figure 1.1: Diagram of infinitesimal volume of optically scattering and absorbing 
medium. For transiting photons 𝑑Ω and 𝑑Ω′ represent outgoing and 
incoming solid angles, respectively, while ?̂? and ?̂?′ represent outgoing and 
incoming vectors, respectively. The total volume 𝑑𝑉 = 𝑑𝑠 ⋅ 𝑑𝐴. 
Gains due to photons scattered into dΩ from angle dΩ′ are represented by the 
scattering term dPsca, while photons generated within dV are accounted for by the source 
term dPsrc. This derives from energy conservation, which assumes a steady-state system 
(i.e. constant illumination source and time-independent optical parameters). By 
integrating over time, and all angles of dΩ′ and dΩ (and optical wavelength, for 
polychromatic sources), we can obtain an expression for fluence that accounts for optical 
energy delivered through a unit area at a given location. Often an exact solution to the 
RTE is unattainable and approximate solutions are needed. One such simplified solution, 
a diffusion approximation, treats photons as diffusing particles in a medium. It is less 
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accurate than the RTE (Andreas, Raymond, and Randall 1998), but more straightforward. 
Another alternative is to use Monte Carlo modeling to stochastically simulate photon 
transport. This typically yields more accurate results than diffusion approximations 
(Flock et al. 1989), but is more computationally demanding. For a thorough treatment of 
optical transport in tissue I direct readers to Wang and Wu, 2007 (Wang and Wu 2007). 
1.2.1.1 Simplification of the Radiative Transport Equation 
In typical PA applications, there is no internal source, and the external source can 
be easily characterized for energy output and beam divergence. This resolves part of the 
RTE, but, if absolute fluence is desired, absorption and scattering must often be 
approximated using methods mentioned above. Still, even if absolute fluence is unknown, 
semi-quantitative results may be obtained using relative differences in PA signal. These 
methods utilize spectroscopic PA (sPA, also called multi-wavelength PA) imaging, and 
often assume that fluence spatial-distribution varies little between wavelengths. That 
assumption relies upon 𝜇𝑠(𝑟, 𝜆), 𝜇𝑎(𝑟, 𝜆) and g(r⃗), remaining relatively constant across 
wavelength and time, and may not be valid for all applications. 
1.2.2 Derivation of tissue-heating function   
Once fluence has been accounted for, we can determine the energy deposited into 
a unit volume. The optical absorption coefficient represents the fraction of light that will 
be absorbed as it propagates. Thus, the product of fluence and optical absorption 
represents the fraction of absorbed light energy (Welch et al. 1989). It is treated as if this 
energy is entirely converted to heat, resulting in a tissue heating function (F(r⃗, λ) ⋅
μa(r⃗, λ) =  H(r⃗, λ) [J/m
3]), which can be related to particle velocity of the acoustic 


















= −∇p Equation 3 
1.2.2.1 Heating and Pressure-Velocity Relationship 
Equations 2 and 3 represent the expansion equation and linear equation of motion, 
respectively.  Equation 2 relates the spatial gradient of displacement (∇u) to individual 
contributions from pressure (∇up), thermal expansion (∇uT) and electrostriction (∇uER), 
which is the process of displacement in dielectric materials in response to an external 
electric field. Equation 3 relates acceleration (∂2u ∂t2⁄ ) to the spatial gradient of pressure 
(∇p). This model assumes that displacements and particle velocities are small, and that 
the medium is acoustically isotropic and homogenous. For biological applications, 
electrostriction is typically several orders of magnitude less than the other terms (Tam 
1986), and so is neglected. The model also ignores shear and volume viscosities, as well 
as shear elasticity. Other important parameters are mass density (ρ, [kg/m3]), the linear 
thermal expansion coefficient (β, [K-1]) and sound velocity (vs, [m/s], vH2O ≈1480 m/s, 
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∂2T
∂t2
 Equation 4 
 By applying the gradient operator to Equation 3, combining that with 








 Equation 5 
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Lastly, by relating temperature change to thermal conduction and heating through 
Equation 5 (Wang and Wu 2007), using thermal conductivity (kth, [W/(m K)]) and 
specific heat capacity at constant pressure (Cp, [J/(kg K)]), we obtain the following 














2T − H) Equation 6 
1.2.3 Photoacoustic Equation 
A few conditions must be met in order for a significant PA signal to be generated. 
This is primarily a function of the laser pulse duration. 
1.2.3.1 Thermal Confinement 
Utilizing short-duration optical excitation is paramount to achieving efficient PA 
energy conversion. Tissue thermal conductivity governs the heat diffusion within the 
tissue. For length dc, [m], the thermal relaxation time (τth, [s]) needed for a thermal 






 Equation 7 
If the laser pulse duration (τp, [s]), is much less than thermal relaxation time 
(τp ≪ τth), then very little absorbed energy can diffuse away from the absorbing region 
during excitation, making the heat “confined” to the absorber. When thermal confinement 
is satisfied, the Laplacian temperature term (kth∇
2T) is eliminated from Equation 6, and 
the pressure is solely a function of the heating term, as shown below. For a more detailed 













 Equation 8 
1.2.3.2 Stress Confinement 
Another important parameter is the stress relaxation time (τst, [s]), which is the 





 Equation 9 
When optical excitation is much quicker than stress relaxation (τp ≪ τst) the 
system is said to be in stress confinement. In such a case PA pressure waves 
constructively interfere across the absorber region. The result is the equivalent of a 
Green’s function solution to Equation 8 (i.e. a delta heating pulse) (Diebold and Sun 
1994). Equation 8 therefore reduces to a straightforward expression for the peak pressure 
(p0, [Pa]) immediately after optical excitation, often referred to as the PA equation. 
 




 F(r⃗, λ)μa(r⃗, λ) = Γ(T)F(r⃗, λ)μa(r⃗, λ) Equation 10 
 The parameters β, vs and Cp are often combined into a single term, the 
Grüneisen parameter (Γ(T), unitless) and their temperature dependence is expressly 
written in Equation 10. This result outlines PA pressure dependence on fluence, optical 
absorption and temperature. Table 1.1 shows examples of thermal- and stress-
confinement times using parameters for water. 
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Confinement condition Absorber size 
1 mm 30 µm 1 µm 100 nm 
Thermal confinement (τth) 70 s 60 ms 70 µs 700 ns 
Stress confinement (τst) 700 ns 20 ns 0.7 ns 70 ps 
Table 1.1: Example thermal and stress confinement times for various absorber sizes. 
Represents the upper-limit of laser-pulse duration for optical excitation if 
ideal PA signal generation is to be achieved. 
1.2.4 Photoacoustic Imaging Data 
Figure 2 is a schematic of a typical PA imaging system and highlights the primary 
components. The resulting PA data is capable of providing an image, or map, of the 
tissue optical absorption. Recall that the PA signals are proportional to the product of the 
fluence and optical absorption. As such, spatial inhomogeneity in fluence can mask the 
underlying optical absorption information, which is of principal interest. For this reason it 
is desirable to spatially decouple optical absorption from fluence. If the fluence 
distribution can be accounted for using modeling or other methods (Cook, Frey, and 





Figure 1.2: Example of typical PA imaging system components. Diagram highlights 
optical excitation (A), followed by generation of PA pressure waves (B), 
which are then received and digitized using a US transducer and system, 
respectively (C), before image reconstruction/processing (D) and final 
image rendering (E, showing combined US-PA image). 
1.2.4.1 Molecular Imaging 
As mentioned above, tissue optical absorption is the pertinent information that PA 
imaging is capable of supplying. Optical absorption is determined by the particular 
molecules present in tissue, which each contribute a unique spectrum capable of 
identifying the particular absorber, or chromophore. For this reason, PA imaging is a 
molecular imaging modality, and by properly leveraging PA imaging techniques, we can 
determine the particular molecular constituents which are present in a given tissue region. 
For a given wavelength, the local optical absorption is the sum of the contribution 
from each individual absorber in the interrogated region of space, resulting in a function 
dependent on both wavelength and absorber concentration (Wang and Wu 2007), as 












 Equation 11 
Where absorption (μa
i (r⃗, 𝜆), [cm-1]) represents the individual contribution from 
the ith chromophore. The product of molar absorptivity (ϵi(λ) [m2/mol]) and molar 
concentration (Ci(r⃗), [mol/m3]), and the product of optical cross-section (σi(λ), [m2]) and 
chromophore number (Ni(r⃗), [m-3]) are equivalent expressions for absorption. 
 Because optical absorption represents a linear sum of chromophores, 
various techniques can be used to estimate concentration. sPA can be used to estimate 
chromophore concentration, provided fluence differences across wavelengths and time-
dependent concentration changes can be accounted for, or are nearly negligible. If the 
fluence is absolutely known, then true concentration estimates can be made (Cook, Frey, 
and Emelianov 2013). Otherwise, concentration estimates are typically relative to one 
another. Either way, such information yields valuable insight into tissue function. 
1.2.4.2 Thermosensitive Photoacoustic Response 
As seen from Equation 10, the PA signal generation depends upon the Grüneisen 
parameter, which is comprised of temperature-dependent variables that are tissue specific 
and, together, lend PA imaging its temperature sensitivity. 
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Tissue Type (~37 °C) ρ [g/cm3] Cp [J/(g K)] vs [m/s] 
Muscle 1.07 3.6 1575 - 1590 
Fat 0.95 2.3 1450 
Liver 1.06 3.6 1590 
Blood 1.06 3.8 1575 
Water 0.99 4.2 1500 
Table 1.2: Typical thermal and acoustic properties for various tissue types. 
Table 1.2 highlights typical physical properties for select tissue types measured at 
37°C (Duck 1990b, 1990a). Note that lipid-based tissues exhibit markedly distinct 
thermal and acoustic properties from most other tissue types. Specific heat capacity and 
speed of sound values typically vary by less than 5% across tissue types in the 
temperature range of 20 – 70 °C, which is not the case for thermal expansion. The 
thermal expansion coefficient of water varies from 0 [K-1] at 4 °C to 5.85×10-4 [K-1] at 
70 °C, and is approximately linear in this range. The Grüneisen parameter for water-
based tissues is often approximated using the behavior of water, and an empirical formula 
has been derived for temperatures measured in degrees Celsius (Oraevsky, Jacques, and 
Tittel 1997). 
Γ(T) ≈ 0.0043 + 0.0053 ⋅ T Equation 12 
Due to the large temperature dependence of the Grüneisen parameter, the PA 
signal amplitude is coupled to temperature. Once a baseline tissue PA signal is measured 
at a known temperature (usually assumed to be body temperature), changes in tissue 
temperature can be remotely observed by comparing PA signals to baseline. This 
temperature dependence operates independent of wavelength and can be used to estimate 
changes in tissue temperature (Irina, Kirill, and Rinat 2005; Shah et al. 2008). 
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Additionally, the Grüneisen temperature dependence of lipid-based tissues is opposite 
that of water-based tissues in the physiologic range and has been used to characterize 
tissues based on lipid content (Wang and Emelianov 2011). Thus, thermosensitive PA 
imaging has great utility for tissue characterization and image guidance. 
1.3 PHOTOACOUSTIC IMAGING TECHNIQUES 
Due to the hybrid nature of photoacoustic imaging, as well as the sensitivity of the 
modality to multiple tissue parameters, there exist several different approaches to 
generating a desirable image. These approaches can vary in which chromophore of 
interest is being imaged (e.g. exogenous vs. endogenous chromophores), how those 
chromophores are visualized (e.g. single-wavelength vs. multiple-wavelength acquisition) 
as well as how the system is configured in order to acquire image data (e.g. single-
element vs. element-array implementations). Often it is preferable to combine multiple 
techniques in order to optimize contrast, resolution or sensitivity (e.g. contrast-enhanced 
spectroscopic imaging using a 1D array transducer). What follows is a brief discussion of 
common techniques and what insight each may offer.  
1.3.1 Photoacoustic Contrast Agents 
Because photoacoustic contrast is based on optical absorption, useful information 
can be gleaned both from visualizing the distribution of endogenous chromophores, as 
well as tracking signal from exogenous contrast agents. The most commonly imaged 
endogenous chromophore is hemoglobin, but other absorbers of interest include melanin, 
and lipid, while common exogenous absorbers include dyes, porphyrins, and 
nanoparticles (NPs). The ideal contrast agent will have a strong, spectrally unique NIR 
absorption. Furthermore, exogenous agents must be bio-compatible, stable, and easily 
cleared or degraded through normal metabolism. Development of agents with said 
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attributes is an intense area of research (Wang, Chuang, and Ho 2012). Figure 1.3 
illustrates the absorption spectra of common tissue components and contrast agents. 
1.3.1.1 Hemoglobin Imaging 
Hemoglobin-variants (i.e. Hb and HbO2) exhibit distinct optical absorption 
spectra in the NIR regime up to approximately 1100 nm, at which point the absorption of 
water begins to dominate and hemoglobin variants appear indistinguishable. As such, 
sPA imaging can be used to determine SpO2 by comparing spectroscopic data to 
Hemoglobin spectra (Prahl 1999; Wang et al. 2006) to determine the relative amounts of 
oxygenated vs. deoxygenated hemoglobin. Since oxygenation has been closely linked to 
tissue function and disease state, Hb has become the most utilized endogenous absorber 
for PA imaging applications. While Hb absorption can confound imaging with exogenous 
contrast agents, studies have shown that proper wavelength and/or contrast agent 
selection can be done to optimize combined Hb and exogenous contrast imaging (Kim et 
al. 2011). 
1.3.1.2 Plasmonic Nanoparticle Agents 
For noble metals, optical properties are determined by their degree of electron 
confinement, which is strongly influenced by their dimensions (El-Sayed 2001). Gold 
and silver NPs can exhibit surface-plasmon resonance (SPR), a phenomenon where the 
electronic state can strongly couple across the surface of the particle. This result allows 
for the electrons to oscillate coherently at particular frequencies which happen to 
correspond to NIR optical frequencies. This results in highly efficient optical absorption 
and scattering at the resonant frequency, which is dependent upon the particle geometry 
and can be selected for by varying particle size and shape (Kelly et al. 2003). 
Additionally, many surface modification protocols exist for NPs. As such, they can be 
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functionalized to improve cytotoxicity, circulation time, stability, aggregation prevention, 
and enable molecular-specific targeting (Niidome et al. 2006; Kumar, Aaron, and 
Sokolov 2008). NPs as PA contrast agents have been synthesized in a variety of 
geometries, including nanospheres (NSs) (Ji et al. 2007), nanorods (NRs) (Nikoobakht 
and El-Sayed 2003), nanoshells (Xiang et al. 2006) and nanocages (Chen et al. 2005), 
with absorption peaks ranging from 500 – 1100 nm and sizes from 2 – 200 nm. These 
represent just a few of the potential NP configurations. 
As mentioned above, when the electron clouds of plasmonic NPs in close 
proximity can interact. This coupling affects the resonant frequency of oscillating 
electrons, and can result in spectral changes in absorption and scattering. This can be 
exploited to detect physiological events in tissue, such as aggregation due to changes in 
endocytosis (Nam et al. 2012), temperature (Zhao et al. 2011) and pH (Wu et al. 2010). 
The podocytes, which are responsible for glomerular filtration, are typically separated by 
a covered filtration slit roughly 25–60 nm wide (Haraldsson, Nyström, and Deen 2008). 
As such, particles smaller than 5 nm have been shown to clear the body through renal 
filtration, whereas larger particles are sequestered by the reticuloendothelial system, 
leading to accumulation in the liver and spleen (Longmire, Choyke, and Kobayashi 
2008). Unfortunately, reducing particle size, which improves renal clearance, tends to 
limit particle tunability and functionalization. Biodegradable clusters of small NPs may 
be a solution. This approach aims to solve the clearance issue while maintaining particle 
function and facilitating translatability of NPs and potential FDA approval (Yoon et al. 
2012). 
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1.3.1.3 Non-plasmonic Nanoparticle Agents 
Non-plasmonic NPs can exhibit strong optical absorption in the NIR regime, and 
because they do not exhibit the characteristic spectral shifts at high densities that occur 
with plasmonic-coupling particles, they can be useful in many applications (Cook, Frey, 
and Emelianov 2013). In addition, they can have distinct features like super-
paramagnetism and broad absorption spectra, opening up applications that would 
otherwise be unavailable using plasmonic NPs alone. Materials include carbon-sheets, 
iron oxide, and copper sulfide. Unfortunately, many of these particles share the same 
biocompatibility and clearance concerns as mentioned previously, requiring careful 
synthesis. 
Single-walled carbon nanotubes (SWNTs) exhibit a broad absorption spectrum 
that allows imaging with optical, NIR, and microwave radiation (Pramanik et al. 2009). 
Generally speaking, broad absorption is problematic for spectral unmixing techniques, 
but SWNTs can be conjugated with dyes to considerably enhance absorption at particular 
wavelengths (Zerda et al. 2010). Super-paramagnetic iron oxide nanoparticles (SPIONs) 
have been used for quantitative PA microscopy where plasmonic coupling from NPs 
would otherwise produce non-linear results (Cook, Frey, and Emelianov 2013). SPIONs 
exhibit magnetic properties, which can be useful both for targeting the particles to a 
particular region, through the use of localized magnetic fields, as well as a multimodal 
imaging contrast agent. However their poor NIR optical absorption makes them 
undesirable solo-contrast agents for most PA applications. SPIONs are currently the only 
FDA-approved medical imaging NPs for human use (Tassa, Shaw, and Weissleder 2011). 
Alternatively, copper sulfide nanoparticles have been synthesized in small sizes around 
10 nm with strong NIR absorption peaks (Ku et al. 2012). Their ease of synthesis and 
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Figure 1.3. Absorption (top) and normalized extinction (bottom) spectra of some 
common tissue components and contrast agents. (Partially reproduced from 
(Mallidi, Luke, and Emelianov 2011)). 
1.3.1.4 Dye-based Contrast Agents 
Dyes are typically small molecules and offer advantages such as rapid clearance 
and biocompatibility over other contrast agents. They can also be molecularly targeted 
(Bhattacharyya et al. 2008) or combined with other particles for increased absorption, 
stability, targeting or delivery capabilities (Akers et al. 2010; Zerda et al. 2010). A variety 
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of dyes absorbing in the NIR have been used for PA and combined PA-fluorescence 
imaging (Kim et al. 2010). While dyes possess many advantages over other agents, they 
exhibit molar absorption values several orders of magnitude lower than other NPs (Jain et 
al. 2006), and they are susceptible to photo-bleaching (Laufer, Zhang, and Beard 2010).  
Indocyanine green (ICG) is a fluorescent dye extensively explored for PA 
imaging. It has been embedded in NPs for cancer-specific targeting (Kim et al. 2007) and 
encapsulated in nanodroplets (NDs) for multimodal imaging (Hannah et al. 2013). ICG’s 
spectral absorption varies with concentration and environment, and may be exploited to 
track dynamic changes (Rajian et al. 2011).  
1.3.2 Tomographic and illumination methods 
Just as the imaging target will dictate what endogenous or exogenous 
chromophores are of interest, so too will it determine the optimal PA imaging setup for a 
particular application.  The two actions that must be performed to gather PA information, 
pulsed light delivery and acoustic reception, can be accomplished in several different 
ways. Typically, pulsed lasers come in one of three varieties: mode-locking lasers (pulse 
duration ≤ 10-10 s), pulsed LEDs (pulse duration ≥ 10-9 s), and Q-switching lasers 
(pulse duration ≈ 10-9 s). As previously stated, PA pressure intensities are largest when 
both stress and thermal confinement are satisfied. Therefore, mode-locking lasers would 
theoretically generate the highest PA signals. However, the optical linewidth (also called 
spectral bandwidth) generated from mode-locking lasers is very broad due to the inverse 
time and frequency domain relationship. Mode-locked lasers also typically have lower 
overall pulse energies (pico- to nano-Joules). For these reasons, mode-locked lasers are 
sub-optimal for PA applications. Some PA systems utilize pulsed LEDs; however, the 
pulse energies of these light sources is also typically low (nano- to micro -Joules), 
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limiting their use to applications such as needle and biopsy guidance, where high 
absorption is assured. Therefore, the bulk of PA imaging applications utilize nanosecond 
Q-switching lasers capable of milli-Joule or greater pulse energies, with typical pulse-
repetition rates of 10s of Hertz. 
 Because the pressure waves are acoustic, PA acquisition can be performed using 
current US technology; however, instead of an ultrasonic pulse-send and subsequent 
echo-receive, the “pulse” is performed by optical excitation and the US system is used 
only for the acoustic receive. Because of their similarities, PA imaging can be 
implemented using a single element, a 1-D array, or even a 2-D array, as is the case for 
US imaging. 
1.3.2.1 Single-element solutions 
The most basic receiver is a single element transducer. This type of receiver 
measures PA signals along a single line, analogous to an US A-line. In order to produce 
an image, the transducer must be moved to acquire multiple A-line positions and 
ultimately form an image. Although primitive and cumbersome, single element 
transducer systems are used in some applications today - the most common being 
intravascular photoacoustic (IVPA) imaging. Single elements are advantageous here 
because they can be made very compact, despite the mechanical components required to 
move the single element. For IVPA applications a single element transducer is combined 
with a small fiber optic (FO) cable used for light delivery. Images are formed by rotating 
the element and FO cable and acquiring US amplitude-lines (A-lines) at several rotational 
positions (Karpiouk, Wang, and Emelianov 2010). The A-lines can be used to then 
reconstruct a traditional brightness-mode (B-mode) US-PA image, as shown in Figure 
1.4. IVPA imaging receivers can be rotated extremely fast (1000s of revolutions per 
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minute) enabling the potential for real-time imaging. This form of imaging will be 
discussed in greater detail in Chapter 4. 
 
 
Figure 1.4. Schematic of IVPA catheter inside of the blood vessel (A). The catheter 
rotates inside of the blood vessel and captures a PA and US A-line at 
multiple positions. A-lines are used to provide a PA image (B), an US image 
(C), then overlaid for a co-registered PA/US image (D). Adapted from 
(Wang et al. 2012b; Dana, Dumani, et al. 2016). 
1.3.2.2 One-dimensional Array Transducers 
The vast majority of PA applications utilize 1-D array receivers because they do 
not require moving parts to render 2-D US or PA images. Linear-array PA transducers 
are very similar to ultrasound transducers in that there is a linear-array of piezoelectric 
elements, allowing multiple simultaneous received positions and more sophisticated 
image processing (e.g., beamforming) to render higher quality images. To provide the 
illumination, optical fibers are placed around the transducer elements in order to optimize 
light delivery within a particular region of the imaging plane. In addition to real-time 2-D 
B-mode images, linear array PA transducers can also be used to generate 3-D image 
volumes by mechanically translating the array orthogonal to the imaging plane (Hoelen 
and de Mul 2000). The resulting data set is a 3-D image stack, comparable to what is 
generated using X-ray computed tomography (CT) or MRI imaging systems. Resolution 
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transducer element elevational-size in that dimension, though poor spatial sampling can 
further reduce resolution. This is an example of photoacoustic tomography (PAT) 
1.3.3 Photoacoustic Microscopy Methods 
Unlike US imaging, PA imaging is not limited to the macroscale. PA microscopy 
(PAM) typically uses a single-element receiver and interrogates the tissue using highly 
focused light. Because PA signals are generated only in the light’s focal zone, optical 
resolution can be achieved, provided optical scattering is minimized. Like optical 
imaging, PAM is limited to superficial structures. Microvasculature and superficial 
pathology can be easily visualized and characterized (Wang 2009; Zhang et al. 2009). 
Because the resolution is subcellular, there is potential to detect in-vivo circulating tumor 
cells (CTCs, indicators of metastasis and disease aggression) for more accurate staging of 
cancer (Galanzha et al. 2009; Weight et al. 2006; Hu et al. 2013; Wu et al. 2014), or to 
monitor highly localized cellular activity (Dana, Fowler, et al. 2016). In addition, 
quantification of absorbers can be performed with PAM, allowing for accurate molecular 
imaging and the potential for in-vivo histology (Cook, Frey, and Emelianov 2013). 
Examples of PA microscopy systems and images are shown in Figure 1.5. 
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Figure 1.5. Examples of PA microscope systems. Adapted with permission from (Wang 
2009). 
1.3.4 Spectroscopic and Multiplex Photoacoustic Methods 
As discussed in above, the total optical absorption spectrum of a region is the 
linear sum of all the absorbers therein. As such, if the chromophore spectra are 
sufficiently distinct (i.e. they can be easily distinguished, such as that of oxygenated and 
deoxygenated Hb at certain wavelengths), then sPA methods can be leveraged to estimate 
the concentration (relative or absolute) of each absorber. Such techniques typically 
require statistical methods, such as linear regression, to spectrally unmix the individual 
contributions in the overall PA image. This is commonly called multiplex imaging. 
Multiplex imaging represents the most versatile application of sPA imaging, as it 
has the capacity to distinguish multiple chromophores of interest in the field of view 
(FOV). This technique can be used with endogenous chromophores to estimate oxygen 
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saturation percentage (SpO2) (Wang et al. 2006), or with exogenous contrast agents, to 
identify the presence of multiple contrast agents in a single FOV (Bayer et al. 2011), as 
shown in Figure 1.6. 
 
 
Figure 1.6. US image of phantoms containing inclusions with cells loaded with silica-
coated gold NRs (SiO2-AuNRs, a). US image overlaid with 830 nm PA 
image (b). Plot of PA spectra (points) and UV-Vis (lines) of two SiO2-
AuNRs contrast agents tuned to have peak absorptions at 780 nm (blue) and 
830 nm (red, c). Molecular map of cells overlaid on US image with 
inclusions containing either 830 nm SiO2-AuNRs (red), 780 nm SiO2-
AuNRs (yellow), or both, after processing multi-wavelength PA data using 
correlation analysis (d). Figure adapted with permission from (Bayer et al. 
2011). 
 Proper wavelength selection is paramount for reliable spectral unmixing of 
multiplex PA image data (Luke, Nam, and Emelianov 2013). If wavelengths are selected 
that do not adequately differentiate chromophores of interest, then spectral unmixing 
algorithms may yield ambiguous results. With respect to absorption, exogenous contrast 
agents used for multiplexed PA imaging should be spectrally distinguishable from one 
another and from endogenous chromophores, such as Hb or lipids. Refer to Figure 1.3 for 
the spectra of common chromophores. 
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1.3.5 Multimodal Photoacoustic Imaging 
PA imaging is a hybrid imaging modality, making it well suited to incorporate 
additional imaging functionality. There are several benefits to the addition of optical or 
ultrasonic capability. Often though, this requires careful design to balance the needs of 
multiple imaging modalities. Accommodating these conflicts can pose considerable 
engineering challenges; still, several attempts have been made toward the realization of 
synergistic multi-modal PA imaging. 
1.3.5.1 Combined Photoacoustic-Ultrasound Imaging 
US imaging makes an ideal candidate for integration with a PA imaging system as 
it can use the same components for US detection as are used for PA detection, making the 
two datasets inherently co-registered. Image reconstruction for both modalities can also 
be performed using the same hardware and software, making combined PA and US based 
imaging relatively straightforward and reducing the hardware costs.  
Because US imaging is sensitive to tissue mechanical properties (Szabo 2004), the 
information provided by US imaging is complementary to PA data. Traditional pulse-
echo US reconstructs an image of backscattered US energy resulting from acoustic 
impedance variations within the tissue (Szabo 2004). This is commonly called US B-
mode imaging and provides good morphological and structural information to 
complement the molecular-based PA imaging data. Examples can be seen in Figures 1.2, 
1.4 and 1.6. 
1.4 CARDIOVASCULAR APPLICATIONS OF PHOTOACOUSTIC IMAGING 
Cardiovascular medicine has benefitted from US imaging for decades and thus the 
introduction of PA to the clinically familiar imaging modality was a natural extension of 
the new technology. The three primary applications of US imaging in the cardiovascular 
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realm are: echocardiography, the assessment of cardiac function; intravascular ultrasound 
(IVUS) for the detection and image guidance of vulnerable plaque in coronary heart 
disease (CHD); and vascular ultrasound for the diagnosis and staging of peripheral and 
carotid artery disease. Though some research has explored applying PA imaging to the 
problem of peripheral and carotid artery disease (Kruizinga et al. 2014), the vast majority 
of research has focused on the development of intravascular photoacoustic (IVPA) 
imaging of coronary arteries (Su, Wang, and Emelianov 2009; Wang et al. 2010; 
VanderLaan et al. 2014; Yeager et al. 2014; Jansen, van der Steen, et al. 2014; Jansen, 
Wu, et al. 2014; Abran et al. 2014; Wang et al. 2012b), though studies have investigated 
the potential of using PA imaging for image guidance and tissue characterization 
purposes in cardiac arrhythmia applications (Dana et al. 2014; Dana, Fowler, et al. 2016; 
Gray et al. 2015). 
1.4.1 Overview of Cardiac Arrhythmia 
The heart is unique in that it is a vital organ that relies on automatic electro-
mechanical (also called excitation-contraction) coupling to function. Cardiac 
electrophysiology (EP) function differs from that of skeletal muscle in that calcium ions 
(Ca) play a vital role in both cardiac cell automaticity (the ability of cardiac cells to 
spontaneously depolarize) and the propagation of action potentials across cells. Normal 
cardiac rhythm functions as follows (Fogoros 1999): 
• The resting membrane potential in the cell is disrupted by changes in the ion 
concentration within the cell, such that the threshold to reach an action potential is 
reached. 
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• Triggering of an action potential (Phase 0) results in a rapid change in cytosolic 
ion concentration, causing rapid depolarization (~ 10 ms) from the resting 
membrane potential of the cell (-90 mV) to the action potential (+50 mV). 
• The rapid depolarization of the action potential completes, resulting in a slight 
decrease in membrane potential as the initial ion channels close and new ones 
open (Phase 1). 
• The action potential is maintained by the delayed and sustained opening of ion 
channels, which causes the membrane potential to plateau for approximately 150 
ms (Phase 2). This phase differs from typical neuronal or skeletal muscle 
electrophysiological function. 
• The resting membrane potential repolarizes as ion channels and ion pumps restore 
the normal electro-chemical gradient of the cell (Phase 3). 
• The myocyte stays at its normal resting membrane potential (Phase 4) until an 
action potential is initiated either through leaky ion channels within the cell itself 
(automaticity of cardiac cells) or through the propagation of electric potentials 
from neighboring cells.  
The initial rapid depolarization of a cardiac cell occurs from the voltage-gated 
opening of sodium (Na) channels, allowing Na influx into the cytosol and increasing the 
membrane potential during Phase 0. Phase 1 represents the closure of Na channels and 
the delayed opening of voltage-gated potassium (K) and chlorine (Cl) ion channels. Phase 
2, which is unique to cardiac cells, is typified by the protracted opening of Ca ion-
channels which allows for the protracted influx in cytosolic Ca, which changes Ca 
concentration by several orders of magnitude. Ca influx itself induces further Ca release 
from intracellular stores, which helps account for the magnitude and duration of Ca 
cytosolic concentration changes. Ca is responsible for electro-mechanical coupling within 
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the myocardial cell, for the prolonged duration of Phase 2 (which determines the cell 
refractory period) and also plays a role in conducting the action potential between 
adjacent cells via gap junctions. Resting membrane potential is restored during Phase 3 
largely by the cytosolic efflux of K and influx of Cl, which result in a net increase of 
negative ions within the cytoplasm which restore the membrane potential. Figure 1.7 
details the entirety of the myocardial action potential and the ions associated with each 
phase. 
Normally, all cardiac cells exhibit automaticity and have the potential to auto-
induce membrane depolarization, known as the pacemaker potential. Therefore, the cells 
with fastest “clock” will determine the cardiac rhythm, as their depolarization initiates 
action potentials in neighboring cells and propagates a depolarization wave throughout 
the myocardium. In normal sinus rhythm (NSR) the pacemaker cells of the sino-atrial 
(SA) node exhibit the most rapid spontaneous depolarization, occurring approximately 
50-60 times a minute under normal conditions, though this can vary considerably across 
individuals and is heavily influenced by the sympathetic and parasympathetic nervous 
system. The SA node determines the heart rate, and initiates depolarization that 
propagates; first through both atria, then onto the atrio-ventricular (AV) node (where 
there is a slight pause), then down through the bundle of His in the ventricular septum, 
and finally through the Purkinje fibers in the ventricular walls. The depolarization is 
followed by mechanical contraction of myocytes that results in the pumping action of the 
heart. This process relies on cytosolic Ca to unlock binding sites on actin filaments so 
that myosin fibers may engage them to initiate contraction (Lehman, Craig, and Vibert 
1994), thus allowing electro-mechanical coupling within the cell. 
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Figure 1.7. Diagram of cardiac action potential and ion fluxes that result in myocardial 
depolarization and repolarization. Provided by (Wikipedia.org 2016). 
1.4.1.1 Atrial Fibrillation 
Cardiac arrhythmia occurs when NSR is disrupted. This can occur when non-SA 
node pacemaker cells, often referred to as ectopic foci, usurp the pacemaker role of the 
SA node and initiate depolarization signals to adjacent cells. This is the case with atrial 
fibrillation (AF), the most common arrhythmia encountered clinically (Mozaffarian et al. 
2015). During AF, ectopic foci, typically located around the pulmonary veins in the left 
atrium, initiate arrhythmogenic electrical signals which disrupt NSR in the atria (Pappone 
et al. 2000). The result is disorganized electrical propagation throughout the atria. This 
prevents orderly contraction of the atria and undermines the ability of the heart to 
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properly fill the ventricles. Patient experiences of AF vary; for some, the result may be 
minor and go unnoticed, while other patients experience severe debilitation or fatigue 
(Mozaffarian et al. 2015). Regardless of patient experience, AF carries significant risks 
for other cardiovascular diseases, such as stroke and coronary heart disease (CHD) 
(Mozaffarian et al. 2015). AF is treated both with antiarrhythmic drugs, as well as with 
surgical intervention. 
1.4.1.2 Current State of Atrial Fibrillation Treatment 
Currently antiarrhythmic drugs represent the first line of treatment for AF, as well 
as other arrhythmias (Santangeli et al. 2011). Unfortunately, many of these drugs are 
burdened with either poor efficacy, severe side-effects, or both (Santangeli et al. 2011). 
Only approximately 1 in 4 AF sufferers is able to maintain NSR using only 
antiarrhythmic drugs (Mozaffarian et al. 2015). For most AF patients a minimally 
invasive surgical procedure, trans-catheter ablation (TCA), represents the best 
opportunity for long-term maintenance of NSR. This procedure introduces one or more 
catheters into the patient’s body, typically through the femoral veins. The catheters are 
then directed to the heart, penetrate through the atrial septum (if needed) and apply some 
form of energy (radiofrequency (Petersen, Chen, Pietersen, Svendsen, and Haunso 1999), 
focused US (Mitnovetski et al. 2009) or cryoablation (Tse et al. 2003)) to destroy the 
offending tissue that is initiating or maintaining arrhythmia. Unfortunately, due to 
limitations of current image guidance tools, the efficacy of these procedures varies 
greatly (Shah 2011). 
1.4.2 Image Guidance for Cardiac Arrhythmia Procedures 
Currently echocardiography (either trans-esophageal or intracardiac) (Marrouche 
et al. 2003) and fluoroscopy are the primary imaging modalities used during TCA 
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procedures, although pre-procedural MRI or CT scans can be used to generate the 3D 
cardiac anatomy for reference. Electro-anatomical mapping systems can also be used to 
reconstruct the cardiac geometry in interactive software, as well as tag locations with 
electrocardiogram measurements (Natale et al. 1998). While these systems are useful for 
visualizing cardiac geometry and structure, they cannot reliably characterize the cardiac 
tissue (Shah 2011), which is necessary to determine if the desired therapeutic endpoint 
has been achieved. Investigations into potential imaging techniques is underway to 
address these limitations, one of which involves PA image guidance. 
1.4.2.1 Visualization of Myocyte Depolarization 
In order to reconstruct the spatio-temporal propagation of depolarization within 
the myocardium, physicians must make some measurement of the electric potential at 
different positions and time-points in the tissue. During electrophysiology (EP) studies of 
AF physicians typically do this by navigating a catheter to different sites within the heart 
and measuring the electric field with the catheter-tip electrode while simultaneously 
measuring the time with respect to the pulse at the SA node. The catheter position is 
recorded by an electro-anatomical mapping (EAM) system, which can attempt to 
reconstruct electrical depolarization once a sufficient number of measurements have been 
made (Natale et al. 1998). Cardiac tissue is typically represented as a 2D surface in the 
3D model space and electrical propagation is projected onto that 2D surface. A similar 
method could be used in a laboratory setting to examine animal EP function for assessing 
novel pharmacotherapeutics. Unfortunately, measurements of electric potential integrate 
the EM field over the volume surrounding the electrode and typically provide only a 
coarse map. A method to visualize EP function with improved resolution and that is 
sensitive to 3D position may provide useful insight into cardiac EP and 
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pharmacotheraputic function. Photoacoustics may be able to add insight so as to provide 
quantitative results that can be scaled from cell studies up to animal studies. 
1.4.2.2 Tissue Characterization for Guided Cardiac Ablation Procedures 
Once the offending tissue is identified, physicians can then target the tissue for 
destruction via catheter ablation. Ablation treats arrhythmia by generating non-
conductive lesions within the tissue that disrupt or isolate arrhythmogenic signals. If 
durable lesions aren’t generated (i.e. if lesions aren’t transmural and contiguous) then the 
risk that the ablated tissue will recover electrical conductivity becomes high, which could 
render the procedure ineffective. Alternatively, if too much energy is applied, then the 
risk of damage to peripheral tissues, as well as complications such as cardiac tamponade, 
increase (Mozaffarian et al. 2015; Go et al. 2013). As such, it is vital to monitor the tissue 
temperature and function to achieve optimal results (Shah 2011). Physicians currently 
lack a reliable method to characterize the ablation substrate to determine when a durable 
lesion has been generated (Shah 2011). PA imaging is being studied as a means to 
address this deficiency. 
1.4.2.3 Thermographic Visualization for Ablation Temperature Monitoring 
Despite the safety of TCA, potentially fatal complications can arise from the 
procedure. Atrioesophageal fistula, which describes a fissure between the left atrium and 
the esophagus, is still a particular danger for AF ablation procedures (Chavez et al. 2015), 
as the esophagus lies directly posterior to the left atrial pulmonary veins. Another 
potential complication that may arise from TCA is cardiac tamponade, which occurs from 
bleeding into the pericardial sack, and can be caused from mechanical trauma or from 
overheating that generates a steam pocket that ruptures the atrial wall (Hsu et al. 2005). 
Partially in an attempt to limit such complications, physicians will often monitor catheter-
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tip temperature. Studies have shown that catheter-tip temperature monitoring improves 
lesion durability, but can also increase the rate of complication, as catheter-tip 
temperature is loosely correlated with tissue temperature (Schwartzman et al. 2001). 
Direct monitoring of tissue temperature would likely both improve TCA efficacy and 
reduce complications (Shah 2011). The temperature sensitivity of PA and US based 
techniques suggests such a method may be able to provide thermographic image guidance 
during procedures in addition to tissue characterization (Pramanik and Wang 2009; 
Chitnis et al. 2010; Dana et al. 2014; Dana 2014). 
1.4.3 Overview of Coronary Heart Disease 
 In 2015 an estimated 635,000 Americans experienced a new coronary 
event linked to coronary artery disease, with an American experiencing a myocardial 
infarction approximately every 43 seconds (Mozaffarian et al. 2015). This emphasizes the 
impact that coronary heart disease (CHD) places on our healthcare system. As such, 
visualization of coronary arteries represents an arena where the recent advent of high-
resolution molecular imaging modalities shows particular promise to have significant 
impacts (MacNeill et al. 2003; Sanz and Fayad 2008).  
1.4.3.1 Summary of Coronary Heart Disease 
At its heart (pun!) CHD is typified by the buildup of lipid and cholesterol 
deposits, or atherosclerotic plaques, on the lumen of the coronary arteries. This buildup 
can lead to stenosis of the artery, which can impede the supply of oxygenated blood to 
myocardial tissue downstream of the occluded area. While severe stenosis can be life 
threatening in itself, plaques can also rupture, leading to the formation of thrombus which 
can completely block the artery and lead to myocardial infarction. Fortunately, the 
formation of atherosclerotic plaques is a protracted process that occurs over a lifetime 
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(Sanz and Fayad 2008), which affords opportunity for diagnosis and treatment. As the 
lipid pool in the plaque increases and/or the fibrous cap which constrains the plaque 
weakens, the risk of rupture and a subsequent acute myocardial event significantly 
increases (Sanz and Fayad 2008; Davies et al. 1994; Muller et al. 1994; Hellings et al. 
2010). Specifically, plaques which have a large (≥3.5 mm2 cross-section, representing 
≥70% stenosis (Narula et al. 2013)) lipid rich pool along with a thin fibrous-cap (≤85 µm 
(Narula et al. 2013)) are particularly rupture prone. Being able to differentiate a rupture-
prone plaque from its stable counterpart could allow additional prophylactic treatment 
options for CHD patients (Wilensky 2013). For that reason, considerable resources have 
been invested toward methods capable of characterizing and stabilizing at-risk plaques. 
1.4.3.2 Current Treatment Practices 
It has been shown that pharmacotherapeutics, such as statins, can improve 
outcomes for patients suffering from CHD (Jain and Ridker 2005; Cannon et al. 2006) by 
both reducing cholesterol production and as anti-inflammatories. Unfortunately, acute 
events, such as thrombus formation due to a ruptured plaque, typically require an 
immediate and invasive response to both clear the thrombus and stabilize any plaques 
that may still pose a threat. This is referred to as percutaneous coronary intervention 
(PCI). While many advances in recent years, such as drug-eluting stents, have made PCI 
very effective at treating ruptured plaques, there still remains a need to better identify 
high-risk plaques for treatment (Sousa et al. 2005). In particular, it has been shown that 
plaque content (i.e. size and composition of plaque) is a valuable predictor of future 
coronary events (Hellings et al. 2010), suggesting that real-time molecular imaging 
would be a valuable tool for PCI procedures. Intravascular photoacoustic (IVPA) imaging 
is one of the modalities being investigated to address this need. 
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1.4.4 Intravascular Photoacoustic Imaging 
PCI procedures have benefitted from intravascular ultrasound (IVUS) imaging for 
decades, making the introduction of PA molecular imaging onto US imaging represent a 
natural extension of a clinically familiar imaging modality. Though some research has 
explored applying PA imaging to the problem of peripheral and carotid artery disease 
(Kruizinga et al. 2014), the vast majority of research has focused on the development of 
intravascular photoacoustic (IVPA) imaging of coronary arteries (VanderLaan et al. 
2014; Abran et al. 2014; Karpiouk, Wang, and Emelianov 2010). These studies have 
focused on exploring methods to characterize plaque content (Jansen, van der Steen, et al. 
2014; Jansen, Wu, et al. 2014; Wang et al. 2010; Wang et al. 2012b; Yeager et al. 2012; 
Yeager et al. 2014), as well as determine the extent of local inflammation (Wang et al. 
2009), both of which influence plaque vulnerability (Hellings et al. 2010; Libby 2002). 
Additionally, IVPA imaging has also been used to visualize coronary stent placement 
(Su, Wang, and Emelianov 2009), which, along with other factors such as vessel size, can 
predict long-term negative outcomes (Elezi et al. 1998). An IVPA system and catheter 
can be implemented with relative ease, with most designs opting to introduce a fiber optic 
(FO) cable for light delivery into an existing IVUS system, as shown in Figure 1.8 
(Karpiouk, Wang, and Emelianov 2010).  This approach uses the IVUS transducer and 
system for the detection and processing of PA signals and represents a minimalistic 
approach to introduce molecular imaging to PCI procedures. 
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Figure 1.8. Diagram of an integrated IVUS and IVPA imaging catheter (left) and 
schematic (right). Adapted with permission from (Karpiouk, Wang, and 
Emelianov 2010). 
1.4.4.1 Spectroscopic Photoacoustic Tissue Characterization  
The most useful addition of IVPA imaging comes allows for spectroscopic 
intravascular photoacoustic (sIVPA) imaging for tissue characterization. sIVPA imaging 
provides molecular information to complement the structural information gathered from 
IVUS imaging (MacNeill et al. 2003). While the optical absorption of lipid is relatively 
low in the wavelength range of 700 – 1000 nm, absorption tends to increase with 
increasing wavelength (Bashkatov et al. 2005a), as is also the case with water (Hale and 
Querry 1973). However, there are two wavelength regions in the NIR where the optical 
absorption of lipid peaks relative to water (Hale and Querry 1973; Bashkatov et al. 
2005a): 1210 and 1720 nm. These wavelengths represent spectral regions where good 
contrast between lipid- and water-based tissues is expected (VanderLaan et al. 2014; 
Jansen, Wu, et al. 2014). Figure 1.9 highlights the potential of combined IVPA/IVUS 
imaging at these wavelengths. 
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Figure 1.9. Combined IVPA + IVUS images of cholesterol and lipid phantom at 1210 
(A), 1235 (B), 1710 (D) and 1680 nm (E). 1235 and 1680 nm represent poor 
lipid-water contrast and were used to generate lipid maps (C and F) using a 
difference method. Adapted with permission from (Jansen, Wu, et al. 2014). 
The contrast between water and lipid is greatest at 1720 nm, but the overall tissue 
optical absorption is approximately 10x greater at 1720 nm than at 800 nm (the center of 
the optical window), making depth penetration a concern (Roggan et al. 1999). 
Furthermore, high-energy, high repetition-rate, pulsed laser sources operating in the 1720 
nm range are limited. Still, research has shown the potential of IVPA imaging at 1720 nm 
and 1210 nm, visualizing plaque-laden arteries through luminal blood, both in vivo and 
ex vivo, using an atherosclerotic animal model (Wang et al. 2012a; Wang et al. 2012b). 
Depth penetration is less of a concern for PA imaging at 1210 nm, and more laser 
sources exist at this wavelength. For this reason, 1210 nm IVPA imaging is also under 
investigation and has shown promise in identifying cholesterol and lipid inclusions in an 
imaging phantom (Jansen, Wu, et al. 2014). Building upon these results, imaging systems 
are currently being developed to provide combined IVUS/IVPA imaging of 
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atherosclerotic plaque in real-time for translation into clinical environments (VanderLaan 
et al. 2014). While these two wavelength bands represent promising wavelength regimes 
for sIVPA imaging, studies have yet to conclusively determine which wavelengths are 
optimal in terms of balancing contrast, imaging depth and sensitivity to atherosclerotic 
disease state (i.e. being able differentiate high-risk, lipid rich plaques from smaller, stable 
plaques). 
1.4.4.2 Thermal Intravascular Photoacoustic Imaging 
As discussed above the mechanism of PA signal generation is temperature 
dependent (Tam 1986). Tissue characterization using Grüneisen thermal dependence is 
possible and has been demonstrated using thermal intravascular photoacoustic (tIVPA) 
imaging (Wang and Emelianov 2011). By modulating the temperature (17.5 ℃ ≤ 𝑇 ≤
38 ℃) while performing IVPA imaging at 1210 nm, lipid deposits in an ex vivo 
atherosclerotic animal model were characterized and differentiated from the nearby 
water-based tissue components (Wang and Emelianov 2011). Furthermore, results 
indicate that the Grüneisen thermal-response of lipid-rich plaques differs from that of 
periadventitial- and abdominal-fat, despite spectroscopic imaging struggling to 
differentiate the lipid types (Wang and Emelianov 2011). While tIVPA imaging may be a 
valuable tool to characterize atherosclerotic tissue, questions still remain as to the 
sensitivity and specificity of this technique. 
1.4.4.3 Modeling of Light Transport for Photoacoustic Imaging 
Despite the initial promise presented by both sIVPA and tIVPA imaging, there 
remain several questions which must be addressed before a full clinical system can be 
developed. Due to various limitations an exhaustive exploration of both the optical 
parameter space, as well as various different pathological states, to optimize IVPA 
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imaging has yet to be done. IVPA imaging typically needs a high-energy (≥1 mJ), short-
duration (<10 ns) laser pulse to generate a sufficiently strong PA signal that can be 
reliably detected. Furthermore, as a medical imaging modality, real-time capabilities (~ 
25 frames per second, >3200 Hz laser-pulse repetition rate) are necessary to have a 
significant impact in the clinical space. Currently there are few, if any, tunable-laser 
sources that meet the above requirements. For that reason, there remains a need to 
optimize IVPA imaging methods before clinical translation can proceed. The advent of a 
means to offer quantified assessment of this problem space would be a boon. Optical 
transport simulation techniques, such as Monte Carlo (MC) modeling, may be able to 
address this need without necessity for costly equipment and lengthy experimentation. 
MC optical modeling has been around since the 1980’s (Wilson and Adam 1983), 
but only in recent years, as computational power has increased, has it become a practical 
method to explore a large parameter space. Studies have shown that MC optical modeling 
tends to produce more accurate results than analytical methods (Flock et al. 1989), which 
rely on simplifying assumptions to generate a solution to the RTE (Wang and Wu 2007). 
Due to the versatility and the reliability of MC optical modeling, considerable research 
has gone into developing MC optical modeling tools. MC software tools have been 
developed for 2D simulation of layered tissues (e.g. skin) (Wang, Jacques, and Zheng 
1995), up to 3D simulations of arbitrary heterogeneous volumes (Jacques 2014). 
Additional models have been developed that account for differences in refractive index 
across tissue-types (Fang and Boas 2009). In terms of improving efficiency, models have 
been adapted to reconstruct the tissue as a surface mesh (Fang 2010), as well as a means 
to parallelize MC simulations on GPUs (Fang and Boas 2009; Fang 2010). The 
availability of reliable MC optical modeling tools makes this method promising as a 
means of simulating IVPA imaging results for different wavelengths and tissue 
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geometries in order to optimize imaging parameters and guide the development of a 
clinically translatable IVPA imaging system. 
1.5 OVERVIEW OF RESEARCH GOALS 
The overall goal of the research contained herein is to facilitate the clinical 
translation of PA imaging as it pertains to cardiovascular applications. To pare down such 
a broad goal, the research thrusts are sub-divided into two application spaces: image 
guidance for treatment of arrhythmia and image guidance for treatment of coronary heart 
disease. While these two research pursuits are diverse in the application space, they are 
unified in that they often rely upon the same fundamental techniques (e.g. spectroscopic 
PA imaging) to improve PA image guidance. Additionally, some of the tools discussed 
herein (e.g. MC optical modeling), once developed, can be readily applied to a variety of 
PA imaging applications in the cardiovascular realm and beyond. In that regard the two 
parallel research interests support the comprehensive goal of developing PA imaging 
methods for tissue characterization and image guidance in cardiovascular applications.  
1.5.1 Image Guidance of Arrhythmia Treatment Goals 
The research herein aims to address two applications of PA imaging with respect 
to image guidance for cardiac arrhythmia applications. The first research discussed in this 
dissertation examines a preliminary PA method to monitor cardiac depolarization. 
Additionally, also explored is a spectroscopic PA imaging method designed to 
characterize ablation lesions in myocardium as a potential means of image guidance for 
ablation procedures. 
1.5.1.1 Visualization of Myocyte Depolarization and Cardiac Electric Potential 
Ca exchange is fundamental to cardiac EP function and is responsible for electro-
mechanical coupling in cardiac myocytes. Additionally, the cytosolic Ca concentration 
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changes by several orders of magnitude during the cardiac cycle. For these reasons, Ca is 
a promising imaging target. As a first step toward PA-based monitoring of myocardial EP 
function, this research explores proof-of-concept PA tracking of myocyte cytosolic Ca 
fluctuations. An appropriate Ca-sensitive PA contrast agent could serve as a probe for 
monitoring Ca levels in the cytosol. Arsenazo III (Asz) is dye which exhibits a shift in 
absorption spectrum as a result of binding Ca ions. Initial investigations using Asz as a 
PA contrast agent for active cardiac myocytes were done with an experimental PA 
microscopy setup, with results discussed in Chapter 2. 
1.5.1.2 Toward Tissue Characterization of Cardiac Ablation Lesions 
PA imaging also has potential to characterize cardiac tissue during the ablation 
process, in order to provide online feedback to physicians for TCA guidance. The process 
of TCA RF-ablation involves targeted hyperthermia at a particular tissue locus. The 
hyperthermia results in a combination of protein denaturation and membrane disruption 
(Thomsen, Jacques, and Flock 1990; Thomsen 1991) that often trigger cellular apoptotic 
and necrotic pathways that eventually heal by replacing damaged myocardium with non-
conductive scar tissue. If PA imaging is going to have a lasting impact as an image 
guidance modality, it must be able to accurately monitor this process and provide 
meaningful information to the physician while ablation is underway. The research herein 
explores a spectroscopic method to improve the sensitivity, specificity and depth at which 
cardiac tissue can be accurately characterized as ablated or non-ablated. By examining 
multiple wavelengths to characterize tissue, such a method can help overcome the 
changes in the fluence distribution that result from tissue hyperthermia. Results from ex 
vivo studies, along with a discussion of translating results to in vivo studies, are presented 
in Chapter 3. 
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1.5.2 Image Guidance of Coronary Heart Disease 
As discussed above, IVPA imaging has undergone several studies to explore its 
ability to visualize atherosclerotic plaques (Wang and Emelianov 2011; Wang et al. 
2012a; Wang et al. 2012b; Jansen, van der Steen, et al. 2014; Jansen, Wu, et al. 2014), 
implantable stents (Su, Wang, and Emelianov 2009) and exogenous contrast agents 
(Yeager et al. 2012; Yeager et al. 2014). While the various studies have effectively 
demonstrated the potential for IVPA imaging to visualize plaques, there has yet to be a 
comprehensive examination across the NIR spectrum to determine optimal NIR 
wavelengths for maximizing imaging depth and assessing plaque content and burden, in 
order to determine which plaques require intervention. Research discussed herein aims to 
provide an examination of those parameters in order to guide translation of IVPA 
imaging into the clinical realm. 
1.5.2.1 Model-based Optimization of Intravascular Photoacoustic Imaging 
In an ideal situation an exhaustive examination of PA results would be obtained 
from conducting PA imaging studies on various tissue and plaque geometries, at many 
wavelengths throughout the NIR spectrum, followed up with histopathological 
examination of all tissue samples to confirm PA imaging results. Unfortunately, due to 
various limitations on time, expense and the availability of equipment and tissue samples, 
such an approach is beyond realization. As an alternative, research in this dissertation 
attempts to replicate those findings through MC simulation of optical transport and the 
resulting PA signal generation for a variety of tissue types, across many wavelengths in 
the NIR regime. In this way, this research approximates the extensive studies discussed 
above, with the intent to optimize IVPA imaging for translational studies. These results 
are discussed in Chapter 4. 
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1.5.3 Summary of Research Goals 
While the studies discussed herein address different applications of PA imaging, 
they are united in that they attempt to advance PA imaging for cardiovascular 
applications, facilitating translation into the clinical realm. This is done initially by 
exploring the potential of PA image guidance for cardiac arrhythmia procedures. The 
exploration of proof-of-concept PA sensing of Ca dynamics aims to determine, as a first 
step, if PA techniques can monitor myocyte EP activity. As TCA treatment often follows 
the initial arrhythmia diagnosis, the next set of PA studies discussed explores a multi-
wavelength method to characterize TCA lesions in ex vivo myocardial samples, with the 
goal of developing a reliable PA protocol for image guidance during cardiac ablation 
procedures. The last study discussed in this dissertation is a thorough exploration of 
IVPA imaging by simulating light propagation and PA imaging results from an IVPA 
system, across a broad spectral range in the NIR. The results of this comprehensive 
simulation can then be used to guide the development of an optimized IVPA system for 
clinical translation. This dissertation concludes in the final chapter by summarizing 
results, particularly as they pertain to PA applications in cardiovascular imaging as a 
whole. This includes a discussion of the limitations of the presented results, as well as 
future studies that capitalize on results presented and a vision of the future of 
cardiovascular PA imaging as a whole. 
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Chapter 2: In Vitro Photoacoustic Sensing Of Calcium Dynamics With 
Arsenazo III2 
2.1 ABSTRACT 
Imaging of cellular electric potential via calcium-ion sensitive contrast agents is a 
useful tool, but currently it lacks sufficient depth penetration. We explore contrast-
enhanced photoacoustic (PA) imaging, using Arsenazo III dye, to visualize cardiac 
myocyte depolarization in vitro. Phantom results show strong linearity of PA signal with 
dye concentration (R2 > 0.95), and agree spectrally with extinction measurements with 
varying calcium concentration. Cell studies indicate a significant (> 100-fold) increase in 
PA signal for dye-treated cells, as well as a 10-fold increase in peak-to-peak variation 
during a 30-second window. This suggests contrast-enhanced PA imaging may have 
sufficient sensitivity and specificity for depth-resolved visualization of tissue 
depolarization in real-time. 
2.2 INTRODUCTION 
2.2.1 Calcium function 
Calcium-ion (Ca) exchange mediates a wide range of mammalian cellular 
functions, such as muscle contraction, cell signaling, cell secretion, glycolysis, cell 
division and growth (Berridge, Lipp, and Bootman 2000). In neuronal and cardiac cells, 
Ca exchange is essential for electrophysiological activity (Catterall and Few 2008), as 
well as being responsible for mammalian myocyte inter-cell electro-mechanical coupling. 
During cardiac myocyte depolarization, cytosolic Ca concentration has been shown to 
rapidly increase by a factor of 10 or greater (Bers 2002). Cardiomyocytes can sustain 
                                                 
2 This chapter is adapted in part from a manuscript titled 'In vitro photoacoustic sensing of calcium 
dynamics with arsenazo III' (Dana, Fowler, Allen, Zoldan, Suggs and Emelianov 2016). Nicholas Dana is 
the primary author of this manuscript. 
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these high concentrations for hundreds of milliseconds (Bers 2002). As such, 
visualization of Ca2+ exchange is a useful tool in the study of cardiac physiology, for 
evaluating cellular dysfunction, and in assessing the efficacy of medical interventions. 
2.2.2 Optical imaging of Ca and current limitations 
Optical imaging – one of the most common methods utilized to assess Ca 
transport – offers high spatio-temporal resolution and a large palette of Ca-sensitive 
fluorescent dyes (Herron, Lee, and Jalife 2012), though it is not without drawbacks. This 
method may require clearance of blood from tissue, and often can only be performed ex 
vivo (Herron, Lee, and Jalife 2012; Sutherland and Hearse 2000). Additionally, due to the 
reliance on fluorescent emission, observation of electrical activity is often limited to the 
tissue surface (Herron, Lee, and Jalife 2012). Such methods are unable to capture the full 
three-dimensional (3D) nature of tissue electrical propagation, which is known to play a 
role in cardiac arrhythmia disorders (Winfree 1994). The availability of an imaging 
technique that can visualize electrical propagation throughout a 3D tissue, with high 
spatio-temporal resolution and high penetration depth, could offer improved insight into 
electrophysiological dysfunction and the mechanisms of medical interventions. 
2.2.3 Arsenazo III dye 
Arsenazo III (Asz) is a Ca chelating dye (Rowatt and Williams 1989), which also 
exhibits a shift in absorbance dependent upon both dye concentration and pH (Palade and 
Vergara 1983). In the presence of dissolved Ca, Asz exhibits absorption peaks at 600 nm 
and 655 nm, the prominence of which depends on the ratio of Ca to Asz (Figure 2.1). At 
575 nm, Asz shows minor variation (< 10%) in absorbance relative to Ca concentration, 
indicating 575 nm can be considered an isosbestic point. Asz has been suggested as a PA 
contrast agent for observation of Ca concentration changes (Cooley et al. 2010), but PA 
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imaging results have yet to be obtained using electrophysiologically active cells or 
tissues. 
 
   
Figure 2.1. Optical extinction of 50 µM Asz dye in buffered saline with varied calcium 
ion concentration. 
2.2.4 Review of photoacoustic imaging  
Photoacoustic (PA) imaging relies on optical excitation of endogengous or 
exogenous chromophores, followed by an ultrasonic detection of the resulting acoustic 
wave (Beard 2011). Specifically, PA signal is generated by chromophores in the tissue 
which absorb photons emitted by a pulsed light source. When the pulse duration of the 
light source is sufficiently short, the absorbed energy results in rapid thermoelastic 
expansion of the chromophore, which generates an acoustic wave that can be detected 
using traditional ultrasonic systems (Beard 2011). As such, local PA signal (𝑝0) is 
proportional to the absorbed energy, which is a product of local optical absorption (𝜇𝑎) 
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and local fluence (F), both of which are a function of wavelength (𝜆). PA signal is also 
proportional to the tissue thermal properties, known as the Grüneisen parameter (Γ) – a 
function of temperature (T). Combined they result in the photoacoustic equation 
(Equation 1, shown below: 
 𝑝0(𝑟, 𝜆, 𝑇) ∝ Γ(𝑇)𝜇𝑎(𝑟, 𝜆)𝐹(𝑟, 𝜆) Equation 1 
The reliance of PA methods on optical absorption make it well suited to monitor 
absorption-based contrast. For that reason, we investigated PA imaging using Arsenazo 
III (Asz), a Ca sensitive dye (Rowatt and Williams 1989), to determine the potential for 
PA based visualization of cytosolic Ca concentration changes resulting from cellular 
depolarization. 
2.3 MATERIALS AND METHODS 
2.3.1 Arsenazo III Dye Preparation 
Asz dye (Sigma-Aldrich Inc., St. Louis, MO, USA) was dissolved in stock 
HEPES buffered normal saline (Sigma-Aldrich Inc., St. Louis, MO, USA). Asz solutions 
were titrated with NaOH and HCl to a pH of 7.4. Ca solution was obtained by dissolving 
CaCl2 (Sigma-Aldrich Inc., St. Louis, MO, USA) into the stock buffered saline solution. 
Ca solution was then added to Asz solution, in varying amounts, to generate different Ca 
to Asz ratios for extinction measurements and for later PA measurements. Optical 
extinction measurements were made using a spectrophotometer (UV-3600, Shimadzu 
Corp., Kyoto, Japan). 
2.3.2 Phantom Imaging Studies 
Initial studies were conducted on phantom imaging targets containing buffered 
Asz-Ca solutions to examine PA signal response with respect to varying Asz and Ca 
concentrations. Asz solution was enclosed in a glass Pasteur pipette and submerged into 
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degassed water.  A 1.5 MHz immersion ultrasound transducer (E1259, Valpey-Fisher, 
Inc., Hopkinton, MA, USA, 1.5-inch diameter, 1.7-inch spherical focus) was used to 
receive acoustic signal. The PA signals acquired by the transducer were amplified by an 
ultrasound pulser/receiver amplifier (5073PR, Olympus NDT Inc., Waltham, MA, USA, 
gain of 39 dB) in receive mode and digitized using an oscilloscope (CompuScope 12400, 
Gage Applied Technologies Inc., Lockport, IL, USA) operating at 200 MHz sampling 
frequency. PA laser excitation was provided by a Q-switched pulsed Nd:YAG laser 
(Quanta-Ray PRO-290, Spectra-Physics Lasers, Mountain View, CA, USA) pumping a 
tunable optical parametric oscillator (Spectra-Physics premiScan/MB, GWU-
Lasertechnik Vertriebsges, Germany) to select the wavelength. The laser pulse-duration 
was 5-7 ns, with a pulse repetition rate of 10 Hz and energy varied from approximately 
10 mJ – 20 mJ per pulse for the wavelengths used. Samples were irradiated at the 
approximate isosbestic point (575 nm) and at the two Ca dependent absorption peaks 
(600 nm and 655 nm).  Laser spot size was approximately one cm diameter and light was 
delivered via air beam. Approximately 5% of laser light energy was redirected and 
measured with a pyroelectric power meter (Nova II, Ophir Ltd., Jerusalem, Israel) to 
account for pulse-to-pulse and wavelength dependent energy variation. LabVIEW 
software (National Instruments, Inc., Austin, TX, USA) was used to integrate 
components and control data acquisition. This configuration allowed for consistent 
optical illumination and energy normalization. A diagram of the imaging setup is 




Figure 2.2. Diagram of phantom imaging setup with air-beam laser irradiation and 
immersion transducer (a). Modified cell-study setup with focused laser and  
hydrophone (b). 
Multiple samples were made by varying Asz dye concentration from 0 µM to 500 
µM, as well as using a 500 µM Asz solution and varying the molar ratio of Ca to Asz 
from 0 to 4. The Asz molar concentration used for PA experiments was 10-fold higher 
than that used in the UV-Vis extinction curves to achieve a high PA signal.  Each sample 
was injected into the Pasteur pipette and measurements of PA signal amplitude (RF-line) 
were taken using the system described above, with 300 averages per sample. 
2.3.3 HL-1 Culture 
HL-1 cardiac myocytes (provided by Dr. William Claycomb, Lousiana State 
University Health Science Center, New Orleans, LA, USA), which are phenotypically 
similar to mature cardiomyocytes and exhibit spontaneous depolarization (Claycomb et 
al. 1998), were used as an in vitro cellular imaging target. HL-1 cell passages 60-80 were 
maintained in Claycomb medium (Sigma-Aldrich Inc., St. Louis, MO, USA) with 10% 
fetal bovine serum (Sigma-Aldrich Inc., St. Louis, MO, USA, Lot# 12J001), 1% 
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Penicillin/Streptomycin (Invitrogen), 1% Glutamax (Invitrogen), and 0.1 mM 
Norepinephrine (Sigma-Aldrich Inc., St. Louis, MO, USA). Cells were subcultured (1:3) 
every 4 days (Geuss et al. 2015). Twelve hours before imaging, HL-1 cells were seeded 
at 80,000 cells/cm2 in Nunc™ Lab-Tek™ II CC2™ two chamber slides (Thermo Fisher 
Scientific, Inc., Waltham, MA, USA). Just prior to imaging, cells were rinsed three times 
and incubated for 20 minutes in Tyrode’s solution (Cold Spring Harbor) containing 100 
µM Norepinephrine, 200 µM Asz and 10 µM DMSO (Sigma-Aldrich Inc., St. Louis, 
MO, USA, to improve cellular uptake of Asz). Cells were then thrice rinsed with 
Tyrode’s solution containing Norepinephrine and immediately imaged using either 
optical or photoacoustic imaging.  
2.3.4 Optical and Fluorescent live-cell imaging 
In order to optically verify cellular uptake of Asz and observe Asz 
binding/unbinding of cytosolic Ca, HL-1 cells were treated with Asz and imaged using 
bright field microscopy (EVOS FL, Thermo Fisher Scientific Inc., Waltham, MA, USA) 
with a rhodamine cube filter (AMEP4652, Thermo Fisher Scientific Inc., Waltham, MA, 
USA, emission 593 nm /40 nm FWHM). This setup was able to observe changes in the 
transmitted light intensity as cytosolic Asz chelates Ca during cellular depolarization 
(Video S1). Additionally, to independently verify HL-1 myocyte cytosolic Ca dynamics, 
cells were incubated with a fluo-4 AM calcium assay kit, (F36206, Thermo Fisher 
Scientific Inc., Waltham, MA, USA) per the manufacturer’s instructions, and imaged 
with fluorescent microscopy using a green fluorescent protein (GFP) cube filter 
(AMEP4651, Thermo Fisher Scientific Inc., Waltham, MA, USA, emission 525 nm /50 
nm FWHM) to verify cellular depolarization (Video S2). 
 59 
To assess Asz cytoxicity, HL-1 cells were treated with Asz and rinsed, as 
described above, and immediately incubated using a LIVE/DEAD® cell viability assay 
kit (L3224, Thermo Fisher Scientific Inc., Waltham, MA, USA) containing calcein-AM 
and ethidium homodimer-1 (EthD). Cells were incubated for 20 minutes in PBS with 1 
µM green-fluorescent calcein-AM to indicate intracellular esterase activity and 2 µM red-
fluorescent EthD to indicate a compromised plasma membrane. For comparison, one 
plate of cells was incubated in PBS with 10 µM DMSO prior to staining with the viability 
assay kit, as a live control, and an additional plate was incubated in PBS with 70% 
ethanol (EtOH). Cells were then imaged with fluorescent microscopy using GFP and 
rhodamine cube filters to visualize calcein-AM and EthD, respectively. Fluorescent 
images are shown in Figure 2.5. 
2.3.5 Photoacoustic Microscopy 
PA signal acquisition for cell studies used a photoacoustic microscopy (PAM) 
system described previously (Cook, Frey, and Emelianov 2013), with a few 
modifications. The needle hydrophone (Precision Acoustics LTD, Dorchester, UK) was 
inserted into the slide chamber and positioned just offset from the laser light path, to 
avoid generation of a PA signal within the hydrophone itself. Hydrophone signals were 
amplified using an RF amplifier (2100L, Electronics & Innovation, Inc., Rochester, NY, 
USA, gain of 50 dB). Laser light was directed into the imaging chamber using mirrors 
and iris apertures, and focused to a spot size of roughly 40 µm by 50 µm (fluence 
estimated to be 4 kJ/cm2). Spot size was measured optically at the slide plane using a 
USAF 1951 positive resolution target (DA009, Max Levy Autograph, Inc., Philadelphia, 
PA, USA). Figure 2.2.b shows a diagram of the slide chamber, hydrophone and focused 
laser. 
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PAM measurements of cells (with and without Asz treatment) were taken in 
several positions on multiple slides. Once signal at a given position was observed on an 
oscilloscope, 300 RF-lines were acquired at 10 Hz. RF-lines were bandpass filtered (0.5 
MHz/5 MHz) and normalized to fluence using Matlab software (MathWorks, Inc., 
Natick, MA, USA).  
By observing PA signal over a retarded-time 30 second window, we can compare 
Asz treated and control non-Asz treated cells on time scales that correspond to several 
depolarization-repolarization cycles. PAM retarded-time data was generated by selecting 
the region of each RF-line corresponding to the location of the cells. The peak amplitude 
was sampled from this region for each RF-line and used to construct a 30 second 
retarded-time signal. This signal was then low-pass filtered at 2 Hz to reduce high-
frequency noise while maintaining the signal from cardiac cells, which is expected to be 
near 1 Hz or below. For Asz treated cells, retarded-time amplitude fluctuations should be 
proportional to cytosolic Ca concentration. Measurements of retarded-time peak-to-peak 
values were taken (indicated by the black arrow in Figure 2.6.b) and analyzed from five 
Asz-treated cell studies and five control cell studies. 
2.4 RESULTS 
2.4.1 Photoacoustic phantom imaging results 
PA phantom results showed linear agreement between PA signal and Asz 
concentration, as shown in Figure 2.3.a. The coefficient of determination (R2) was 0.99, 
0.98 and 0.90 for 575 nm, 600 nm and 655 nm, respectively, with an average R2 = 0.954.  
PA phantom spectra with varying Ca to Asz ratio also show general agreement 
with both extinction data using 50 µM Asz, as well as previous results reported by 
Rowatt and Williams (Rowatt and Williams 1989). Both data indicate that at a molar 
 61 
ratio of Ca to Asz equal to one, we expect to see a plateau in the optical extinction at 600 
nm, which is reflected in Figure 2.3.b. Data also indicate that extinction at 575 nm should 
remain generally constant, which is indicated in Figure 2.3.b. Data at 655 nm indicate 
that extinction should continually increase with increasing Ca to Asz ratio up four, but 




Figure 2.3. PA signal versus Asz concentration with linear fit (dashed line) to PA data 
(a). with R2 values of 0.99, 0.98 and 0.90 for 575 nm, 600 nm and 655 nm, 
respectively. PA signal from 500 µM Asz dye with varying Ca:Asz ratio (b).  
Different colors-markers represent results using 575 nm (blue-circle), 600 
nm (red-x) and 655 nm (yellow-diamond) laser light.  
2.4.2 Optical imaging results 
Cells incubated with the fluo-4 AM and imaged with fluorescence microscopy 
showed obvious variation in fluorescence emission across time-lapse images (Video S2). 
This result verified cellular depolarization and cytosolic Ca variation. 
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Similarly, cells treated with Asz and imaged using bright field microscopy with a 
rhodamine filter also showed fluctuation in time-lapse series of images (Figure 2.4, Video 
S1). While these optical changes were less obvious than those observed using fluo-4, 
these images served as verification that Asz was being successfully incorporated into HL-
1 cardiac myocyte cytosol and was responding to dynamic Ca concentration changes. 
 
 
Figure 2.4. Bright field microscopy images, using a red-fluorescent filter, of HL-1 cardiac 
myocytes incubated with Asz. Images (a) and (b) are part of a time-lapse 
series, ∆t = 10 seconds. 
2.4.3 Cell viability study 
Cell viability images indicate that, following 20 minute Asz treatment, most cells 
exhibit esterase activity and indicate intact plasma membranes (Figure 2.5, Asz row), 
suggesting most cells are alive immediately following Asz treatment. Though, when 
compared to live-control images (Figure 2.5, PBS row), viability results suggest that Asz 
treatment does decrease cell viability, as indicated by the increased EthD stained cells 




Figure 2.5. Fluorescence microscopy images following cell viability assay for Asz-treated 
cells (Asz), PBS treated live-control cells (PBS) and Ethanol treated dead-
control cells (PBS + EtOH). Green channel (column a) indicates calcein-AM 
fluorescence (i.e. estera esterase activity/live cells), red channel (column b) 
indicates DNA-bound EthD fluorescence (i.e. disrupted plasma 
membrane/dead cells), with overlaid images (column c) for comparison. 
Micrograph bar indicates 200 µm scale. 
2.4.4 Photoacoustic sensing of dynamic calcium concentration 
PA RF-line data collected from Asz treated cells and control non-treated cells 
were compared with respect to their peak PA amplitudes (n = 5, each). RF-line data from 
Asz treated cells showed, on average, > 100-fold increase in peak RF-line amplitude as 
compared to control cells (Figure 2.6.a). 
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Retarded-time PA data (Figure 2.6.b) underwent peak-to-peak analysis, indicated 
by the black arrow in Figure 2.6.b. Data were compared between Asz treated cells and 
non-Asz treated cells. For retarded-time data, Asz incubated cells showed, on average, a 




Figure 2.6. PA RF-line of Asz-treated cells and control cells (a). Retarded-time signal of 
Asz-treated cells and control cells (b). Arrow indicates example of peak-to-
peak measurement. 
2.5 DISCUSSION 
2.5.1 Linearity of phantom-study photoacoustic signal with respect to Arsenazo 
concentration 
PA signal observed during phantom studies showed a strong linear relationship to 
Asz concentration at 575 nm and 600 nm (R2 = 0.99 and 0.98, respectively), as expected, 
though PA data at 655 nm did not exhibit as strong a linear relationship to Asz 
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concentration (R2 = 0.90). This is likely due to low optical absorption of Asz (w/o Ca) at 
655 nm, which would reduce signal-to-noise ratio (SNR). 
Optical extinction of Asz dye is known to have non-linear absorption based on 
dye concentration (Palade and Vergara 1983), in addition to those absorption changes 
dependent on pH and cation concentration. As such, quantitative comparisons between 
PA measurements from phantom studies and UV-Vis molar extinction coefficients could 
not be made. Nonetheless, the PA data did show increased signal with increasing Ca to 
Asz ratio at 600 nm and 655 nm and flat signal at 575 nm (Figure 2.3.b), which 
qualitatively agrees with UV-Vis data in Figure 2.1. PA signal at 600 nm exhibited an 
inflection point near a Ca to Asz ratio of one (Figure 2.3.b), which agrees with both UV-
Vis data (Figure 2.1) and results from Rowatt, et al. (Rowatt and Williams 1989). At 
higher (≥ 2) Ca to Asz ratios, UV-Vis data (50 µM Asz concentration) indicates 
absorption should be greater at 600 nm than at 575 nm, but this was not observed in PA 
phantom measurements (500 µM Asz concentration). Furthermore, as mentioned above, 
the PA signal at 655 nm did not increase as much as UV-Vis data would predict for 
higher Ca to Asz ratios. These results are likely attributable to the higher (10-fold) Asz 
concentrations used in PA experiments. At these higher concentrations, the non-linear 
absorption of Asz may become significant. Previous work by Palade, et al, showed that 
molar extinction, at a given wavelength, differed by approximately a factor of two when 
comparing Asz samples whose concentrations varied by a factor of 100 (Palade and 
Vergara 1983).  This could account for observed discrepancies between the extinction 
data and PA phantom results. Unfortunately, initial PA phantom results using matching 
50 µM Asz concentration showed poor SNR. To achieve the same SNR using a 10-fold 
dilute solution, at least 100-fold more averages would be needed, at which point dye 
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photo-bleaching and photo-chemical reactions may impact results. For that reason, a 
higher Asz concentration was used in PA phantom imaging studies. 
2.5.2 Optical verification of HL-1 depolarization 
HL-1 cells stained with both fluo-4, AM (Video S2) and Asz (Figure 2.4, Video 
S1) showed variations in light intensity as observed using fluorescent and bright field 
microscopy, respectively. While the quality of the images in Figure 2.4 is low, due to 
both low light intensity and low contrast, it does indicate that Asz was present in cells 
and responding to cytosolic Ca concentration. HL-1 cells observed with fluo-4 generally 
showed poor electrical coupling with their neighbors, which has been observed 
previously (Geuss et al. 2015). As such, electrical synchronization occurred only on the 
order of a few cells, at most, which corresponds to a circular region of roughly 40 µm 
diameter. The PAM system, utilizing highly focused optical excitation (roughly 40 µm 
diameter spot size), was able to overcome the issues associated with highly localized 
depolarization, albeit at the cost of lower SNR. 
2.5.3 Photoacoustic sensing of calcium transients proof-of-concept 
Asz treated cells showed a significant increase over control cells in their 
maximum RF-line amplitude (Figure 2.6.a), as well as a 10-fold increase in the peak-to-
peak values in the retarded-time traces (Figure 2.6.b), suggesting the PAM studies using 
Asz dye were successful in observing absorption changes resulting from Asz 
binding/unbinding dynamic cytosolic Ca. It should be noted that peak-to-peak analysis 
was done without any peak-threshold criteria (i.e. minimum increase over the 
neighboring values). When any peak-threshold criteria was used, very few “peaks” were 
observed in control retarded-time data, though data from Asz treated cells still 
demonstrated multiple peaks in all samples. This suggests this technique may have 
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sufficient sensitivity for PA imaging of dynamic Ca concentration to visualize ion 
changes in vivo, once properly adapted.  
Because PA signal generation results from absorbed light, it is not limited by 
ballistic-photon propagation, as other optical techniques are. This technique could 
potentially allow 3D reconstruction of cellular depolarization at moderate (~ 1 cm) tissue 
depths. It also has the ability to monitor depolarization in real-time, as was demonstrated 
herein. 
2.6 CONCLUSION 
These results demonstrate proof-of-concept for contrast-enhanced PA imaging to 
monitor ion-concentration changes resulting from cellular depolarization. While these 
initial results are promising, work remains to develop non-toxic, NIR-absorbing, ion-
sensitive contrast agents.  Ideal agents would exhibit a strong absorption shift in the NIR 
(preferably at 1064 nm) upon ion binding, and have minimal cytotoxicity. This would 
also allow translation of contrast-enhanced PA monitoring of dynamic ion concentration 
to animal models, where electric and ionic coupling will be present up to the organ level. 
Such studies would allow quantitative comparison of PA data to ECG/EMG 
measurements, and further assess the potential of this technique to spatiotemporally 
resolve 3D tissue depolarization. 
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Chapter 3: In Vitro Photoacoustic Characterization Of Radiofrequency 
Cardiac Ablation Lesions3 
3.1 ABSTRACT 
Radiofrequency (RF) ablation to treat atrial arrhythmia is limited by an inability 
to reliably assess lesion durability and transmurality. In this study, we investigate the 
feasibility of combined ultrasound (US) and spectroscopic photoacoustic (sPA) imaging 
to visualize RF ablation lesions in 3-D based on unique differences in the optical 
absorption spectra between normal and ablated myocardial tissue. We aim to determine 
feasibility of photoacoustic characterization of myocardial ablation lesions in vitro. 
Tissue samples were excised from the ventricles of fresh porcine hearts. Lesions were 
generated using an RF catheter ablation system using 20 - 30 W of power applied for 40 - 
60 s. Ablated samples were imaged in the NIR regime (740-780 nm) using a combined 
PA/US imaging system. Measured PA spectra were correlated to the absorption spectra 
of deoxy-hemoglobin and ablated tissue to produce a tissue characterization map (TCM) 
identifying 3-D lesion location and extent. Tissue samples were stained and photographed 
for gross pathology. TCM and gross pathology images were co-registered to assess TCM 
accuracy. The TCM reliably characterized ablated and non-ablated tissue up to depths of 
3 mm. The TCM also assessed lesion position and extent with sub-millimeter accuracy in 
multiple dimensions. Segmented TCMs achieved greater than 69% agreement with gross 
pathology. These results suggest that sPA imaging has the potential to accurately assess 
RF ablation lesion size and position with sub-millimeter precision and may be well suited 
to guide trans-catheter RF atrial ablation in clinical practice. 
                                                 
3 This chapter is adapted in part from a manuscript titled 'In vitro photoacoustic visualization of myocardial 
ablation lesions', (Dana, Di Biase, Natale, Emelianov and Bouchard, 2014). Nicholas Dana is the primary 
author of this manuscript. 
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3.2 INTRODUCTION 
3.2.1 Atrial Fibrillation 
Atrial fibrillation (AF) is currently the most common arrhythmia encountered in 
clinical practice, with estimates as high as 6.1 million sufferers in 2010 in the United 
States alone (Roger et al. 2012; Miyasaka et al. 2006). AF has been implicated in an 
increased risk of stroke, dementia, heart failure and an excess mortality rate (Roger et al. 
2012; Wolf, Abbott, and Kannel 1991; Wolf et al. 1998; Benjamin et al. 1998). Anti-
arrhythmic drugs are burdened with significant side effects, toxicity and poor capability 
to maintain NSR and thus are not the ideal treatment option for AF patients (Shah 2011; 
Cappato et al. 2010; Santangeli et al. 2011). Radio-frequency (RF) trans-catheter ablation 
is currently the most effective treatment for AF (Shah 2011) as it can isolate the firing of 
ectopic foci, typically located around the pulmonary veins (Haissaguerre et al. 1998; 
Pappone et al. 2000). Unfortunately, RF ablation lesions can vary considerably with 
catheter contact force, orientation, size and RF energy parameters (Shah 2011; 
Rosenbaum et al. 1994; Petersen, Chen, Pietersen, Svendsen, and Haunso 1999; Petersen, 
Chen, Pietersen, Svendsen, and Haunsø 1999). Lesion “reconnection” and “recovery” has 
been a major cause for procedural failure and can necessitate repeat procedures (Shah 
2011; Cappato et al. 2010). Furthermore, ablation procedures carry the risk of severe 
complications, such as atrio-esophageal fistulae or cardiac tamponade (Shah 2011; 
Cappato et al. 2010). These limitations of RF trans-catheter ablation will not be 
significantly improved without a real-time (RT) tool to characterize lesions 
intraoperatively (Shah 2011). 
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3.2.2 Guidance of atrial fibrillation treatment 
Several attempts have recently been made to address this need by probing changes 
that occur in tissue as RF energy denatures proteins and disrupts native structure. MRI 
has been used both to guide RF trans-catheter ablation (Ranjan et al. 2012) and to provide 
thermographic information (Kolandaivelu et al. 2010). Unfortunately, MRI for these 
applications tends to suffer from poor spatial resolution and low frame rates (1.8 mm and 
< 5 frames per second [fps], respectively, for real-time MRI and 1.7 mm and < 1 frame 
per 4 cardiac cycles, respectively, for MRI thermography) (Ranjan et al. 2012; 
Kolandaivelu et al. 2010). Additionally, both techniques require the advent of MRI 
compatible equipment (Ranjan et al. 2012; Kolandaivelu et al. 2010), and long-duration 
MRI studies can be cost prohibitive. 
Optical coherence tomography (OCT) is being investigated as a means to assess 
lesion formation and provide real-time feedback to physicians during ablation procedures 
(Fleming et al. 2010). OCT relies on back-scattered light from a coherent source to 
interrogate tissue optical properties. The reliance on quasi-ballistic photon propagation 
limits OCT by imposing a maximum imaging depth of approximately 1 mm (Fleming et 
al. 2010), restricting the use of OCT to only atrial regions where tissue is thinnest and 
limiting assessment of transmurality. Acoustic radiation force impulse (ARFI) imaging is 
an ultrasound (US)-based elasticity imaging technology being investigated as a means to 
intraoperatively identify RF ablation lesions (Eyerly et al. 2010; Eyerly et al. 2012). 
ARFI imaging interrogates mechanical properties by analyzing the ARFI-induced 
dynamic response of tissue. ARFI relies on micrometer-order tissue displacement, 
making it particularly susceptible to motion artifacts, that results in a significant fraction 
of unusable images (Eyerly et al. 2012). 
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3.3.3 Photoacoustic imaging 
Photoacoustic (PA) imaging is making inroads as a novel medical imaging 
technique utilizing short-duration laser pulses (Xu and Wang 2006; Beard 2011) which 
are absorbed by chromophores (such as deoxy-hemoglobin [Hb]) in the tissue, resulting 
in thermoelastic expansion and generation of an acoustic (Xu and Wang 2006; Beard 
2011). These local transients can be imaged using a traditional US transducer (Bouchard 
et al. 2012; Shah et al. 2008; Wang et al. 2012a), providing an optical absorption map 
with resolutions on the order of tens of micrometers (or hundreds of micrometers using a 
7.5 MHz US probe, which is common for EP intracardiac or transesophageal US 
applications and comparable to MRI) and at imaging depths in excess of a centimeter (Xu 
and Wang 2006; Beard 2011; Bouchard et al. 2012; Shah et al. 2008; Wang et al. 2012a). 
The peak photoacoustic pressure, generated during thermal and stress 
confinement, is commonly modeled as: 
 




)  𝜇𝑎𝑏𝑠(𝑟, 𝜆) 𝐹(𝑟, 𝜆) 
Equation 2 
where 𝛽(𝑟, 𝑇) [K-1] is the temperature dependent thermal coefficient of volume 
expansion,  𝑣𝑠(𝑟, 𝑇) [cm s
-1] is the sound velocity in tissue, 𝐶𝑝(𝑟, 𝑇) [J kg
-1 K-1] is the 
heat capacity at constant pressure,  𝜇𝑎𝑏𝑠(𝑟, 𝜆)  [cm
-1] is the optical absorption coefficient 
and 𝐹(𝑟, 𝜆) [J cm-2] is the local optical fluence(Xu and Wang 2006; Beard 2011). As 
such, 𝑟, 𝜆 and 𝑇 represent spatial distribution, optical wavelength and temperature, 
respectively. 
PA imaging contrast is provided by variations in optical absorption (𝜇𝑎𝑏𝑠) 
resulting from variations in the concentration of endogenous or exogenous 
chromophores. Due to the wavelength dependence of 𝜇𝑎𝑏𝑠 (Swartling et al. 2003; 
Thomsen, Jacques, and Flock 1990), spectroscopic photoacoustic imaging (sPA) can be 
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performed for tissue characterization purposes (Ntziachristos 2010). PA imaging's 
reliance upon ultrasonic sensing allows straightforward co-registration with anatomical 
US images, providing molecularly sensitive anatomical PA/US images (Bouchard et al. 
2012; Shah et al. 2008; Wang et al. 2012a). For these reasons, PA imaging is being 
pursued as a powerful medical imaging modality in cancer detection (Mallidi, Luke, and 
Emelianov 2011), disease staging (Wang et al. 2012b) and therapy monitoring (Shah et 
al. 2008). 
3.3 METHODS 
3.3.1 Sample preparation and ablation 
Fresh porcine hearts (Sierra for Medical Science, Whittier, CA) were acquired 
within 24 hours of sacrifice and were never frozen. The ventricles were harvested and 
samples were excised from these portions to produce approximately 20x20x10 mm3 sized 
specimens for ablation. The ablation system consisted of a Stockert 70 RF generator 
combined with a COOLFLOW® irrigation pump and a THERMOCOOL® irrigated tip 
catheter (Biosense Webster Inc., Diamond Bar, CA). During each ablation, the catheter 
was flushed with PBS. RF energy was applied at a rate of 20 - 30 W for 40 - 60 s. Tissue 
samples were submerged in normal PBS during ablation and then patted dry and returned 
to an airtight container and refrigerated.  
3.3.2 Imaging system setup and procedure 
Normal PBS was used to acoustically couple the imaging system with the tissue. 
Imaging was performed on a combined PA/US imaging system consisting of a Vevo® 
2100 US imaging system (FUJIFILM VisualSonics Inc., Toronto, ON, Canada) paired 
with an LZ-250 transducer (21-MHz center frequency) with integrated fiber optics 
connected to a pulsed, tunable Nd:YAG laser (680 - 970 nm wavelength range). A single 
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three-dimensional (3-D) combined PA/US B-mode scan was performed on each sample 
at 710 nm. From that 3-D volume, a single 2-D plane corresponding to the brightest 
region of the PA signal was selected for sPA imaging from 680 - 840 in 2-nm steps. Ten 
frames were averaged into a single PA/US image at each sampled wavelength (e.g. 
Figures 3.2A and 3.3B). Energy was measured at the fiber bundle output using an 
external power meter. This protocol was used to image eight ablated samples harvested 
from two porcine hearts. Later, a full 3-D PA/US volume was acquired for each 
wavelength from 740 – 780 nm in 5-nm steps. At each wavelength, six PA/US volumes 
were averaged. The resulting 3-D sPA data were normalized to the average laser energy 
at each corresponding wavelength. This second protocol was used to image six ablated 
samples from two additional porcine hearts. A schematic of the imaging system is shown 
in Figure 3.1. 
 
 
Figure 3.1. Schematic of combined PA/US imaging system. 
 75 
3.3.3 Sample staining procedure 
For the purpose of sample staining, nitro-tetrazolium blue (NTB) salt (Sigma-
Aldrich Corp., St. Louis, MO) was chosen to identify macroscopic myocardial tissue 
necrosis (Ramkissoon 1966). The NTB solution was prepared by dissolving NTB in 
normal PBS at 0.5 mg ml-1 and maintained at 35 C°, as outlined by Ramkissoon 
(Ramkissoon 1966). All specimens were incubated in the NTB solution for 15 minutes, 
then patted dry and photographed for gross pathology. 
3.3.4 ROI selection and analysis 
Equal-sized regions-of-interest (ROIs; 0.04 mm2) of the PA signal center 
(Ablated) and a specimen region external to the lesion (Non-ablated) were selected from 
the 2-D sPA dataset for analysis, as shown in the white boxes in Figure 3.2A. 
3.3.5 Contrast and reference spectra 
Contrast-to-background ratio (CBR) was calculated using the mean PA signal 
intensity for the Ablated and Non-ablated ROIs. To obtain PA signal spectra, the mean 
PA intensities for both ROIs were calculated and plotted as a function of wavelength; 
Figure 3.2B shows representative spectra observed in Ablated (red) and Non-ablated 
(blue) myocardium (normalized for display purposes). These spectra differ considerably 
near 760 nm, where the Non-ablated spectrum has a prominent hump, which correlates 
well with the extinction spectrum of Hb (Jacques 2013), and is absent from the Ablated 
spectrum. For this reason, two spectra (Figure 3.2D) were selected for a Pearson 
correlation test to characterize the two tissue types. Ablated reference spectra were 
obtained by averaging ROIs from ablated samples (n = 8) harvested from two separate 
hearts. The known extinction spectrum for Hb was normalized and used as a reference for 
the non-ablated tissue. 
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3.3.6 Spectroscopic photoacoustic image processing and correlation 
Prior to the correlation test, each sPA dataset was filtered spatially and to reduce 
noise. For the 3-D sPA data, each 3-D volume was filtered using a 3-D sliding average 
kernel. Voxel-by-voxel correlation, using both the Ablation-reference and the Hb-
reference spectra, was performed on each 2-D and 3-D sPA dataset through 740 - 780 
nm. For each sPA dataset, Ablation reference and Hb reference correlation maps were 
obtained. A final tissue characterization map (TCM, Figure 3.2C) was then generated. 
Voxels of the TCM showing high (r ≥ 0.65) Ablation-reference or Hb-reference 
correlation were displayed as either red or blue, respectively, whereas voxels showing 
high correlation to both spectra were color coded green. TCM voxels showing poor 
correlation (r < 0.65) to both spectra were not color coded. For each voxel that correlated 
to either Ablation or Hb reference spectra, the p-value of the correlation was calculated 
based on the null hypothesis. 3-D rendering of the data (Figure 3.4A and 3.4B) was 
achieved with Amira (VSG, Burlington, MA); a clipping plane was introduced at the 
location of the tissue bisection (Figure 3.4B) to compare 3-D TCMs with the side-view 
gross pathology (Figure 3.4D). 
3.3.7 Image registration and comparison 
Three-dimensional TCM/US data was co-registered with matching photographed 
gross pathology. Gross pathology photographs were acquired in top-view and side-view 
orientations. Both orientations were adjusted so that the gross pathology field of view 
(FOV) represented the same FOV as the US volume. In the top-view gross pathology 
images, tissue sample boundaries and the ablated region were manually segmented from 
the photograph background (Figure 3.3A, blue and red, respectively) and a line was 
placed to identify the tissue bisection plane. An equivalent top-view orientation was then 
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reconstructed using the TCM/US volume data with matching segmentations performed 
on this reconstructed view. 
A straightforward rigid image registration was applied to both top- and side-view 
image sets. Once the top-view gross pathology and matched TCM/US data were co-
registered, an image slice was selected from the TCM/US data that corresponded to the 
tissue bisection plane. A similar segmentation and registration process was then 
performed on the side-view gross pathology and selected TCM/US data (Figures 3.3C 
and 3.3D, respectively). 
Once both the top- and side-view image sets were co-registered, the accuracy of 
the TCM was determined. The centroids of the ablated-region segmentations were 
calculated for each gross pathology and TCM set. For each co-registered set, the lateral, 
axial and elevation offsets between the centroids were measured. Agreement between the 
segmentations was assessed by comparing the maximum axial, lateral or elevation extent 
of the segmented region. The % Area agreement was defined as follows: 
% Area Agreement = (𝐼𝑇𝐶𝑀 ∩ 𝐼𝐺𝑃 𝐼𝑇𝐶𝑀 ∪ 𝐼𝐺𝑃⁄ )×100% Equation 3 
Where 𝐼𝑇𝐶𝑀 and 𝐼𝐺𝑃 represent the segment TCM image and gross pathology 
image, respectively, and ∩ and ∪ are the intersect and union sets, respectively. For the 
side-view co-registered samples, two samples were utilized to assess elevation offset, 
while four samples were utilized to assess lateral offset; all six side-view co-registered 
samples were utilized to assess axial offset. 
3.4 RESULTS 
3.4.1 Single-wavelength analysis 
Figure 3.2A shows a representative single-wavelength combined PA/US image 
acquired at 710 nm. Based on matched gross pathology images of the stained sample, the 
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red-orange region located at the image center, at approximately 11 mm depth, correlates 
to the core of the lesion. For Figure 3.2A, 𝐼?̅?𝑏𝑙 = -7.8 ± 3.0 dB, 𝐼?̅?𝑎𝑏𝑙 = -38.6 ± 2.4 dB 
(both normalized to the PA signal peak intensity at 710 nm), and CBR is 30.7 ± 3.1 dB.  
 
 
Figure 3.2. Single-wavelength PA image (710 nm) overlaying US image with Ablated 
and Non-ablated ROIs (A). Mean ROI photoacoustic signal plotted vs. 
wavelength (B). Tissue characterization map (TCM) (C). Reference spectra 
for Ablated (averaged over eight samples from two hearts) and Non-ablated 
(derived from optical extinction data from deoxy-Hb) tissue (D). 
3.4.2 Spectroscopic analysis 
Both normalized spectra from the ROIs in Figure 3.2A are shown in Figure 3.2B. 
The Ablated absorption spectrum monotonically decreases, which agrees with results 
obtained by Swartling, et al. (Swartling et al. 2003) The Non-ablated absorption spectrum 
agreed well with that of Hb (Jacques 2013), notably displaying a prominent hump near 
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760 nm. In this wavelength range, Hb is expected to be the dominant absorber in a 
harvested (i.e. oxygen depleted) myocardial sample. 
An example of the TCM overlaying the corresponding B-mode US image is 
displayed in Figure 3.2C. The correlation maps demonstrate the ability to visualize both 
ablated and non-ablated tissue at greater depth and extent than that afforded by single-
wavelength PA images. Figure 3.2C indicates, at lateral positions of 6 mm and 10.5 mm, 
the correlation protocol was able to identify 2 - 3 mm of ablated myocardium beneath at 
least an additional millimeter of non-ablated myocardium. This was typical of both 2-D 
and 3-D imaged samples, where the sPA data showed good correlation to absorbers up to 
a depth of 3 mm. The average correlation p-value (as estimated using a two-tailed 
student’s T-test) over all voxels was 0.0104 ± 0.0098, suggesting that the overall 
correlation was significant. 
3.4.3 Lesion dimension statistics 
The results of the 3-D segmentation comparison are shown in Table 3.1. For the 
top-view orientation (Figures 3.3A and 3.3B), good agreement between the gross 
pathology images and TCM was achieved, with no elevation and low lateral (0.4 mm) 
offset measured. The absolute difference between the average lateral and elevation extent 
was 1 mm or less, and well within the standard deviations for both measurements. The 
mean segmented lesion areas were calculated to be 37.8 ± 15.8 mm2 and 41.8 ± 16.4 mm2 
for the TCM and gross pathology, respectively. The difference between these areas was 
4.0 mm2 (approximately 10% total lesion area), which is within the standard deviations of 
both measurements. The % Area Agreement, as defined in Equation 3, was 
approximately 70% averaged across all 6 samples, indicating good TCM and gross 
pathology agreement for all 3-D volumes. 
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TCM offset - 0.4 ± 0.4 0.0 ± 0.7 - 
TCM extent - 7.4 ± 1.8 7.3 ±1.6 37.8 ± 15.8 
Gross pathology 
extent 
- 6.5 ±1.9 8.3 ±1.5 41.8 ± 16.4 
% Area agreement - - - 69 ± 11% 
Side-view orientation 
TCM offset 1.2 ± 0.8 0.1 ± 0.7 0.9 ±1.5 - 
TCM extent 3.4 ± 1.0 8.0 ± 1.4 6.3 ± 1.9 14.5 ± 4.9 
Gross pathology 
extent 
5.3 ± 1.0 7.8 ± 1.4 10.9 ± 3.7 30.7 ± 10.1 
Area agreement - - - 36 ± 18% 
Table 3.1. Comparison of lesion segmentation metrics (n = 6 samples total) from top- and 
side-view gross pathology and TCM/US registrations. 
For the side-view orientation (Figures 3.3C and 3.3D), the two samples cut 
parallel to the elevation axis showed an average of a 0.9-mm offset in that dimension. 
The samples cut laterally showed good lateral agreement (offset of 0.1 mm). The axial 
dimension showed the greatest offset, averaging 1.2 mm across all 6 samples. The 
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average axial extent of the lesion segmentations was 3.4 ± 1.0 mm and 5.3 ± 1.0 mm, for 
the TCM and gross pathology, respectively. Mean segmented areas were calculated to be 
14.5 ± 4.9 mm2 and 30.7 ± 10.1 mm2 for the TCM and gross pathology, respectively, 
while the % Area Agreement was 36% (averaged across 6 samples). 
 
 
Figure 3.3. Top-view (A) and side-view (C) stained sample gross pathology with sample-
boundary (blue) and Ablated-region (red) segmentation. Matching top- (B) 
and side-view (D) TCM-US images with segmented Ablated region (red). 
The 3-D rendered data compared well with the matching gross pathology (Figures 
3.4A-D). In this data set, there are two distinct regions of ablated tissue surrounded by 
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non-ablated tissue and separated by an approximately 2-mm non-ablated gap (Figure 
3.4A). The tissue is also consistently identified to depths greater than 2 mm, for both 
ablated and non-ablated myocardium, and generally agrees well with the matched gross 
pathology (Figure 3.4C and 3.4D). 
 
 
Figure 3.4. Three-dimensional rendering (A) of TCM volume with clipping plane 
corresponding to tissue bisection (B). Matching top- (C) and side-view (D) 
gross pathology photographs with axes and FOVs indicated by arrows and 
boxes, respectively. 
3.5 DISCUSSION 
3.5.1 Segmentation metrics 
Single-wavelength PA imaging shows high contrast from the lesion core, which 
indicates it may be useful as a pilot scan to locate the approximate lesion center, but it 
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lacks the ability to fully differentiate ablated vs. non-ablated myocardium. In comparison, 
the sPA-based TCM demonstrated the ability to reliably identify ablated and non-ablated 
myocardium with high accuracy and sub-millimeter precision (Figures 3.2C, 3.3B, 3.3D, 
3.4A and 3.4B). TCM images of ablated and non-ablated tissue appear relatively uniform 
across the entire imaged area or volume (Figures 3.2C, 3.3B, 3.3D, 3.4A and 3.4B). All 
TCM images showed consistent tissue characterization and correlated well to matched 
images of gross pathology to at least 2 mm in depth (Figures 3.2C, 3.3 and 3.4). 
One caveat of PA imaging is that imaging artifacts, resulting from refractive 
index discontinuities, can occasionally be seen near tissue boundary locations. These 
artifacts, however, would be minimal in an in vivo environment, as the imaging target 
would not be an explanted tissue sample with tissue-solution boundaries. Also, 
spectroscopic-based images, such as a TCM, may further reduce artifacts by correlating 
multiple wavelengths and reducing the effects of saturated voxel regions by identifying 
absorbers. It should also be noted that the particular imaging system used has reduced 
SNR at the left and right frame edges, which also contributes to image artifacts in the 
TCM as broadband noise weakly correlates with the Ablated spectrum. Given the 3-D 
datasets (Figures 3.3B, 3.3D, 3.4A and 3.4B) were acquired using only six averages and 
without laser energy pulse-to-pulse normalization, increased frame averaging, improved 
energy normalization and increased surface fluence should improve TCM quality and 
increase depth penetration beyond 3 mm. Given its depth penetration capabilities, PA 
imaging may be best suited for guidance of trans-catheter ablation of atrial arrhythmia. 
3.5.2 Image registration comparison 
When considering the segmentation metrics, it should be first noted that a basic 
rigid registration method was utilized that did not account for tissue deformation, which 
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will inherently introduce error. Despite this limitation, excellent agreement was achieved 
with the top-view comparisons, with no elevation and small lateral offset observed. 
Furthermore, the average top-view segmented areas differed only by 4 mm2, yielding a % 
Area Agreement of 69 ± 11%; this area agreement is comparable with other lesion 
imaging methods currently being developed (Eyerly et al. 2010). 
For the side-view orientation, lateral offset was improved when compared to the 
top-view orientation (0.1 mm vs. to 0.4 mm). The relatively high axial offset (1.2 mm) 
observed in this orientation is attributable to the limited ability in this initial 
implementation of sPA imaging to characterize tissue at depths greater than 3 mm; this 
penetration depth can be increased with improved frame averaging, improved energy 
normalization and increased laser fluence. With said improvements the ability of this 
imaging modality to reliably characterize tissue and assess transmurality at depths > 3 
mm could be determined. As can be seen in Figure 3.3C and 3.4D, the ablated regions 
extend axially from approximately 10 mm to 15 mm and 11 mm to 16 mm, respectively 
(5 mm in both instances). The deepest 2 mm of ablated myocardium was not visualized, 
so the axial position of the segmented TCM centroid naturally appears shallow compared 
to the centroid of the segmented lesion from photographed gross pathology. This also 
accounts for the lower % Area Agreement score (36%) when compared with the top-view 
results (69%). 
3.5.3 Three-dimensional rendering comparison 
The 3-D rendering (Figures 3.4A and 3.4B) of the dual-lesion data gave the 
opportunity to examine the ability of the system to identify adjacent lesions. We can 
clearly see two distinct regions, approximately 4 mm in diameter each, which correlate 
strongly to the Ablated reference (red); surrounding these two regions is tissue that 
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consistently correlates to the Non-ablated reference (blue). This segmentation agrees well 
with gross pathology images, shown in Figures 3.4C and 3.4D. Additionally, a small 
region of tissue that correlates to both reference spectra is seen lying between the two 
lesions in Figure 3.4B (green). This segmentation agrees well with matching gross 
pathology (Figure 3.4D), as a small isthmus of ambiguous tissue lies between the two 
lesions (approximately 11 mm in the axial and elevation dimensions). This result 
emphasizes the ability of sPA to identify regions where lesion contiguity may be in 
question. 
3.5.4 Thermal denaturation effects 
Given that the PA spectrum observed in ablated tissue results from bulk 
hyperthermia-induced protein denaturation, resulting from tissue heating, it is believed 
that this spectrum would not vary significantly from patient to patient, nor vary 
significantly between normal or pathologic myocardium. Also, given that thermal 
damage generally eliminates the observed birefringence resulting from myocardial 
muscle-fiber orientation, it is believed that PA imaging would be insensitive to fiber 
orientation. 
3.6 CONCLUSION 
In conclusion, for this initial study, we demonstrate the feasibility of using sPA 
imaging to provide 3-D visualizations of ablated and non-ablated myocardium in an 
excised porcine myocardial ablation model. When compared with co-registered stained 
gross pathology, sPA imaging achieved sub-millimeter accuracy in identifying lesion 
position and extent and reliably characterized tissue to depths of 3 mm, including 
identifying adjacent and non-contiguous lesions. These initial results suggest that sPA 
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imaging, with its molecular specificity and high spatial resolution, may be well suited as 
a clinical tool to guide trans-catheter ablation of atrial arrhythmia. 
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Chapter 4: In Vitro Photoacoustic Characterization Of High-Intensity 
Focused Ultrasound Ablation Lesions In Cardiac And Liver Tissues4 
4.1 ABSTRACT 
High intensity focused ultrasound (HIFU) thermal therapies are limited by 
deficiencies in existing image guidance techniques. Previous studies using single-
wavelength photoacoustic (PA) imaging have demonstrated that HIFU lesions generate 
contrast with respect to native tissues, but have not sufficiently assessed lesion extent. 
The purpose of this study is to demonstrate feasibility of characterization of in vitro 
HIFU ablation lesion dimensions using 3D multi-wavelength PA imaging. Fresh porcine 
cardiac and liver tissue samples were embedded in agar phantoms and ablated using a 
2.5-MHz small-animal HIFU system. 2D and 3D multi-wavelength photoacoustic-
ultrasonic (PAUS) scans were performed in the NIR range to characterize the change in 
the absorption spectrum of tissues following ablation and were compared to stained gross 
pathology to assess treatment margins and lesion extent. Comprehensive 2D multi-
wavelength PA imaging yielded a spectrum in ablated tissue that did not display the 
characteristic local maximum in the optical absorption spectrum of deoxy-hemoglobin 
(Hb) near 760 nm. 2D tissue characterization map (TCM) images reconstructed from 3D 
TCM volumes reliably characterized lesion area and showed >70% area-agreement with 
stained gross pathology. Additionally, tissue samples were heated via water bath and 
concurrently interrogated with 2D PAUS imaging. PA signal exhibited an initial 
amplitude increase across all wavelengths, corresponding to an initial temperature 
increase, before then exhibiting a spectral change. This study suggests that multi-
wavelength PA imaging has potential to obtain accurate characterization of HIFU lesion 
                                                 
4 This chapter is adapted in part from a manuscript titled 'Multi-Wavelength Photoacoustic Visualization of 
High Intensity Focused Ultrasound Lesions' (Gray, Dana, Dextraze, Maier, Emelianov and Bouchard, 
2015). Nicholas Dana is one of two primary co-authors of this manuscript. 
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extent and may be better suited to guide HIFU ablation therapies during clinical 
treatments than single-wavelength methods. 
4.2 INTRODUCTION 
4.2.1 High intensity focused ultrasound 
High intensity focused ultrasound (HIFU) is a minimally invasive technique that 
has developed significantly over the last two decades for the treatment of benign and 
malignant conditions in soft tissues (Bailey et al. 2003; Kennedy 2005). HIFU treatments 
use ultrasound transducers with highly controlled beams to instantly achieve destructive 
temperatures at their focus. This technique has been used to treat targets that may be 
several centimeters below the skin surface, while preserving healthy tissue since 
hyperthermal therapy tends to occur at the focus of the beam (Kennedy 2005). HIFU is of 
clinical interest for several conditions, including atrial fibrillation of cardiac tissue (Lee et 
al. 2000; Groh et al. 2007), central nervous system disorders of the brain (Jagannathan et 
al. 2009), treatment of both benign and malignant solid tumors through thermal ablation 
(Kennedy 2005), and enhanced drug delivery at treatment sites (Dromi et al. 2007). In the 
United States, HIFU has been indicated for clinical treatment of uterine fibroids and 
malignant bone metastases (U.S. Food and Drug Administration 2005).  
Image guidance is employed during HIFU for treatment planning, tissue 
temperature, and assessment of tissue damage during and after treatment (i.e. estimating 
treatment margins) (Kennedy 2005). Real-time image guidance has accommodated 
adaptive ablation planning, leading to increased efficacy of HIFU treatments and 
improved precision in estimating treatment margins (Kennedy 2005). Imaging guidance 
for hyperthermal therapy has been provided by magnetic resonance (MRI) imaging, 
computed tomography (CT), and ultrasound (US), all of which have been able to 
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elucidate anatomical structures and heating-probe location (Goldberg et al. 2005). Several 
of these techniques have demonstrated the capability to monitor tissue temperature 
changes, yet only MRI is used as a standard-of-care technique for image guidance during 
clinical treatments (Hynynen et al. 1993; Jolesz 2009).  
4.2.2 Photoacoustic imaging 
Photoacoustic (PA) imaging is a relatively novel technique that is gaining 
attention due to its feasibility of implementation as a point-of-care imaging solution, its 
molecular sensitivity, and its ready compatibility with existing US technology (Dana, 
Dumani, et al. 2016; Bouchard, Sahin, and Emelianov 2014). PA imaging can be 
achieved through extracorporeal or interstitial application of near-infrared (NIR) laser 
pulses, which are absorbed by endogenous chromophores or exogenous contrast agents 
(Dana, Dumani, et al. 2016). Due to the “optical window,” in which optical absorption by 
water, fat, and blood decreases dramatically in the NIR region (650-1100 nm), imaging 
depths of several centimeters can be achieved in soft tissues (Smith, Mancini, and Nie 
2009). Photon energy absorbed by chromophores is converted into mechanical energy 
through a rapid thermal expansion, which results in the generation of an acoustic transient 
that propagates through soft tissue and may be detected by a standard US transducer at 
the tissue surface (Bouchard, Sahin, and Emelianov 2014; Dana, Dumani, et al. 2016). 
Detected signals can then be used to estimate a map of optical absorption with sub-
millimeter spatial resolution. Since PA signals are detected using an ultrasonic 
transducer, PA images can be co-registered with US images (Bouchard, Sahin, and 
Emelianov 2014; Dana, Dumani, et al. 2016). These photoacoustic-ultrasonic (PAUS) 
images allow for the presentation of anatomical information alongside estimated optical 
absorption, and thus molecular composition, of the tissue.  
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The amplitude of PA pressure waves, 𝑝0(𝑟, 𝑇, 𝜆), generated as a result of optical 
absorption by chromophores in tissue, are dependent on the speed of sound in tissue 
(𝑣𝑠
2(𝑟, 𝑇) [cm s-1]), a temperature-dependent volume expansion coefficient (𝛽(𝑟, 𝑇) [K-
1]), the isobaric heat capacity in tissue (𝐶𝑝(𝑟, 𝑇) [J kg
-1 K-1]), the optical absorption 
coefficient of the tissue (𝜇𝑎𝑏𝑠(𝑟, 𝜆) [cm
-1]), and the optical fluence (𝐹(𝑟, 𝜆) [J cm-2]) as 
(Bouchard, Sahin, and Emelianov 2014; Dana, Dumani, et al. 2016): 
 




)  𝜇𝑎𝑏𝑠(𝑟, 𝜆) 𝐹(𝑟, 𝜆) 
Equation 4 
Contrast in PA images primarily arises from variations in the optical absorption 
coefficient, which depends on both the concentration of chromophores in tissue and the 
wavelength of the laser source. Due to the wavelength dependence of the optical 
absorption coefficient, multi-wavelength photoacoustic imaging can be performed by 
tuning the wavelength of the laser through the entire NIR region in order to estimate the 
optical absorption properties of the tissue (Mallidi, Luke, and Emelianov 2011; 
Bouchard, Sahin, and Emelianov 2014; Dana, Dumani, et al. 2016). Varying the location 
of the PAUS transducer or using a 2D transducer array and obtaining PA signals at 
several wavelengths allows for the generation of a multi-wavelength 3D PAUS volume. 
Additionally, the temperature dependence of pressure wave generation may allow for 
real-time monitoring and characterization of temperature change during ablation(Shah et 
al. 2008; Larin et al. 2000; Irina, Kirill, and Rinat 2005; Pramanik and Wang 2009).  
4.2.3 Current image-guidance methods 
Image guidance techniques greatly improve the outcome of HIFU treatments by 
allowing physicians to more accurately and completely estimate treatment margins, yet 
existing imaging modalities are not entirely satisfactory for treatment guidance 
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(Schlesinger et al. 2013; Rosenthal et al. 2015). Currently, image guidance of HIFU 
treatments is performed using several standard imaging modalities. Traditional pulse-
echo B-mode US provides excellent anatomical information and can provide short-term 
identification of hyperechoic regions of tissue corresponding to microbubble formation at 
the site of the HIFU focus; however, it cannot provide quantification of lesion extent 
(Vaezy et al. 2001). Elastography can be used to assess and characterize induced lesions, 
but can be difficult to implement in vivo and provide a significant number of false-
positives (Righetti et al. 1999). Magnetic resonance imaging (MRI) allows for excellent 
identification of treatment targets, treatment planning, and real-time tracking of relative 
temperature changes at the site of ablation through MRI thermography (Ottenhausen et 
al. 2013), but it is limited by the high cost and equipment incompatibility imposed by 
high magnetic field strengths. PA imaging is a promising modality for image guidance of 
HIFU therapies because of its ready compatibility with existing technology and capability 
to monitor target and healthy tissue during ablation with sub-millimeter spatial resolution. 
This level of spatial resolution in fact exceeds the spatial resolution of existing 
temperature MRI guidance techniques (1-2 mm) (Quesson, de Zwart, and Moonen 2000). 
4.2.4 HIFU guidance with PA imaging 
PA imaging provides several unique qualities that make it promising as an 
alternative to existing image-guidance techniques for HIFU. PA imaging is capable of 
both thermography and spectroscopy (Shah et al. 2008; Lee et al. 2013; Dana et al. 2014), 
allowing for real-time assessment of temperature changes and tissue state. In practice, 
conventional US techniques such as Doppler imaging or microbubble-contrast perfusion 
assessment can also be applied concurrently with PA imaging to assess nearby critical 
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structures, such as vessels (Dana, Dumani, et al. 2016; Bouchard, Sahin, and Emelianov 
2014).  
Previous studies of HIFU ablations in vitro and in vivo using PA imaging have 
shown that PA imaging is capable of providing image contrast in the ablation region 
(Chitnis et al. 2010; Cui, Staley, and Yang 2010; Cui and Yang 2010, 2011; Sun and 
O’Neill 2013; Funke et al. 2009). This change in contrast at the ablation site may be 
attributed to a change in the concentration of chromophores in the tissue as a result of 
heating (Tanya et al. 2006). However, single-wavelength methods typically fail to 
provide enough information to reliably quantify the precise position and dimensions of 
HIFU lesions. Studies using radio-frequency ablation have shown that multi-wavelength 
PA imaging is capable of detecting changes in the concentration of chromophores—
specifically in the concentration of deoxy-hemoglobin (Hb)—following thermal ablation 
and that these multi-wavelength methods allow PA imaging to identify an optical 
absorption spectrum specific to ablated tissue and distinct from the typical Hb spectrum 
(Dana et al. 2014; Sun and O’Neill 2013). In this study, we use the previously described 
technique (Dana et al. 2014; Sun and O’Neill 2013) in an in vitro environment following 
HIFU and water-bath ablation of cardiac and liver tissue samples. 2D and 3D multi-
wavelength PA data of ablated tissue samples is then correlated to these two absorption 
spectra to create Tissue Characterization Maps (TCM), which are used to quantitate 
lesion size for comparison to stained gross pathology. Additionally, we examine the 
temperature dependence of the PA signal as tissue samples are heated in a PBS bath.     
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4.3 METHODS 
4.3.1 Sample preparation and ablation procedure 
Imaging samples were acquired from fresh porcine cardiac and liver tissues 
(Animal Technologies Inc., Tyler, TX) within 24 hours of sacrifice and were never 
frozen. Excised tissues from one liver and two hearts were used to make three liver 
samples and three cardiac samples, each approximately 30x30x20 mm3 in size. Each 
specimen was embedded into an agar phantom for HIFU sonication. The HIFU 
transducer was acoustically coupled to the agar phantoms using ultrasound gel and 
samples were each sonicated for 120 seconds at power settings between 22 and 30 watts 
using a LabFUS 2.5-MHz small-animal HIFU system (Image Guided Therapy Inc., Paris, 
France). Photographs of the HIFU system, HIFU transducer, and imaging system are 
presented in Figure 4.1. Following ablation, tissue specimens were removed from their 
agar phantoms, and the uppermost 1.5 – 2 mm of tissue surface was removed in order to 
expose ablation lesions to allow for tissue-sample photography and later co-registration 




Figure 4.1. Photographs of experimental equipment. A) LabFUS 2.5-MHz small-animal 
HIFU system. B) Close-up view of eight-element, 2.5-MHz HIFU 
transducer. C) Vevo LAZR 2100 combined PAUS imaging system. Red 
arrow indicates motorized platform for elevation scanning during 3D 
imaging. 
Additionally, fresh bovine liver tissues (Animal Technologies Inc., Tyler, TX) 
were acquired within 24 hours of sacrifice and never frozen. Two samples were excised 
from one liver and submerged in normal PBS in an imaging chamber containing a heat 
exchanger. The goal of this experiment was to monitor the tissue PA signal as a function 
of bath temperature. The tissue sample was located in the center of the copper tubing coil, 
which comprised the heat exchanger, to generate an approximately isotropic temperature 
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field. Bath temperature was measured via thermocouple at a location a few millimeters 
from the upper surface of the tissue imaging plane. 
4.3.2 Imaging setup 
Following the aforementioned ablation procedure, specimens were anchored in a 
thin layer of gelatin and submerged in normal phosphate buffered saline (PBS) to achieve 
acoustic coupling between the tissue sample and the PAUS transducer. PAUS imaging 
was performed using a Vevo LAZR 2100 imaging system equipped with a 21-MHz US 
transducer coupled to a pulsed Nd:YAG laser capable of irradiating from 670-970 nm 
(FUJIFILM VisualSonics Inc., Toronto, Canada). In each sample, a single-wavelength 
3D PAUS scan was performed over the extent of the tissue sample in order to identify a 
single plane containing the ablation lesion. The location of the lesion was chosen by 
selecting an area in the 3D PAUS scan exhibiting a hyperechoic US signal and high PA 
contrast. After identification of the lesion, a 2D comprehensive multi-wavelength PA 
scan was performed on this plane using wavelengths ranging from 680-970 nm in 3-nm 
steps. A multi-wavelength 3D PAUS scan was then performed on each tissue over a 
volume including the ablation lesion using five wavelengths in the NIR region (740, 750, 
760, 780, 900 nm), corresponding to a distinct feature in the Hb absorption spectrum 
(Jacques 2013), and averaging eight frames for each wavelength and location. 
For the bath-heated samples, multi-wavelength PA imaging was done using five 
wavelengths in the NIR region (740, 750, 760, 770, 780 nm), corresponding to the same 
Hb spectral feature. First, a baseline multi-wavelength PA acquisition was performed. 
The bath-heat exchanger was then activated, and the tissue bath temperature rapidly rose 
to approximately 60 °C. PA imaging at all wavelengths was conducted at one-minute 
intervals for the first 30 minutes, then at five-minute intervals thereafter, up to 60 
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minutes. Bath temperature was measured at each imaging time-point. Immediately post-
imaging, the tissue sample was removed from the water bath and bisected at the imaging 
plane. Photographs were taken of the sample prior to heating, as well as at the point of 
bisection post-heating. 
4.3.3 Staining procedure 
Following imaging, samples were stained using triphenyl tetrazolium chloride 
(TTC) salts for registration and comparison of gross pathology to PAUS data (Sigma-
Aldrich Corp., St Louis, MO). TTC is a redox indicator of metabolic activity: the white 
stain accumulates in cells and is oxidized to a deep red color by a variety of molecules 
associated with metabolic activity (Berridge et al. 1996). Tissue in the ablation region has 
undergone necrosis and should become white/gray in color, while metabolically active 
healthy tissue outside the ablation region will become a deep red. Staining solutions were 
prepared by dissolving 0.1 mg/ml TTC in normal PBS. Tissue samples were submerged 
in staining solution and incubated at 37° C for 20 minutes with constant stirring. After 
staining, tissue samples were patted dry and photographed. Bath-heated tissue samples 
were not stained as the tissue was clearly coagulated throughout the entire tissue volume. 
4.3.4 2D multi-wavelength PA analysis 
The comprehensive 2D multi-wavelength scans were analyzed to assess whether 
HIFU treatment results in a change in the PA spectra of tissue. Regions of interest (ROI) 
were selected in areas showing high PA contrast and areas showing low PA contrast, 
corresponding to areas of ablated and non-ablated tissue, respectively. The mean PA 
signal inside each ROI was calculated for each wavelength scanned and plotted to display 
the absorption spectra for ablated (liver and cardiac, respectively) and non-ablated tissue 
(Figure 4.2).  
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4.3.5 Creation of tissue characterization maps  
Tissue characterization maps (TCMs) were generated using a correlation-based 
algorithm. Reference absorption spectra for ablated and Hb absorbers were obtained from 
the comprehensive multi-wavelength PA data (liver or cardiac, as appropriate) using 
previously described methods (Dana et al. 2014). The filtered PA data were compared to 
two reference spectra (i.e. Hb correlation and a distinct ablated correlation for each tissue 
type), resulting in two 3D datasets of Pearson correlation coefficients. These two 3D 
correlation datasets (i.e. Hb correlation coefficients and ablated correlation coefficients) 
were then processed with a simple thresholding algorithm. Correlation thresholds of 0.6 
were used for both Hb and ablated reference spectra. PA voxels were then classified 
based on the respective thresholds and correlation coefficients. Voxels that correlated 
strongly (i.e. displayed correlation coefficients above the threshold) to only one reference 
spectra were classified accordingly (i.e. class 2 for ablated; class 1 for Hb). Voxels that 
correlated strongly to both were classified according to their greatest correlation 
coefficient. Voxels that correlated strongly to neither reference spectra were classified as 
0 (no correlation). Thus, a trinary 3D TCM was constructed for each PA dataset and 
compared to photographed gross pathology. For the bath-treated tissue samples, an 
equivalent process was employed, save that a correlation threshold of 0.65 was used. A 
2D TCM was generated at each time point, and the 2D multi-wavelength PA signal was 
examined as a function of time (i.e. thermal exposure).  
4.3.6 Image registration and characterization of ablation size 
HIFU 3D TCM data were co-registered with top-view photographs of stained 
gross pathology by manual registration based on corresponding visual landmarks. Top-
view C-scan TCMs were obtained by taking the mode along the depth axis for each voxel 
at the surface of the TCM volume. Mode calculations were performed from a depth 0.184 
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mm (corresponding to five voxels, which tended to avoid subsurface fluence artifacts) 
below the surface of the volume to a depth 1.29 mm (corresponding to 35 voxels) below 
the surface. Borders between areas of ablation and non-ablation were manually 
segmented in matched TCMs and pathology photographs by three experts, generating 
three segmentations for each TCM or pathology photograph. The segmentations for each 
TCM or photograph were analyzed automatically using MATLAB. Pixel-wise lesion area 
was calculated from each expert-segmentation of corresponding TCM data and gross 
pathology photographs. The mean and standard deviation of lesion areas from the expert 
segmentations were calculated and subsequently converted to physical dimensions 
(mm2). Percent area agreement between gross pathology and TCMs was calculated for 
each tissue sample as:  
 
% Area Agreement = [1 −
(𝐼𝑇𝐶𝑀−𝐼𝐺𝑃)
𝐼𝐺𝑃
] ×100% Equation 5 
An SNR analysis was done, comparing SNR up to 8 mm tissue depth, while 
varying the number of averages. A 0.21x0.18 mm2 sliding kernel was used, analyzing 
signal along a depth line located in the center of the ROI shown in Figure 4.5A. 
Additionally, a noise image was acquired (degassed water, no laser irradiation) to assess 
PA image noise at the equivalent depth. Up to 64 averages were used. Analysis was done 
on beam-formed image data, using the following equation: 
 
 SNR = 10 ⋅ log10 (
𝑃𝐴̅̅ ̅̅
𝜎𝑛𝑜𝑖𝑠𝑒
) Equation 6 
Where 𝑃𝐴̅̅ ̅̅  and 𝜎𝑛𝑜𝑖𝑠𝑒 denote the ROI mean PA signal and noise standard 
deviation, respectively. The SNR threshold was empirically determined by analyzing the 
depth, and thus corresponding SNR, at which the TCM loses continuity (i.e. the point at 
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which the gaps in the solid TCM regions become as large as or larger than the spatial 
averaging kernel used). 
4.4 RESULTS 
4.4.1 2D multi-wavelength PA analysis 
Figure 4.2 displays the results of 2D multi-wavelength PA imaging performed in 
liver tissue. Figure 4.2A shows an overlay of the single-wavelength PA signal at 710 nm 
on its matched US image. ROIs shown in Figure 4.2A represent the area averaged at each 
wavelength to generate the reference spectra from ablated and non-ablated tissue; these 
spectra are shown in Figure 4.2B. We expect the dominant absorber to be Hb in this 
wavelength region as the ex vivo tissue samples should be oxygen-depleted. Non-ablated 
tissue displays an absorption spectrum that agrees well with that of Hb (Dana et al. 2014) 
as the characteristic local maximum in the absorption spectrum around 760 nm is readily 
apparent. The absorption spectrum in the ROI corresponding to ablated tissue decreases 
monotonically with increasing optical wavelength and does not display the characteristic 
760-nm local maximum of the Hb absorption spectrum, indicating a likely change in the 




Figure 4.2. Results of 2D comprehensive multi-wavelength PA imaging. A) Overlay of 
single-wavelength PA data at 710 nm on matched US image. High PA 
contrast and US hyper-echogenicity exhibited in area where lesion is 
expected. B) Plot of mean PA signal in each ROI indicated at each 
wavelength. Mean PA spectrum in areas outside lesion exhibit the 
characteristic peak of Hb around 760 nm; peak not seen in area of high PA 
contrast where lesion is expected. 
4.4.2 Lesion area statistics 
TCMs were created by correlating to wavelengths in the region between 740 and 
780 nm; the region where ablated tissue and Hb absorption spectra are most distinct. 
Tissue characterization was achieved at depths up to 3 mm below the surface of the 
tissue, while gross pathology indicated that lesions extend 5-7 mm in depth. Examples of 
3D TCM volumes overlaid on matching US volumes for liver and cardiac tissues are 




Figure 4.3. Renderings of 3D TCM volumes overlaid matching 3D US volumes. A) Full 
liver sample 3D volume rendering and B) cut-away view of 2D frame in the 
interior of the lesion of the same liver volume. C) Full cardiac sample 3D 
volume rendering and D) cut-away view of 2D frame in the interior of the 
lesion of same cardiac volume. 
Results of area calculations performed on manually segmented lesions in both 
TCMs and gross pathology photographs can be found in Table 4.1; a representative 
sample image can be found in Figure 4.4. In TCM volumes, we observed that tissue 
bordering the areas of strong ablation correlation tended to correlate poorly to both 
ablated and non-ablated absorption spectra. These areas were segmented in addition to 
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Figure 4.4. Comparison of gross pathology and TCM data for one liver tissue sample. A) 
Photographed stained gross pathology. Red box indicates area of tissue 
displayed by 2D TCM data. B) Zoomed in photograph of stained gross 
pathology. Manual segmentation of gross pathology overlaid in green. C) C-
scan 2D TCM plane reconstructed from TCM volume for manual 
segmentation. Blue indicates Hb correlation, Red indicates ablated spectrum 






#1 #2 #3 #1 #2 #3 
Pathology area 
(mm2) 
16.9±1.8 35.3±3.7 22.2±2.0 11.4±1.0 10.3±0.1 3.5±0.2 
Total region 
(ablated + border) 
area (mm2) 
15.7±1.9 28.1±0.2 22.2±0.1 11.5±0.4 7.21±0.2 3.2±0.1 
% Area Agreement 
Total region 
93.2% 79.8% 99.9% 99.1% 70.0% 91.7% 
Ablated region area 
(mm2) 
8.53±0.1 25.6±0.1 20.0±0.1 11.6±0.6 7.2±0.2 2.1±0.2 
% Area Agreement 
Ablated region 
50.6% 72.5% 90.2% 98.3% 70.1% 61.2% 
Table 4.1. Lesion registration results. 
For the bath-heated samples, Figure 4.5A – E shows a 2D TCM overlaid on co-
registered B-Mode US images for five time points, with a rectangular square identifying 
an ROI for spectral analysis. At baseline (Figure 4.5A) strong correlation to Hb is 
observed to approximately 4 mm in depth across the entire width of the tissue sample. 
The depth of this correlation decreases to about 2 mm by 15 minutes (Figure 4.5B). By 
30 minutes, a thin layer correlating to ablated tissue can be identified at the tissue surface 
(Figure 4.5C). At 45 minutes (Figure 4.5D), 1 – 2 mm of ablated tissue is identified at the 
surface, with only sporadic Hb is identified beneath the surface, and this trend continues 
at 60 minutes (Figure 4.5E). Figure 4.5F shows a surface plot of the mean PA signal of 
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the ROI, normalized to baseline, as a function of wavelength and time. The PA signal 
rapidly increases for the first 5 minutes after heating onset, but still maintains the Hb 
spectral shape (local maximum at 760 nm). Amplitude decreases slightly, but spectral 
shape is maintained until approximately 30 minutes, at which point the spectra begins to 
flatten, correlating more strongly to the ablated reference spectra thereafter (as shown by 
the surface color). Figure 4.5G allows for better comparison of the spectra at prominent 
time points. Note that at 5 minutes after heating onset (bath temperature of 52 °C) a PA 
signal increase of approximately 80% from baseline can been seen across all 
wavelengths. The signal decreases slightly, but remains relatively constant at roughly 
50% above baseline until about 30 minutes after heating onset. At 30 minutes, we can see 
the PA spectrum flattening out, and by 45 and 60 minutes, we observe a monotonically 




Figure 4.5. Comparison of TCMs (same color-coding as previously stated) and spectra 
for sample subjected to PBS-bath thermal treatment. A – E) TCMs overlaid 
on coregistered US B-mode image for time-points 0 (baseline), 15, 30, 45 
and 60 minutes of thermal treatment, respectively. White rectangular box 
denotes a 1x0.5 mm2 ROI selected for analysis, maintained at constant depth 
from tissue surface. F) Surface plot of mean PA signal in ROI (normalized 
to baseline), as a function of wavelength and time. Surface color-map 
represents mean TCM color value across ROI at each time point. G) PA 
signal spectra from F for time-points 0, 5, 15, 30, 45 and 60 minutes (time-
points at 0, 15, 30, 45 and 60 minutes correspond to images A – E, 
respectively). 
Analysis of TCMs against the SNR results suggests that an SNR of 10 dB is 
generally sufficient for reliable tissue characterization using this method. By increasing 
averages, we found SNR using this method can be improved approximately proportional 
to √# averages,  allowing accurate TCMs at greater depths in tissue, though at the cost 
of increased imaging time. 
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4.5 DISCUSSION 
4.5.1 Tissue characterization map accuracy 
In this initial study, we demonstrate that multi-wavelength PA imaging can 
provide estimates of lesion extent with gross pathology area agreement greater than 79% 
in liver and greater than 70% in cardiac tissue. As has been shown previously (Cui, 
Staley, and Yang 2010; Cui and Yang 2011; Funke et al. 2009)and demonstrated in this 
study (Figure 4.2), high PA signal contrast in the ablated lesion center can be obtained 
using a single laser wavelength. However, PA imaging data from a single wavelength 
tends not to be sufficient to completely characterize the extent of the ablation lesion. 
While single-wavelength PA imaging may be useful to perform a quick 3D scan and 
obtain a rough identification of the lesion center, multi-wavelength TCMs provide 
significantly more information about the boundaries and extent of ablation lesions, as 
shown by comparing Figure 4.2A and Figure 4.3B and Figure 4.5A – E. Focusing on the 
wavelengths where the absorption spectra of ablated and non-ablated tissue display 
different features, multi-wavelength TCMs were able to identify HIFU ablation lesions in 
ex vivo cardiac and liver tissue and obtain area agreement with gross pathology 
photographs in excess of 70% and with sub-millimeter spatial resolution. TCMs 
compared well with manually segmented gross pathology photographs (minimum 70% 
area agreement), demonstrating multi-wavelength PA imaging as a potential tool for 
HIFU lesion identification and quantification. 
4.5.2 Photoacoustic image artifacts 
Despite our success in the identification and characterization of HIFU ablation 
lesions in cardiac and liver tissues, limitations in PA imaging and our experimental setup 
prevent ideal characterization of lesion dimensions. Imaging artifacts immediately at the 
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surface of the tissue were observed and are believed to be the result of subsurface photon 
fluence and refractive index discontinuities between the surface of the tissue and the PBS 
used to couple the tissue to the ultrasound transducer. In our study, these artifacts were 
mitigated when creating 2D TCM images of the top-view plane by using a depth 0.184 
mm below the tissue surface as the starting point for reconstruction of the C-scan 
projected views.  
4.5.3 Limitations of light penetration and imaging depth 
PA based TCMs also underestimated lesion depth in this experiment. Depth of PA 
imaging is limited by scattering of photons which increases the likelihood of absorption 
by chromophores at shallower depths in the tissue. In this experiment, imaging depths 
were limited to no more than 3 mm below the surface of the tissue, yet HIFU lesions 
extended 5-7 mm in depth. Several techniques could be employed in order to increase the 
penetration depth of imaging, including increased photon fluence and increased frame 
averaging to improve the signal-to-noise ratio at depth, as discussed below. Interstitial 
delivery of light by laser fibers also allows for significantly deeper light delivery to 
provide image guidance of treatments on deep-lying tissues, such as the liver and kidneys 
(Mitcham et al. 2013). By employing these methods, it should be possible to extend 
imaging depth beyond 3 mm in ex vivo experiments. Additionally, penetration depth 
could possibly be improved in in vivo experiments due to the fact that tissues will be 
highly oxygenated. Optical absorption by oxygenated hemoglobin is roughly an order of 
magnitude lower in the NIR spectrum than that of Hb (Mallidi, Luke, and Emelianov 
2011; Jacques 2013). This reduction in optical absorption may allow increased optical 
penetration depth while maintaining energy, but it may require re-optimizing imaging 
wavelengths to maintain contrast between ablated and native oxygenated tissue. 
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4.5.4 Lesion peripheral region analysis 
A noteworthy effect observed in this experiment was the appearance of a ring of 
tissue surrounding the area correlating to ablated tissue in TCMs that did not correlate 
well to either the obtained ablated tissue spectrum or the standard Hb spectrum. This 
effect was observed in both liver and cardiac tissue in our study and has been reported in 
previous studies (Dana et al. 2014). In cardiac tissues, the area of non-correlation was not 
always observed. An example of this effect is seen in Figure 4.4C, where an area of non-
correlated tissue (i.e. black) borders the upper area correlating highly to ablated tissue 
(i.e. red) at the core of the lesion. The segmentation region containing the region of 
ablation-correlated (red) and non-correlated (e.g. also including the black region 
extending from 4-6 mm in elevation in Fig. 4C) tissue showed better agreement with 
segmented ablation regions in gross pathology photographs than the segmentations of the 
ablation-correlated region alone. Regions of ablation correlation alone tended to 
underestimate the area extent of lesions when compared to gross pathology 
segmentations. The change in the PA spectrum in ablated tissue likely results from 
hyperthermia-induced changes in the Hb chromophore. It is possible that incomplete 
conversion of Hb occurs at the edge of the ablation region due to reduced increase in 
local temperature as compared to the core of the lesion, resulting in an absorption 
spectrum that did not correlate well to either Hb or the lesion core. 
4.5.5 Thermographic photoacoustic imaging potential and limitations 
The capacity of PA imaging to assess temperature has been previously 
demonstrated by examining changes in PA amplitude (Shah et al. 2008). By applying 
similar techniques, we were able to track the relative temperature rise in the bath-heated 
tissue sample during the first several minutes. As shown in Figure 4.5F, the PA amplitude 
then decreases slightly after five minutes. We suspect this is primarily a result of changes 
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in surface fluence. As can be seen in the B-Mode US images in Figure 4.5, the tissue 
swells initially (B and C), before contracting partially (D and E). This initial tissue 
swelling is likely the result of increased osmotic pressure in the bath, following 
temperature increase. The swelling is likely to affect and the surface fluence, due to a 
change in separation between the tissue and light emission source. The tissue contraction 
observed in Figure 4.5D and Figure 4.5E is likely due coagulation of ECM proteins, 
which concurs with the observed strong correlation of the PA signal to the ablated 
reference spectrum (red region in Figures). These results highlight the potential 
complementary nature of PA thermography and multi-wavelength analysis. Tissue 
coagulation may also explain the decrease in PA amplitude after 30 minutes, as increased 
optical scattering following coagulation will reduce fluence, and thus PA signal, at 
greater depths. While these factors confound PA thermography in this experiment, these 
issues may not be as prevalent in clinical applications for several reasons. First, tissue 
hyperthermal therapy typically occurs on the order of several seconds to a few minutes 
and is typically much more spatially localized, which may reduce large scale tissue 
swelling or edema. Lastly, if an optical scattering increase within an ROI correlates to a 
change in the observed PA spectra, as suggested by this study, it may serve as a partial 
endpoint for hyperthermal therapy, rather than a mitigating factor to image guidance. 
Furthermore, if changes in optical fluence and absorption can be accounted for (perhaps 
by collecting some backscattered light for diffuse reflectance assessment (Hennessy et al. 
2013)), PA thermography may be able to quantify thermal dose, comparable to what is 
currently done using MRI thermography. 
 112 
4.5.6 Signal-to-noise ratio analysis 
The SNR analysis suggests that roughly 10 dB SNR is necessary for reliable TCM 
analysis. Our particular system showed that, with 64 averages, the SNR up to 5 mm can 
be improved to allow for reliable TCM analysis. While increased averaging may be 
prohibitive in some clinical applications, such as cardiac imaging, this analysis suggests a 
baseline to predict TCM accuracy as a function of depth for a given application and 
imaging system 
4.6 CONCLUSION 
We have demonstrated the feasibility of using multi-wavelength PA imaging to 
create tissue characterization volumes that allow the differentiation of HIFU-induced 
tissue ablation lesions from non-ablated tissue and to estimate the treatment margins of 
tissue ablations in 2D planes in ex vivo cardiac and liver tissue samples following a 
HIFU ablation. Multi-wavelength PA imaging demonstrates that HIFU-induced 
hyperthermia results in changes in the Hb absorption spectrum that can be leveraged for 
PA-based segmentation. Multi-wavelength TCMs were used to successfully identify 
lesion size with a greater accuracy than single-wavelength methods. Multi-wavelength 
TCMs agreed with gold-standard stained pathology images (70% area agreement) and 
were able to successfully assess lesion margins with a spatial resolution comparable to 
existing temperature MRI techniques. Additionally, we demonstrated the complementary 
nature of PA thermography and multi-wavelength TCMs. Further in vivo experiments 
concurrent with treatment must be performed to assess PA signal changes in living 
tissues. These results suggest that multi-wavelength PA imaging and PA thermography 
present a promising modality for guiding hyperthermia therapies that depend on precise 
knowledge of temperature and lesion extent in order to preserve critical structures. 
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Chapter 5: Intravascular Photoacoustic Imaging Optimization Using 
Monte Carlo Optical Modeling And Analysis 
5.1 ABSTRACT 
Coronary heart disease, typified by the presence of coronary atherosclerotic 
plaques, is a significant killer in the industrialized world. Percutaneous catheter 
intervention (PCI) is a common treatment method used to stabilize vulnerable plaques 
that could otherwise rupture. Intravascular photoacoustic (IVPA) imaging is being 
explored to improve and guide PCI treatments by characterizing vulnerable plaques, but a 
clinical IVPA imaging system has yet to be introduced. We utilized a sophisticated 
Monte Carlo (MC) optical model to simulate IVPA excitation in simulated coronary 
tissues to identify optimal wavelengths in terms of optical penetration and visualization 
of lipid. NIR wavelengths from 800 – 1800 nm were simulated and single- and dual-
wavelength image data was analyzed utilizing image-subtraction and segmentation. 
Results indicate light penetration is best in the range of 1050 nm to 1370 nm, where 5% 
fluence can be readily achieved at clinically relevant depths of 2 mm or more in arteries. 
Analyses of optical fluence show that, over the arterial lumen, fluence can vary by over 
an order of magnitude, confounding assessments of lipid content. Segmentation-lipid 
correlation peaked in single-wavelength images at 1210 nm and 1720 nm, though 
correlation overall was quite poor. Subtraction-images showed much better correlation 
between segmentation and lipid content, with several bands of high correlation, the most 
promising of which utilized 1210 nm as a primary wavelength. Considerations of light 
penetration, fluence variation and lipid visualization suggest that using a primary 
wavelength near 1210 nm light, paired with a secondary wavelength near 1360 nm may 
offer the most promising clinical implementation of IVPA imaging as it allows 
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differentiation of plaque from luminal blood pool and lining, while optimizing light 
penetration and reduce fluence variation across images. 
5.2 INTRODUCTION 
5.2.1 Coronary heart disease and treatment 
Coronary heart disease (CHD) affects 6.2% of American adults (aged ≥ 20 years) 
and contributes to American adults experiencing a myocardial infarction every 43 
seconds, on average (Mozaffarian et al. 2015).  This exacts an annual financial cost in 
excess of $200 billion in 2010 (Mozaffarian et al. 2015) and an incalculable toll in human 
suffering. CHD occurs when lipid accumulates at the endothelium of the coronary 
arteries, resulting in the formation of an atherosclerotic plaque (Libby 2002). Plaque 
accumulation can occur over many years, and may result in narrowing of the lumen, 
which reduces blood flow downstream, or may develop into a vulnerable plaque, which 
can rupture, resulting in thrombus formation and myocardial infarction (Libby 2002). 
Coronary-stent placement via percutaneous catheter intervention (PCI) is an accepted 
treatment method to stabilize vulnerable plaques (Fischman  et al. 1994). Much research 
has been conducted to differentiate vulnerable plaques from their stable counterparts, and 
several pertinent imaging-related markers have been identified, such as fibrous-cap 
thickness and the presence of a necrotic core (Fleg et al. 2012; Narula et al. 2013). It has 
also been shown that patient outcomes improve when PCI stenting-procedures utilize 
image guidance techniques, such as intravascular ultrasound (IVUS) imaging (Roy et al. 
2008). These results highlight the potential for image guidance to improve the outcomes 
of patients suffering from CAD. Photoacoustic (PA) imaging a novel imaging modality 
that is being explored to address this need. 
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5.2.2 Photoacoustic imaging 
In brief, PA imaging is a hybrid optic-ultrasonic imaging modality which utilizes 
short-duration laser pulses (Xu and Wang 2006; Beard 2011; Dana, Dumani, et al. 2016) 
which are absorbed by chromophores in the tissue, resulting in thermoelastic expansion 
and generation of an acoustic transient (Xu and Wang 2006; Beard 2011; Dana, Dumani, 
et al. 2016). These transients can be imaged using a traditional ultrasound (US) 
transducer (Bouchard et al. 2012; Shah et al. 2008; Wang et al. 2012a) and used to 
generate an estimate of the distribution of optical absorbers in the tissue, making PA 
imaging a molecular imaging modality. The peak photoacoustic pressure is commonly 
modeled as: 
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where 𝛽(𝑟, 𝑇) [K-1] is the temperature dependent thermal coefficient of volume 
expansion,  𝑣𝑠(𝑟, 𝑇) [cm s
-1] is the sound velocity in tissue, 𝐶𝑝(𝑟, 𝑇) [J kg
-1 K-1] is the 
heat capacity at constant pressure,  𝜇𝑎(𝑟, 𝜆)  [cm
-1] is the optical absorption coefficient 
and 𝐹(𝑟, 𝜆) [J cm-2] is the local optical fluence (Xu and Wang 2006; Beard 2011). As 
such, 𝑟, 𝜆 and 𝑇 represent spatial distribution, optical wavelength and temperature, 
respectively, and the term containing 𝛽(𝑟, 𝑇), 𝑣𝑠(𝑟, 𝑇) and 𝐶𝑝(𝑟, 𝑇) is often referred to as 
the Grüneisen parameter, Γ(𝑟, 𝑇) [unitless] (Equation 8). 
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5.2.3 Intravascular photoacoustic imaging 
Intravascular photoacoustic (IVPA) imaging, combined with IVUS imaging, has 
been extensively leveraged as a means to provide image guidance and characterization of 
atherosclerotic plaques (Wang et al. 2010; Wang and Emelianov 2011; Wang et al. 
2012a; Wang et al. 2012b; Yeager et al. 2012; VanderLaan et al. 2014; Yeager et al. 
2014; Jansen, van der Steen, et al. 2014; Jansen, Wu, et al. 2014; Allen et al. 2012; 
Karpiouk, Wang, and Emelianov 2010) and to evaluate coronary stent placement (Su, 
Wang, and Emelianov 2009). Results have demonstrated the promise of IVPA imaging 
using both endogenous contrast (Wang et al. 2010; Wang et al. 2012a; Jansen, van der 
Steen, et al. 2014; Jansen, Wu, et al. 2014) and exogenous contrast agents (Wang et al. 
2009; Yeager et al. 2012). Investigations have indicated there are two primary spectral 
regions, 1210 nm and 1720 nm, that show promise for visualizing the lipid content in 
plaque (Wang et al. 2012a; Jansen, Wu, et al. 2014; Wang et al. 2010). These various 
results have propelled IVPA imaging from the research realm toward its development as 
a clinical imaging modality (VanderLaan et al. 2014; Karpiouk, Wang, and Emelianov 
2010; Abran et al. 2014; Li et al. 2015; Piao et al. 2015). While promising, results have 
yet to demonstrate which of these two spectral regions may provide optimal plaque 
characterization results and also how said results might best be improved by the addition 
of secondary wavelengths for imaging. Given the compromises involved in designing an  
imaging system, such as balancing design, function and cost (Fleg et al. 2012), 
developing an optimized translatable imaging system is not a trivial task. 
 For an IVPA/IVUS imaging system to successfully translate into the clinical 
realm, it must do several things:  
1. Demonstrate the ability to reliably and accurately assess coronary diameter and 
stenosis (Narula et al. 2013; Fleg et al. 2012). 
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2. Demonstrate reliable and accurate visualization and quantification of plaque 
burden in the artery, which has been shown to be useful in characterizing 
vulnerable plaque (Narula et al. 2013; Wilensky 2013; Fleg et al. 2012). 
3. Demonstrate the ability to achieve the above results while imaging through 
several millimeters of blood and tissue, which should be sufficient in most 
situations, given the average coronary artery diameter of 3.5 mm (Waller et al. 
1992). 
4. Provide this image guidance and characterization in real-time, preferably at a 
frame-rate of 30 frames per second. 
5. Accomplish all of the above while trying to maximize cost-effectiveness, thus 
reducing the barrier to clinical translation (Fleg et al. 2012). 
5.2.4 Current barriers to translation of intravascular photoacoustic imaging 
Many previous results have relied upon an optical parametric oscillator (OPO) to 
provide tunable wavelength selection for IVPA studies (Wang et al. 2010; Wang and 
Emelianov 2011; Wang et al. 2012a; Wang et al. 2012b; Yeager et al. 2012; VanderLaan 
et al. 2014; Yeager et al. 2014; Jansen, van der Steen, et al. 2014; Jansen, Wu, et al. 
2014). While versatile and useful in a research setting, this is unlikely to be suitable for a 
clinical imaging system, as these laser systems typically suffer from slow pulse repetition 
frequency (~10 Hz) and can be cost-prohibitive. Given the desire to provide real-time 
imaging, an IVPA system that reconstructs a single image from 128 scan lines will need a 
laser source with a pulse repetition frequency of several kilohertz (1 laser pulse per scan 
line x 128 scan lines per frame x 30 frames per second = 3840 laser pulses per second). 
This number will increase linearly with the number of imaging wavelengths. This laser 
source must also provide a sufficiently high pulse energy so as to excite a measurable PA 
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signal at depths in excess of 2 mm through blood and tissue to reliably image within the 
average coronary artery (Waller et al. 1992). While not impossible, it is unlikely that a 
laser and optics system or collection of systems would be able to accomplish these tasks 
while providing illumination at many wavelengths. For that reason, it seems reasonable to 
consider that an optimized clinical IVPA imaging system provide results using only one 
or two wavelengths, but no more. With this constraint in mind, we can consider how we 
might determine an optimal IVPA imaging configuration. 
Ideally, in order to develop a clinical IVPA imaging system, one would conduct 
exhaustive experiments, preferably using IVPA imaging systems currently in 
development (VanderLaan et al. 2014; Karpiouk, Wang, and Emelianov 2010). This 
would require using multiple fresh coronary artery samples, with different disease states, 
with each imaged exhaustively in the NIR, followed by comprehensive histopathology to 
establish pertinent metrics such as luminal stenosis, plaque burden and cap thickness. 
Unfortunately, given the dearth and fragility of available tissue samples, such a 
comprehensive imaging study is unrealistic. Fortunately, other options, such as optical 
modeling, may offer insight into the details of an optimized clinical IVPA imaging 
system. 
5.2.5 Modeling-based optimization of intravascular photoacoustic imaging 
Monte Carlo (MC) optical modeling is a technique in which the probabilistic 
propagation of photons through a medium simulated and then combined to calculate a 
final fluence distribution.  MC modeling has been used for decades to elucidate light 
transport and distributions in biomedical applications (Wilson and Adam 1983; Prahl et 
al. 1989; Wang, Jacques, and Zheng 1995; Fang and Boas 2009; Jacques 2014). In brief, 
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MC models treat light transport in tissue as a stochastic process, where the optical 
properties of a given tissue type are modeled by a set of parameters: 
1. The probability of a photon being absorbed, defined as the absorption coefficient, 
𝜇𝑎 [cm
-1]. 
2. The probability of a photon being scattered, defined as the scattering coefficient, 
𝜇𝑠 [cm
-1]. 
3. The average angle of scattering, defined by the anisotropy, 𝑔 [unitless], and a 
phase function (the Henyey-Greenstein (Henyey and Greenstein 1941) phase 
function is commonly used in biomedical applications, though several others have 
been suggested). 
4. The refractive index of the material, 𝑛 [unitless] (not all models incorporate this 
information). 
Simulations utilize random number generators and, using known or estimated 
optical properties, determine the path length of a photon packet, the fraction of energy 
absorbed and the new vector of propagation of a photon after each light-matter 
interaction (Wilson and Adam 1983; Prahl et al. 1989; Wang, Jacques, and Zheng 1995; 
Fang and Boas 2009; Jacques 2014). This continues until the energy of a photon packet 
decreases below a critical threshold, at which point transport of that packet is typically 
terminated (Wilson and Adam 1983; Prahl et al. 1989; Wang, Jacques, and Zheng 1995; 
Fang and Boas 2009; Jacques 2014). A new photon packet can then be launched, and the 
process repeated, until the fluence distribution within the tissue is adequately simulated. 
MC models have been developed for homogenous (Wilson and Adam 1983) and layered 
tissues (Wang, Jacques, and Zheng 1995), three-dimensional (3D) voxellated media 
(Fang and Boas 2009; Jacques 2014) and mesh-based structures (Fang 2010), with 
simulations optimized to run on CPUs, as well as graphics processing units (GPU) (Fang 
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and Boas 2009; Fang 2010). The success of MC models can be attributed to their high 
accuracy when compared to experiments (Flock, Wilson, and Patterson 1989) and their 
superiority to alternative methods, such as diffusion theory (Flock et al. 1989). 
We aim to leverage the accuracy and versatility of MC optical modeling to 
simulate the fluence distribution in typical IVPA imaging applications and provide 
insight into which system configurations may provide the best balance of contrast, 
imaging depth and lipid visualization. We have developed a model to simulate IVPA data 
across a range of NIR wavelengths, using several different tissue geometries. The goal of 
this study is not to supplant experimental studies, which are invaluable, but rather to 
guide them by providing insight into which imaging schemes show the most promise, so 
that the limited resources available for IVPA imaging studies can be utilized in the most 
beneficial matter. In this way, we intend the model-based results provided herein to be 
used alongside future IVPA imaging experiments and to inform IVPA imaging system 
development going forward. 
5.3 METHODS 
5.3.1 Overview of Monte Carlo model 
MCXLAB, the software used herein for optical modeling, was developed using 
CUDA (Nickolls et al. 2008) by Fang and Boas (Fang and Boas 2009) and implemented 
in MATLAB (MathWorks, Inc., Natick, MA). The simulation defines a 3D gridded 
model space, where each voxel is tagged with an integer that designates the media 
comprising that voxel. Each media is defined by four optical parameters (𝜇𝑎, 𝜇𝑠, 𝑔 and 𝑛, 
as described above), which, together, define the optical properties of the entire simulation 
space (Fang and Boas 2009). The optical properties of the external space were also 
defined, as well as the conditions at the model-exterior boundary (non-reflective 
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boundary). The model space used a grid spacing of 20 µm, which was approximately 
equivalent to the overall minimum mean free path (MFP) across the tissue types and 
wavelengths used, as suggested by previous models (Wang, Jacques, and Zheng 1995). 
The result was a voxel volume of 20 x 20 x 20 µm3, with uniform grid spacing in the X, 
Y and Z dimensions, with each dimension spanning 8 mm total, for a total simulation 
space volume of 8 x 8 x 8 mm3. 
Illumination was modeled as a side-firing optical fiber, very similar to what has 
been described in previous experimental setups (VanderLaan et al. 2014; Jansen, van der 
Steen, et al. 2014; Karpiouk, Wang, and Emelianov 2010). The side firing source was 
located in the center of the model volume. The optical source was modeled as a uniform 
cone, emanating from the side of the fiber (conic-axis parallel to the X-Y plane), with a 
half-angle of 16.7 degrees (0.292 radians). The side-firing ultrasonic transducer was 
modeled as being co-localized with the source, with the axis of ultrasonic propagation 
assumed to be co-linear with optical conic-axis. Using previously reported unfocused 
transducer parameters (Karpiouk, Wang, and Emelianov 2010), the transducer sampling-
volume, corresponding to the 3D “footprint” of the transducer, was estimated in model 
space by using reported transducer size and frequency characteristics. The transducer 
footprint was modeled as being equivalent to the transducer area up to the far-field 
transition zone (𝑑ff ), where 𝑑ff ≈ 𝑎
2 𝜆𝑈𝑆⁄ = 1.6 mm, 𝑎 is the piston-transducer radius 
(250 µm) and 𝜆𝑈𝑆 is the ultrasound wavelength (approximately 38.5 µm at 40 MHz in 
tissue) (Szabo 2004). In the far-field zone, the transducer footprint was modeled as 
diverging according to the full-width half-maximum (FWHM) estimation provided by 
Szabo (Szabo 2004), shown in Equation 9. Figure 5.1 shows a 3D overlay of the optical 
fiber, light cone and transducer footprint, as well as a fluence cross-section of a 
simulation done at 1000 nm in water. 
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FWHM ≈ 0.7047 𝜆US 𝑑 𝑎⁄  Equation 9 
5.3.2 Consolidation of model output 
Once the initial optical simulation was run, a normalized 3D fluence distribution 
was generated, containing the estimated fluence at each voxel, 𝐹(𝑟, 𝜆). The PA signal at 
each voxel was modeled by taking the product of the fluence, the optical 
absorption, 𝜇𝑎(𝑟, 𝜆), and the Grüneisen parameter, Γ(𝑟, 𝑇), for water-based (0.14) or 
lipid-based (0.81) tissues, which has been reported previously at room temperature (Yao 
et al. 2014). The result was a 3D distribution of PA amplitudes, 𝑝0(𝑟, 𝜆, 𝑇), equivalent to 
what is modeled by Equation 1. Those PA signals which overlapped with the transducer 
footprint (the intersect of the two regions) were recorded. The source and transducer were 
then rotated in the X-Y plane, which is equivalent to rotating an IVPA imaging catheter 
in a coronary artery, and the process was repeated. This was done every 2.81 degrees 
(0.049 radians) to sample the entire 360 degree arc in 128 steps, as this allowed the entire 
2D plane to be spatially sampled at least once, with most voxels being sampled multiple 
times. Once the entire arc had been sampled, the PA signal contributed from each of the 
128 simulations was combined, summed across the Z dimension (which corresponded to 
the coronary artery axis), and then normalized to the number of times each voxel was 
sampled. The result was an estimated two-dimensional (2D) distribution of PA signal 
sources which would be observed by the IVPA imaging system, 𝐼𝑃𝐴(𝑥, 𝑦, 𝜆), as well as a 
2D fluence distribution, 𝐼𝐹(𝑥, 𝑦, 𝜆), at a given wavelength. This entire simulation process 
was performed at wavelengths from 800 nm to 1800 nm, in 10 nm steps, for each of the 
four simulated tissue samples. Photon packets totaling 3x106 were launched for each 
simulation, with the average runtime of a single simulation being 12 seconds, and the 
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total runtime of all simulations totaling 172 hours. Simulations were performed on a 
Windows 7 (Microsoft, Seattle, WA) computer with 16 GB of RAM, an Intel Core I7-
4770 processor (Intel, Inc., Santa Clara, CA) and a NVidia GTX 1080 GPU (NVidia, 
Inc., Santa Clara, CA). The resulting data was comprised of 404 simulated image sets, 
across 101 wavelengths and four tissue types. 
 
 
Figure 5.1. (A) Volumetric rendering of optical fiber (blue), light cone (red) and 
transducer footprint (green). (B) Fluence cross-section (Y = 0 mm, 40 dB 
scale) of an optical simulation at 1000 nm in water.  
5.3.3 Tissue models and optical properties 
Four 3D tissue volumes were generated for the model. Two samples were 
designed that represented vulnerable plaques that would require intervention. The other 
two samples were designed so as to be unlikely to rupture and produce a thrombus, and 
thus would not require intervention. A recent study by Narula, et al., examined 295 
histopathologic samples of atherosclerotic coronary disease (Narula et al. 2013). Their 
results indicate that a cap thickness of < 54 µm was the best indicator of plaque type, 
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followed by macrophage infiltration, necrotic core area (≥ 3.45 mm2) and that % luminal 
stenosis did not significantly differentiate stable from vulnerable plaques (Narula et al. 
2013). Based on these results, we designed our two vulnerable plaques models as having 
a thin cap (< 60 µm) and a large lipid-pool (> 3.9 mm2), as would be expected with a 
large necrotic core. Conversely our stable plaque sample contained a thicker cap (> 80 
µm) and a modest lipid pool (≤ 2.4 mm2). The last tissue sample modeled was essentially 
a healthy artery, with minimal fatty streaks and no stenosis. Other tissue properties, such 
as the thickness of intimal, medial and adventitial tissue, as well as the blood volume, 
were selected based on average values reported in literature (Waller et al. 1992). The 
region external to the adventitial tissue was modeled as pericardial (PC) fluid (Ben-Horin 
et al.). Also, in each tissue sample, extending co-linearly with the Z-axis for 4 mm was a 
320 µm diameter optical fiber, as would be needed for light delivery in a catheter 
implementation. Aside from the fiber optic extending partway into the tissue volume, the 
tissue samples did not vary along the Z-dimension.  Figure 5.2 shows a cross-section of 




Figure 5.2. Cross-section of modeled tissue volumes at plane Z = 0 mm. Diffuse (A) and 
Confined (B) represent vulnerable plaques, with large lipid pools and thin 
caps. Stable (C) represents a stable plaque with a modest lipid pool and a 
thick cap. Streaks (D) represents a healthy artery with minimal lipid pool. 
Legend on the right denotes tissue types. Dashed line denotes location 
where light penetration analysis was done. 
The optical properties of the seven tissue constituents in the NIR regime were 
tabulated from several sources, as described in Table 5.1. Absorption data were extracted 
from the literature and, if needed, joined and smoothed to provide a continuous spectrum 
across the desired range. Scattering data were also extracted from the literature and 
smoothed by fitting data to a two-term function as suggested by Jacques (Jacques 2013).  
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The optical properties of lipid were estimated based on measurements taken of adipose 
tissue (Bashkatov et al. 2005b; van Veen et al. 2005; Zamora-Rojas et al. 2013), and 
fibrous cap properties were estimated based on measurements taken of the thin fibrous 
layer derived from human aorta (Çilesiz and Welch 1993). PC fluid was modeled based 
on measurements taken of blood and plasma (Roggan et al. 1999). All other tissue 
samples were modeled based on optical measurements taken from the tissue themselves, 
as shown in Table 5.1. Blood was assumed to have an oxygen saturation (SpO2) of 95%. 
At longer NIR wavelengths (> 1000 nm).  The optical absorption of most tissues closely 
mirrors that of water (Jacques 2013), and so, when literature data were not available at 
longer wavelengths (typically beyond 1000 nm), the optical absorption of intimal, medial, 
adventitial tissues and PC fluid was estimated by linearly fitting available data to 
measurements made of sea water (Hale and Querry 1973) and extrapolating, as has been 
previously suggested (Jacques 2013). Figure 5.3 shows the final absorption and scattering 
values used in the model for the 7 tissue types. The optical fiber was assumed to be 




Figure 5.3. Optical absorption (A) and scattering (B) coefficients used to model tissue 
types. Sources for data can be found in Table 5.1. 
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Tissue optical parameters and sources 
(values estimated at 1210 nm) 
Tissue type 𝜇𝑎(𝜆) [cm
-1] 𝜇𝑠(𝜆) [cm
-1] 𝑔(𝜆) 𝑛 Sources 
Intima 0.120 9.98 0.89 1.40 
(Keijzer et al. 1989) 
(Hale and Querry 1973) 
Media 0.155 16.1 0.86 1.40 
(Keijzer et al. 1989) 
(Hale and Querry 1973) 
Adventitia 0.256 13.1 0.89 1.40 
(Keijzer et al. 1989) 
(Hale and Querry 1973) 
Fibrous cap 0.453 15.8 0.90 1.40 (Çilesiz and Welch 1993) 
Blood 0.132 42.1 0.94 1.35 
(Roggan et al. 1999) 
(Hale and Querry 1973) 
Lipid 0.181 15.2 0.93 1.47 
(Zamora-Rojas et al. 2013) 
(van Veen et al. 2005) 
(Bashkatov et al. 2005b) 
PC fluid 0.100 0.0421 0.80 1.34 
(Roggan et al. 1999) 
(Hale and Querry 1973) 
Table 5.1. Comparison of tissue optical parameters for absorption, 𝜇𝑎(𝜆) [cm
-1], 
scattering, 𝜇𝑠(𝜆) [cm
-1], anisotropy, 𝑔(𝜆) [unitless] and index of refraction, 
𝑛 [unitless], as well as the data sources used to estimate values. Blood was 
assumed to be 95% oxygen saturated. Anisotropy values typically varied by 
less than 0.05 across the wavelength range used for a given tissue type. Due 
to the low dispersion of water and lipid, index of refraction was assumed to 
be constant for all tissues. 
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5.3.4 Depth penetration and simulation signal-to-noise analysis 
Once the outputs from the simulations were consolidated, several analysis 
methods were used to determine the quality of expected imaging results. For the 2D 
fluence distributions, optical penetration depth was assessed by sliding a 100 x 100 µm2 
averaging kernel along the dashed line in Figure 5.2 and recording where fluence 
attenuated to 5% at each wavelength. SNR in the fluence estimates, which is way to 
address if the number of simulated photons was sufficient, was calculated by sliding a 
100 x 100 µm2 kernel across each 𝐼𝐹(𝑥, 𝑦, 𝜆) image and calculating the mean fluence ( 𝐼?̅?) 
and standard deviation (𝜎𝐹) at each position. The SNR at that position was then taken to 
be the ratio of the two (𝐼?̅? 𝜎𝐹⁄ ), and then the mean SNR across the entire image was 
calculated in order to estimate the SNR of the optical simulation process. 
5.3.5 Segmentation and correlation analysis 
To provide a useful metric to gauge the accuracy of the simulated results to 
visualize lipid, and thus plaque area, we implemented a simple segmentation algorithm to 
the IVPA images, 𝐼𝑃𝐴(𝑥, 𝑦, 𝜆), followed by calculation of the Matthew’s correlation 
coefficient (MCC) (Matthews 1975) to determine the quality that imaging scheme to 
visualize plaque content. The segmentation algorithm used Otsu’s method (Otsu 1975) to 
apply a binary segmentation that designated each voxel of the fluence distribution as 
either lipid or non-lipid, and then compared those results to the tissue cross-section image 
as ground truth. Voxels containing lipid were True (the yellow regions in Figure 5.2), all 
other tissue types were False. By comparing segmentation results with ground truth 
images voxel by voxel, we calculated true positive (TP), false positive (FP), true negative 
(TN) and false negative (FN) numbers for each image. These were used to determine the 





√(𝑇𝑃 + 𝐹𝑃)(𝑇𝑃 + 𝐹𝑁)(𝑇𝑁 + 𝐹𝑃)(𝑇𝑁 + 𝐹𝑁)
 
Equation 10 
 The MCC is related to the 𝜒2 statistic and is a good estimator of a binary 
classifier (Powers 2011). The MCC has an upper and lower bound of 1 and -1, 
respectively. An MCC of 1 indicates a perfect match between true and measured positive 
and negative values, while an MCC of -1 indicates a perfect reversal of positive and 
negative matches, both of which indicate utility in the imaging results. A value for the 
MCC was calculated for each of the 101 wavelengths, 𝑀𝐶𝐶(𝜆),  and for each of the four 
tissue models. A composite MCC was calculated at each wavelength by combining the 
TP, TN, FP and FN results from all tissue models. 
5.3.6 Subtraction-image analysis 
 Additionally, given that a dual-wavelength IVPA imaging system seemed 
the most probable implementation of a multi-wavelength IVPA imaging platform, 
analysis was done to determine which wavelength-pairs may provide the best assessment 
of plaque content. A simple wavelength-subtraction method was applied to generate a 
subtraction-image, 𝐼𝑃𝐴
− (𝑥, 𝑦, 𝜆1, 𝜆2) = 𝐼𝑃𝐴(𝑥, 𝑦, 𝜆1) - 𝐼𝑃𝐴(𝑥, 𝑦, 𝜆2). After subtraction, any 
voxels containing negative intensity values were set to zero. This was done to emphasize 
primary wavelengths with high-lipid absorption. The data was then processed using the 
same segmentation method described above, and a single MCC was calculated for each 
𝐼𝑃𝐴
− (𝑥, 𝑦, 𝜆1, 𝜆2) image. The result is a 101 x 101 (wavelength x wavelength) MCC 
heatmap, 𝑀𝐶𝐶ℎ𝑚(𝜆1, 𝜆2), for each tissue model, and a final composite MCC heatmap 
using the TP, TN, FP and FN data across all  𝐼𝑃𝐴
− (𝑥, 𝑦, 𝜆1, 𝜆2) image segmentations.  
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5.4 RESULTS 
5.4.1 Signal-to-noise results 
The average SNR in the fluence distributions, 𝐼𝐹(𝑥, 𝑦, 𝜆), across all wavelengths 
and tissue geometries was 12.6 ± 2.2, and never fell below 6.3 for any simulation, 
indicating the number of photon packets launched was sufficient.  
5.4.2 Visualization of simulated IVPA results 
Figure 5.4 shows simulated IVPA data, 𝐼𝑃𝐴(𝑥, 𝑦, 𝜆), from the four tissue models 
at 1210 nm, displayed on logarithmic dB scale. Optical absorption of lipid at 1210 nm is 
a local maximum, and exceeds that of water (as seen in Figure 5.4A), which contributes 
to the high PA signal seen in the lipid regions in Figure 5.4 (lipid regions are shown in 
yellow in Figure 5.2). As seen in Figure 5.4, the optical fluence varies by more than an 
order of magnitude across the lumen and arterial wall. 
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Figure 5.4. Simulated PA data at 1210 nm, 𝐼𝑃𝐴(𝑥, 𝑦, 1210 𝑛𝑚), for Diffuse (A), 
Confined (B), Stable (C) and Streaks (D) tissue models. Images are 
presented on decibel scale. Note that 1210 nm represents a local absorption 
maxima of lipid over water, as shown in Figure 5.3A, which is demonstrated 
by the high-intensity signals in the lipid regions, which are shown in yellow 
in Figure 5.2.  
5.4.3 Variations in depth penetration and single-image segmentation  
Figure 5.5 shows the results of the depth penetration analysis (A) and the single-
image segmentation results (B). The 5% fluence threshold shown in (A) corresponds to 
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the probability of a photon transiting across the effective MFP length three times, as one 
would calculate using a Beer-Lambert approach (𝐼 𝐼0
⁄ = 𝑒−𝑧⋅𝜇𝑒𝑓𝑓 ≈ 0.05, 𝑧 =
3×𝑀𝐹𝑃𝑒𝑓𝑓) (Wang and Wu 2007). For that reason, it is a useful metric to compare 
between wavelengths and also against other optical modeling results. The 5% fluence 
threshold varied between 1.5 mm and 2 mm for most wavelengths examined, but the 
wavelength window from approximately 1050 nm to 1350 nm showed improved depth 
penetration. The correlation assessment shown in Figure 5.5B indicates modest 
correlation overall, but the wavelength regions near 1210 nm and 1720 nm, which 
represent peaks in the lipid optical absorption, show the best correlation overall. This is in 
agreement with previous studies, which have found IVPA imaging contrast between lipid 
and water is best at these wavelengths (Wang et al. 2010; Wang et al. 2012a; Wang et al. 




Figure 5.5. Analysis of light penetration across the four tissue types and the composite 
results (A). A 5% normalized fluence threshold was used, and the average 
distance of that threshold from the source was calculated for each 
wavelength and tissue model. Analysis was done along the dashed lines in 
Figure 5.2, which corresponds to the approximate “center” of the lipid-rich 
region. Correlation analysis for the segmented 𝐼𝑃𝐴(𝑥, 𝑦, 1210 𝑛𝑚) data for 
the four tissue types and the composite results (B). Two wavelength regions 
stand out, near 1210 nm and 1720 nm, which correspond to the local 
absorption maxima of lipid over water. 
5.4.4 Results of image-subtraction and segmentation 
Figure 5.6 shows an example of the image-subtraction process and the 
segmentation results obtained. 𝐼𝑃𝐴(𝑥, 𝑦, 𝜆) images are shown on the same linear scale at 
1210 nm (Figure 5.6A) and 1530 nm (Figure 5.6B). Note the much higher PA signal 
observed at 1530 nm, particularly near the light source, as compared to 1210 nm. This is 
primarily due to the optical absorption of water being roughly an order of magnitude 
greater than that of lipid at 1530 nm (Figure 5.6A). For this reason, the corresponding 
subtraction image (𝐼𝑃𝐴
− (𝑥, 𝑦, 𝜆1, 𝜆2), Figure 5.6C), with negative values set to zero, 
emphasizes the lipid-filled regions and deemphasizes other tissue regions, as can be seen. 
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As a result, the segmented image, shown in Figure 5.6C, strongly correlates to the lipid-
filled regions visible in yellow in Figure 5.2A. 
 
 
Figure 5.6. Simulated PA data, 𝐼𝑃𝐴(𝑥, 𝑦, 𝜆), for Diffuse tissue model at 1210 nm (A) and 
1530 nm (B). Images are displayed on linear scale for comparison. 
Subtraction image, 𝐼𝑃𝐴
− (𝑥, 𝑦, 𝜆1, 𝜆2), using data displayed in (A) and (B), 
shown on a linear scale (C). Note that negative valued-data is set to zero, as 
described above. Segmented image based on (C), with predicted lipid-rich 
regions as white (D).  
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5.4.5 Correlation heatmap results 
Results from the image segmentation and correlation analysis on the subtraction-
images, 𝑀𝐶𝐶ℎ𝑚(𝜆1, 𝜆2), is shown in Figure 5. for all four tissue models, as well as a 
composite MCC heatmap (Figure 5.7E). In general, results suggest that using a primary 
wavelength near 1210 nm showed good correlation using a range of secondary 
wavelengths, as evidenced by the red horizontal bands centered near 𝜆1= 1200 nm that 
are present in all heatmaps shown in Figure 5.7. The peak MCC value of 0.9998 for the 
composite data occurs at 𝜆1= 1220 nm and 𝜆2= 1530 nm, though several MCC values in 
the aforementioned band are comparable. MCC values centered around the 1720 nm lipid 
were generally ≥ 0.5, though correlation was poorer at this wavelength compared to 
results obtained using wavelengths near 1210 nm.  
 
 
Figure 5.7. MCC heatmap, 𝑀𝐶𝐶ℎ𝑚(𝜆1, 𝜆2), data from analysis of subtraction images, 
𝐼𝑃𝐴
− (𝑥, 𝑦, 𝜆1, 𝜆2), for Diffuse (A), Confined (B), Stable (C) and Streaks (D) 
tissue models, as well as composite MCC analysis from all four tissue types 
(E). The left and bottom axes represent the primary (𝜆1) and secondary (𝜆2) 
wavelengths used, respectively. All images are on the same scale, shown at 
the right of (E). 
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5.5 DISCUSSION 
It should be noted that the results demonstrated by this work represent the 
absolute best that an IVPA imaging system may hope to achieve, rather than the expected 
results from a particular imaging setup. The fluence simulations are normalized to unity 
across all imaged angles, wavelengths and tissue samples. This would be achieved only if 
the pulse-to-pulse and wavelength-dependent energy variation of the laser system could 
be perfectly accounted for. Furthermore, this model presumes that the IVPA imaging 
system can reconstruct the absorber map to an exquisitely high degree. This model did 
not account for the attenuation of PA signals as they transit through tissue, nor the 
introduction of image artifacts due to variations in the speed of sound or refraction at 
media boundaries, nor for detecting PA signals in the transducer Fresnel zone, nor the 
transfer function of the detector system, nor noise (Szabo 2004). All of these factors will 
degrade image quality to some extent, and thus the results presented here are a 
generalized ideal. The model discussed can be modified or expanded to account for each 
of these factors, in turn. 
5.5.1 Signal-to-noise ratio and computation time 
The fact that the mean SNR never fell below 6.3 across all simulations suggests 
that the number of photon packets launched and the computation time were sufficient to 
provide modeled fluence distributions with minimal discontinuities and noise. The 
smoothness of that data can be seen in Figure 5.4, where sharp variations in intensity are 
visible only at tissue boundaries. Results suggest that sufficiently high SNRs can reliably 
be accomplished while either significantly reducing the number of photon packets 
launched, which would reduce computation time, or by maintaining computation time 
while using a GPU with reduced the processing. Given the current generation of NVidia 
GPUs (1000 series) show a roughly 60% increase in efficiency compared to the previous 
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generation (900 series) (Fang 2016), implementation of this model may be done on older 
hardware without sacrificing SNR or requiring excessive runtimes. 
5.5.2 Discussion of general imaging results 
Examination of data simulated at 1210 nm, shown in Figure 5.4, indicates that 
IVPA signals may vary by an order of magnitude within the same tissue and region (e.g. 
blood-filled lumen in Streaks, Figure 5.4D). Note that the optical absorption between 
lipid and blood varies by less than a factor of 2 at 1210 nm (Figure 5.3A), and that the 
Grüneisen parameter does not vary with wavelength. Given this realization, it may be that 
the spatial variation in fluence may dominate the subtler variation in optical absorption 
between tissue types, and end up being the primary contrast mechanism in image 
generation. While not completely unexpected, this finding runs contrary to an ideal 
molecular imaging modality, one whose contrast depends primarily upon the molecular 
imaging target (i.e. tissue optical absorption). IVUS imaging may partly allay these 
concerns, as it can provide additional context to morphology and tissue content (Wang et 
al. 2011). 
5.5.3 Optical depth penetration and wavelength selection 
As can be seen in Figure 5.5A, the 5% fluence threshold exceeded 2 mm, on 
average, in the wavelength region from 1050 nm to 1370 nm. Given that the average 
coronary artery has a diameter of approximately 3.5 mm (Waller et al. 1992), this 
wavelength window may represent the optimal imaging region in terms of achieving 
sufficient light delivery throughout the coronary artery. At wavelengths below 1050 nm 
the increased optical absorption of hemoglobin (Hb) in blood (Figure 5.3A) strongly 
attenuates light, as seen in the analysis of the Streaks sample (purple line), which shows 
reduce depth penetration across most wavelengths. Additionally, the high optical 
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absorption of water at wavelengths past 1370 nm results in the same strong light 
attenuation, this time across all tissue models. It is serendipitous that the 1210 nm optical 
absorption peak of lipid should fall in the middle of the window of reduced optical 
attenuation. Though the optical absorption difference (contrast) between lipid and water 
is greater at 1720 nm than at 1210 nm (Figure 5.3A), given the overall strong light 
attenuation at the former wavelength, achieving real-time IVPA imaging with sufficient 
SNR across the entire imaging area at 1720 nm may prove challenging. This analysis 
suggests that efforts should focus on developing IVPA imaging systems designed to 
operate in the 1050 nm to 1370 nm range. Still, as laser pulse energy and ultrasonic-
detector sensitivity vary across systems, it may be possible to achieve adequate IVPA 
signal generation at increased depths while imaging at 1720 nm. 
5.5.4 Single-wavelength correlation discussion 
Overall MCC values for single-wavelength images showed peaks at 0.125 (1210 
nm) and at 0.098 (1720 nm). While these findings confirm previous results that indicated 
1210 nm and 1720 nm optimized lipid-water contrast, ideal MCC values would be near 1 
(or -1). The most likely reason for this is that, at most wavelengths, the fluence spatial 
variations exceed those of optical absorption, and thus dominate the imaging results. 
While easy to account for visually, this is likely to confound an automated global-
segmentation algorithm like the one used, which attempts to separate the entire image-
space into a bimodal histogram for segmentation (Otsu 1975). Indeed, in addition to 
IVPA imaging at multiple wavelengths, it may be possible to implement an adaptive 
segmentation algorithm that significantly improves segmentation correlation. Once a 
clinical IVPA imaging system is in further development and imaging wavelength(s) are 
determined, such an optimized algorithm could be implemented. 
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5.5.5 Image-subtraction and heatmap discussion 
Figure 5.4 (A and B) displays the difference in imaging results obtained at 
different wavelengths, due to both differences in the fluence distribution, as well as 
differences in optical absorption. This highlights the fact that selection of an IVPA 
imaging wavelength must strike a balance between optical absorption, depth penetration 
and fluence variation. Since initial studies have indicated the potential of IVPA imaging 
at 1210 nm and 1720 nm (Wang et al. 2010; Wang et al. 2012a; Wang et al. 2012b; 
Jansen, van der Steen, et al. 2014; Jansen, Wu, et al. 2014), it is logical to build upon 
previous findings by implementing a segmentation algorithm that selects for primary 
wavelengths (𝜆1) in these wavelength regions. Our segmentation scheme accomplished 
this using image-subtraction, which has the potential to yield negative pixel intensities, 
with any negative values clipped to zero. This scheme ensures that information is only 
retained in IVPA images where the PA intensity (Γ(𝑇) 𝜇𝑎(𝑟, 𝜆) 𝐹(𝑟, 𝜆)) at the primary 
wavelength exceeds that of the secondary wavelength. Given that ground truth is defined 
by the presence or absence of lipid in a voxel, this method selects for primary 
wavelengths where the PA signal from lipid is the highest, which is likeliest to occur near 
1210 nm and 1720 nm. This explains the 1210 nm and 1720 nm horizontal bands of 
strong MCCs observed in Figure 5.7. This also explains why the heatmaps are 
imperfectly reflected across the diagonal, as one would normally expect by inverting the 
primary and secondary wavelengths. The peak composite MCC occurs at 𝜆1= 1220 nm 
and 𝜆2= 1530 nm, the latter of which the optical absorption of water (𝜆2) exceeds that of 
fat by a factor of 10. The fact that the MCC maximum occurs at 𝜆1= 1220 nm and 𝜆2= 
1530 is the result of the negative-value clipping process, rather than due to information 
contained within the simulated IVPA imaging data. This was evidenced when examining 
the histogram (not shown) of the image in Figure 5.6C, which showed an excess of 
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intensity values at or near zero. As such, evaluation of MCC heatmaps should be weighed 
against considerations of fluence variation and optical penetration depth. 
Figure 5.8 gives an example of applying the same image-subtraction and 
segmentation process at wavelengths where depth penetration is comparable (~2 mm), 
1210 nm (Figure 5.8A) and 1360 nm (Figure 5.8B). While IVPA intensity is still 
dominated by water at 1360 nm (Figure 5.8B), the difference is not as drastic as in Figure 
5.6 (note the different scale used). Segmentation correlation is still very high using this 
wavelength pair (MCC >0.99), and light penetration depth is improved compared to 1530 
nm. These results are not obvious from a cursory examination of the optical properties 
shown in Figure 5.3, but rather seem to derive from the complex nature of light 
interaction with the particular geometry of coronary arteries, as well as the imaging target 
of lipid-rich plaques. Because the only extended tissue component likely to intervene 
between the IVPA imaging catheter and an atherosclerotic plaque is blood, a two-
wavelength IVPA imaging system will excel if it is able to suppress signal from blood 
and minimize imaging artifacts resulting from fluence variation across laser-pulses and 
wavelengths. While, in principle, this could be done for nearly any combination of 
wavelengths, it is most practical to accomplish when fluence distributions remain 
relatively constant across two wavelengths. For this reason, the overall results suggest 
that the 1050 – 1370 nm wavelength range seems the most promising. In this range the 
optical absorption of water-based tissues remains relatively constant, as does the resulting 
fluence distribution, while the contrast between lipid and water scales by a factor of five 




Figure 5.8. Simulated PA data, 𝐼𝑃𝐴(𝑥, 𝑦, 𝜆), for Diffuse tissue model at 1210 nm (A) and 
1360 nm (B). Images are displayed on linear scale for comparison. 
Subtraction image, 𝐼𝑃𝐴
− (𝑥, 𝑦, 𝜆1, 𝜆2), using data displayed in (A) and (B), 
shown on a linear scale (C). Segmented image based on (C), with predicted 
lipid-rich regions as white (D). Note that very high correlation can be 
observed using the same segmentation process at wavelengths where depth 
penetration is comparable. 
As such, for a generalized IVPA imaging system, the optimal two-wavelength 
imaging solution may occur using a primary imaging wavelength of 1210 nm, and a 
secondary wavelength of 1360 nm. Should implementation of IVPA imaging at 1360 nm 
be limited by available laser sources, analysis suggests IVPA imaging at 1210 nm could 
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be complemented by a number of wavelengths in the 1050 – 1370 nm window. What will 
likely determine the implementation of a dual-wavelength IVPA clinical imaging system 
is the cost and availability of laser sources. Nd:YAG lasers produce high-energy pulses at 
1064 nm 1320 nm and can be used as pump lasers for solid-state lasing mediums, as well 
as dye-based mediums and Raman lasing mediums. While together these lasing materials 
cover a broad wavelength range (Wikipedia.com 2015), dye-based lasers can require 
frequent maintenance and thus solid-state or Raman lasers present the most viable 
candidates to achieve the desired laser wavelengths. Indeed, a Ba(NO3)2 Raman laser at 
1197 nm has already been demonstrated for IVPA imaging applications, operating at 2 
kHz with 2 mJ pulse energy (Wang et al. 2014). This setup, coupled with a primary or 
secondary diamond Raman laser (McKay et al. 2012) operating at 1240 nm or 1490 nm, 
respectively, may prove the optimal implementation for a dual-wavelength clinical IVPA 
imaging solution capable of real-time characterization of atherosclerotic plaque. 
5.6 CONCLUSION 
In this work we describe a sophisticated optical model to simulate IVPA imaging 
results in the NIR regime, with the goal of improving the translation of optimized real-
time IVPA imaging to the clinical realm. IVPA imaging was modeled in four coronary 
artery tissue samples from 800 nm to 1800 nm in 10 nm steps. Optical depth penetration 
was evaluated and a segmentation algorithm was employed to evaluate single-wavelength 
and dual-wavelength subtraction IVPA imaging capabilities for identifying lipid-rich 
regions. Comparisons between segmentation results and ground truth tissue cross-
sections yielded MCCs to determine the quality of imaging results. Optical depth 
penetration is highest in the wavelength range of 1050 – 1370 nm, where the 5% fluence 
threshold extends beyond 2 mm from the optical source. MCC results indicate that single-
 148 
wavelength IVPA imaging of atherosclerotic plaque is best at 1210 nm and 1720 nm, at 
which the former wavelength lies within the increased optical penetration range. 
Subtraction-image results suggest there are several secondary wavelengths that may 
adequately compliment primary IVPA imaging at 1210 nm which significantly improve 
the segmentation correlation. When these results are weighed against considerations of 
optical depth penetration and fluence variation across wavelength, it seems the 1210 nm 
and 1360 nm wavelength pairing may prove an optimal IVPA imaging implementation, 
though the availability of laser sources will likely affect a final imaging solution. 
Validation of these results with matched experiments is vital to both confirming these 
findings and expanding the use of this model for additional IVPA imaging applications. 
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Chapter 6: Summary And Future Directions Of Photoacoustic Imaging 
For Cardiovascular Applications 
6.1 ABSTRACT 
While photoacoustic (PA) imaging has seen many advances in the realm of 
cardiovascular imaging, work remains to establish determine the full impact of PA 
imaging in this regime. In general, remaining work can be divided into two categories: 
development of improved contrast agents and development and testing of clinical 
imaging systems. The work explored herein using PA techniques to sense calcium 
dynamics in myocytes utilized a dye with known cytotoxicity issues, which proved to be 
a limiting factor in the study. Development and characterization of calcium-sensitive, 
biocompatible PA contrast agents is necessary for PA sensing of calcium dynamics to 
move beyond this initial stage. For applications exploring PA imaging to guide and 
characterize cardiac thermal ablation procedures, studies thus far have largely focused on 
ex vivo studies. For this technology to have any clinical impact, research must translate 
into studies using in vivo cardiac animal models, preferably using catheter-based PA 
imaging implementations. Intravascular photoacoustic (IVPA) imaging applications have 
already seen testing using catheter implementations in animal models. However, the 
IVPA imaging results discussed herein were obtained solely using optical modeling. The 
next step is to validate these results with a matching experiment, ideally using plaque-
bearing coronary tissue samples or in vivo animal model studies. Such results could 
confirm our findings and are necessary before these results can impact future clinical 
IVPA system development. 
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6.2 INTRODUCTION 
The work discussed in this dissertation focuses on photoacoustic (PA) imaging in 
cardiovascular applications, particularly as they apply for image guidance and tissue 
characterization. These applications, while promising, still reside in the arena of research, 
though inroads are being made to translate findings into the clinical realm. In this chapter 
we discuss some of the obstacles to that translation, and the direction future work must 
undergo to overcome this limitation. 
6.3 PHOTOACOUSTIC SENSING OF CELLULAR CALCIUM DYNAMICS 
In Chapter 2 results obtained investigating a PA method to detect cellular calcium 
dynamics was discussed (Dana, Fowler, et al. 2016). This study utilized arsenazo III 
(Asz), a calcium chelating dye, as a PA contrast agent. This proof-of-concept study 
successfully established the possibility of using PA methods to sense cytosolic calcium 
exchange (Dana, Fowler, et al. 2016), however, there are limitations to this study that can 
be addressed by future work. 
6.3.1 Limitations of current calcium-sensitive dyes as photoacoustic contrast agents 
The main limitation of this work, as it stands, involves the use of Asz dye as a 
contrast agent. Cytosolic Asz dye is known to bind to cellular proteins (Beeler, Schibeci, 
and Martonosi 1980) and produce free radicals (Docampo, Moreno, and Mason 1983). As 
such it likely impairs cell viability. We observed, using optical imaging and PA imaging, 
that cellular activity rapidly decreased after Asz treatment, resulting in a very narrow 
imaging window (10-20 minutes after completion of Asz treatment). While this window 
provided sufficient time to conduct our study, the use of a cytotoxic contrast agent is 
counter to the overarching goal of this study, which is to develop a non-invasive or 
minimally invasive PA technique to assess cardiac electrophysiology (EP), preferably for 
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longitudinal studies. For that reason, development of non-toxic, ion-sensitive contrast 
agents is essential to exploring this technique in an in vivo model. 
One potential candidate for such development involves using an organically 
bound transition metal that absorbs strongly in the NIR (Marshall et al. 2006). Such 
agents have shown a high degree of optical tunability and very strong optical absorption 
(Marshall et al. 2006). However, their use of a metallic ion may subject them to the same 
cytotoxicity concerns afflicting Asz. Cyanine derivatives have been developed that 
absorb strongly in the NIR, and are already being investigated as PA contrast agents 
(Temma et al. 2014). These agents may alleviate concerns with cytotoxicity and can 
likely be easily functionalized for calcium sensitivity. What remains to be seen is how 
that functionalization may translate into sensitivity of the final agent, and whether that 
can be visualized with PA imaging. Several organic chromophores have been 
investigated for use in OLEDs (Qian et al. 2009), and they may have potential as PA 
contrast agents. Such materials have the benefit of strong absorption out past 900 nm 
(Qian et al. 2009), and can likely be easily functionalized. They have yet to be 
investigated as PA contrast agents, though, so questions about their biocompatibility have 
not been addressed. Indeed, it may prove difficult to solubilize or encapsulate these 
agents without affecting their absorption or limiting their exposure to cytosolic calcium. 
Still another possibility exists by exploiting the potential of calcium-sensitive polymers. 
Studies have shown that alginate gels exhibit tunable properties in response to calcium 
concentration (Stowers, Allen, and Suggs 2015). It may be possible to modify such gels 
to exhibit swelling in the presence or absence of calcium. If such gels were laden with 
plasmonic nanoparticles (Luke, Yeager, and Emelianov 2012), such volume changes 
could modulate plasmon-coupling between particles, thereby providing wavelength-
dependent changes in optical absorption. Alternatively, such gels have exhibited changes 
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in stiffness as a result of calcium concentration (Stowers, Allen, and Suggs 2015). It may 
be possible to incorporate into such gels phase-changing PA contrast agents, like those 
investigated by Hannah, et al.¸(Hannah et al. 2014). It may be that such gel stiffness 
dynamics modulate the rate, and thus the frequency content, of nanodroplets. If that is the 
case, RF analysis of such signals may be able to determine the stiffness dynamics of the 
gel, and thus the underlying calcium dynamics driving them. Investigations have yet to be 
done on many of the contrast agents and systems discussed above, yet with such a diverse 
field of contrast agent candidates, it is likely that future studies will yield promising 
results that can move this work forward.  
If such a candidate is found, it will need to be fully characterized as a contrast 
agent. Ideally, direct comparisons of PA data to optical absorption, rather than optical 
extinction, would be made for a given contrast agent. Such comparisons require 
comprehensive measurement of absorption and scattering, at multiple dye concentrations 
and dye to cation ratios. This would allow for quantification of optical properties and 
stability, as well as ion-sensitivity. Biocompatibility would also have to be examined for 
any such dye to be impactful on in vivo studies, which ultimately is the goal of this 
technique.  
6.3.2 Future applications of photoacoustic sensing of ion dynamics 
Once appropriate dyes are identified translating this method into an in vivo study 
to visualize ion-dynamics in live tissue is the goal. The promise of this technique to 
provide non-invasive assessment of EP function on the cellular and tissue scale is quite 
promising for applications involving pharmacologic efficacy or side-effects. Even if such 
methods prove too difficult to translate into the clinical realm, the potential of contrast-
enabled PA imaging of EP function as a research tool holds great promise. 
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Finally, beyond the scope of cardiac EP, such dyes may extend these techniques 
to any EP application, if they can be functionalized to report on the appropriate biological 
substrate. Such applications may offer improved spatial resolution and depth penetration 
over current techniques, if suitable contrast-agents can be found. 
6.4 PHOTOACOUSTIC IMAGE GUIDANCE AND CHARACTERIZATION OF CARDIAC 
ABLATION 
6.4.1 Realization of real-time imaging 
There are several still unexamined aspects of using PA imaging to guide trans-
catheter ablation of atrial arrhythmia. Clearly any tool used to guide trans-catheter 
ablation must be real-time (RT) or near-RT, and in the work described in Chapter 3 and 
Chapter 4 we have not examined using PA imaging during radiofrequency (RF) lesion 
creation. PA imaging frame rate is practically limited by the pulse repetition frequency of 
the irradiating laser. Our initial system is capable of providing near-RT imaging (1-2 
frames per second each consisting of several optical wavelengths with no averaging), and 
many laser systems, operating at kHz frequencies, are currently available that could 
provide RT PA imaging. Once studies have demonstrated which wavelengths are optimal 
for in vivo imaging, a system could be constructed using select wavelengths, operating at 
kHz pulse repetition rates, to provide frame rates well in excess of 30 frames per second. 
6.4.2 Translating toward in vivo and eventual clinical imaging 
Corroboration of these results in an in vivo model is necessary in order to confirm 
that the findings reported here are relevant to further clinical application. One recent 
study (Chitnis et al. 2010) has reported inconclusive findings, showing that while most 
single-wavelength ex vivo studies reported positive PA contrast in the ablation lesion, it 
is possible to observe negative contrast in ablation lesions in vivo. One proposed 
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explanation is that variations in thermal deposition between in vivo and ex vivo models 
may lead to a different distribution of chromophores between the two environments. As 
our method relies upon correlation to multiple laser wavelengths, it may be possible to 
identify a difference in the chromophores present in the ablated regions of in vivo and ex 
vivo models. While the data in this study suggests Hb is present in significant quantities 
before ablation and is significantly reduced following ablation, it is not clear which 
chromophore(s) is generating PA signal in the ablated region. Previous work has 
suggested that increased temperatures during thermal therapy may give rise to a variety 
of hemoglobin derivatives, which may account for the observed contrast between normal 
and ablated tissue (Tanya et al. 2006; Farahani et al. 1999; Black and Barton 2004). 
While production of hemoglobin derivatives is often cited as a potential source of 
contrast in ablated tissues, to our knowledge, no study has shown definitively that the 
proposed derivatives are produced in significant concentrations in tissue. Studies of the 
thermal unfolding and aggregation process of hemoglobin using 2D infrared spectroscopy 
have shown that thermal degradation is a complex, multi-step process that is irreversible 
once local tissues reach a certain temperature threshold: initial destabilizations in the 
structure of hemoglobin occur at low temperatures between 30-44° C; complete thermal 
unfolding occurs between 44-54° C; and irreversible aggregation of the denatured protein 
occurs at temperatures above 54° C (Yan et al. 2004). This complex, three-stage 
denaturation process involves several potentially irreversible conformation changes in the 
structure of hemoglobin. Given the dependence of protein absorption on the 3D structure 
of the protein, these irreversible, temperature-dependent structural changes in 
hemoglobin may explain the observed elimination of the 760-nm peak in the Hb 
spectrum in ablated tissue. Partial unfolding of Hb may yield a range of different 
absorption spectra in ablated tissues rather than a single absorption spectrum 
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corresponding to a single chromophore. This range of unfolding states could explain the 
observed correlation discrepancies at the edges of tissue lesions and could be developed 
to benchmark levels of partial tissue coagulation. In future studies, it would be useful to 
submit samples of ablated and non-ablated tissues to hemopathological and chemical 
assays in order to identify with confidence which chromophores are present and in what 
concentration before and after ablation. 
6.4.3 Visualization of cryoablation lesions 
Also still unexamined is the feasibility of using PA imaging to characterize 
cryoablation lesions. As mentioned above, the denaturation process in Hb is highly 
temperature dependent. Since little research has been done to directly compare the optical 
absorption of hyper- versus hypothermia-induced myocardial lesions, further studies must 
be conducted to assess the feasibility of using this method to characterize cardiac 
cryoablation lesions, which may yield an entirely different absorption spectrum upon 
ablation. 
6.4.4 Development of a clinical imaging device 
Development of in vivo imaging solutions will be necessary to apply PA imaging 
clinically for guidance of cryo-, RF and high-intensity focused ultrasound (HIFU) 
ablation treatments. Although development of an in vivo system for PAUS imaging will 
not be a trivial task, building upon previous work by Cui et al. (Cui and Yang 2010; Cui, 
Staley, and Yang 2010; Cui and Yang 2011) and Prost et al. (Prost et al. 2012) may 
improve single-device integration, which allows straightforward co-registration of PA 
and ultrasound (US) imaging spaces, as well as the possible integration of an HIFU 
energy source also. Another avenue for development of such a clinical probe may benefit 
from recent advances in combined RF-US catheters (Wright et al. 2011) and the 
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development of light delivery mechanisms utilized for intracardiac laser ablation 
(Dukkipati et al. 2012). Still another is to implement PA imaging by adapting an 
intracardiac echocardiography catheter. These devices have served to implement US-
based elastography imaging to characterize cardiac ablation lesions (Eyerly et al. 2010; 
Eyerly et al. 2012), and by the modest addition of an optical fiber to the catheter, it may 
be possible add PA imaging capabilities onto the US and elastography capabilities 
already implemented. Such a device would be capable of a variety of imaging modalities, 
potentially offering physicians a wealth of information with little disruption to current 
technology. Regardless of which devices prove most advantageous, by capitalizing on 
shared optical and ultrasonic system components, such a system may add considerable 
functionality while minimizing the increased cost associated with added hardware. This 
would overcome a significant hurdle for clinical translation. 
6.4.5 Addition of photoacoustic thermography 
Additionally, due to the temperature dependence of 𝛽(𝑟, 𝑇), thermographic PA 
(tPA) mapping with high thermal and temporal resolutions (< 1 K and ~ 1 s, respectively) 
is possible (Shah et al. 2008; Pramanik and Wang 2009; Beard 2011). Guidance of 
myocardial ablation procedures represents an ideal application of tPA mapping as PA 
imaging has the potential to provide thermographic information co-registered with 
anatomical (US) and molecular (sPA) information. A previous study (Hsiao, Wang, and 
Deng 2013) monitored the PA signal ratio at two different wavelengths during tissue 
heating, verifying that PA signal variations occur consistently across wavelengths until 
the tissue undergoes a change of state (i.e. thermal coagulation), as we observed. By 
adapting such complementary PA-signal amplitude analysis to the multi-wavelength 
techniques described herein, a comprehensive PA thermographic and tissue 
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characterization image guidance system may be realized. This feature of PA imaging has 
tremendous potential for cryo-, RF and HIFU ablation guidance, both in the cardiac 
regime and beyond  
6.5 MONTE CARLO MODELING IN INTRAVASCULAR PHOTOACOUSTIC IMAGING 
6.5.1 Validation of modeling-based results 
While the validity of MC optical modeling has long been established, subtle 
changes in tissue optical properties and geometry can yield large differences in results. 
For this reason, the most obvious work yet remaining is to corroborate these results with 
a set of matched simulation-experimentation trials. Ideally, to validate these findings, 
IVPA imaging could be done on post-mortem coronary artery samples, which could then 
be sectioned, stained and imaged with a light microscopy to determine their tissue 
constituents. Microscopy images could then be digitized and the 3D tissue geometry 
specific to each sample could be recreated in the model space. Thus, direct comparisons 
using the same tissue geometry and composition can be made between experimental and 
modeling results. If this proves impractical, matched experiments can be done using ex 
vivo tissue samples of animal origin, or even with tissue mimicking phantoms, provided 
they recreate the geometry and optical properties pertinent to coronary artery imaging 
applications. This would need to be done at several wavelengths in the NIR, if not across 
the entire 1000 nm range analyzed. Specifically, some key wavelengths (e.g. 1210 nm, 
1360 nm, 1530 nm and 1720 nm) must be included in this simulation-experimentation 
comparison as they represent critical findings discussed herein. Experimental validation 
of these findings is vital to these results having a significant impact on developing IVPA 
clinical imaging systems. 
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6.5.2 Expanding the scope of the described optical model 
Beyond validation of these results, the modeling software provided by Fang and 
Boas (Fang and Boas 2009) can be easily adapted for various IVPA applications. Thus, 
this modeling scheme can be used to simulate different optical fiber configurations so as 
to optimize the fluence distribution within the transducer footprint. It could be adapted to 
simulate different rotation rates and A-line sampling schemes to the optimal balance 
between imaging frame rate and line density. Simulations could be done involving 
contrast agents to identify macrophage infiltration, which is a significant vulnerable 
plaque indicator (Narula et al. 2013). Such studies could identify the optimal absorption 
characteristics of tunable contrast agents to balance sensitivity, specificity and imaging 
depth for IVPA imaging applications. Various aspects of imaging system development 
that would otherwise be tedious or cost-prohibitive to explore experimentally can be 
investigated using this modeling. 
6.5.3 Unification of optical and acoustic modeling 
The next, and perhaps most exciting, step would be to couple this optical 
simulation with an acoustic model. Previous efforts have seen success using such 
methods in PA applications (Jacques 2014) and adapting these techniques to IVPA 
imaging should not prove onerous. Such a model could account for the various aspects of 
IVPA imaging that were ignored in this model, such as the attenuation, diffraction, 
refraction and interference of ultrasonic signals as they propagate from source to detector. 
Acoustic wavelengths at 40 MHz in tissue (~40 µm) is on the same order of magnitude as 
the MFP of photons and the voxel size used in this model (20 µm), easing the adaptation 
of optical simulation results to the acoustic simulation regime. Preferably, such a 
combined PA model would be used in tandem with matched experiments, as described 
above, providing the most accurate fusion of IVPA experimental and modeling schemes. 
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6.5.4 Toward real-time modeling for enhancement of photoacoustic imaging 
Lastly, as computational power improves, it may be possible to implement such 
an optical model in real-time or near real-time, perhaps using a pre-compiled lookup-
table method (Hennessy et al. 2013). Such a technique may incorporate information from 
IVUS and IVPA imaging to estimate in real-time the 3D distribution of optical 
absorption, and thus provide the absolute chemical composition of the tissue. While not 
currently available, such possibilities may be feasible by the time clinical IVPA imaging 
systems are in the latter stages of clinical trials. Such an application represents the ideal 
fusion of modeling and medical imaging in order to improve patient outcomes. 
6.6 SUMMARY 
The work discussed in this dissertation covers a broad range of PA imaging as it 
pertains to cardiovascular applications, including research at different stages of 
development. Despite this breadth, due to the similarity of the imaging applications and 
goals, developments in one application often translate into advancements in all. For 
example, the optical model discussed in Chapter 5 could be easily adapted to provide 
insight into the PA imaging of cardiac ablation lesions. Additionally, the signal and 
image processing algorithms discussed in Chapter 3 and Chapter 4 could be adapted to 
IVPA imaging applications, or to visualization of EP signals. It may be that, in the not 
too distant future, a composite cardiac PA imaging suite, capable of imaging a handful of 
NIR wavelengths, is able to provide image guidance and tissue characterization in a range 
of cardiac applications. The work described in these chapters should serve as progress 
toward realization of such an imaging system. 
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Appendix A: Brief History And Background Of Photoacoustic Imaging5 
A.1 INTRODUCTION  
Photoacoustic (PA) imaging (also called optoacoustic imaging) is a hybrid 
optical-ultrasound imaging modality that relies on optical excitation to generate 
ultrasonic waves in tissue. PA signal generation depends upon the optical absorption 
properties of the imaging target, making PA imaging a molecular imaging modality. By 
observing PA pressure transients using an ultrasound (US) system, and because PA signal 
generation relies only on absorbed photons, PA imaging is able to overcome the imaging 
depth limitations common to optical techniques. It is also well suited to take advantage of 
the reduced tissue optical absorption in the near-infrared (NIR), as well as utilize various 
contrast agents for improved imaging. For these reasons it has become a promising 
medical imaging modality, with applications including the evaluation of coronary heart 
disease (CHD), stem cell treatment monitoring, cancer diagnosis, and treatment guidance, 
just to name a few. In order to provide additional context for the results discussed in this 
dissertation, a brief history of the development PA imaging is provided in this appendix. 
A.2 HISTORY OF PHOTOACOUSTIC IMAGING 
A.2.1 Discovery of the photoacoustic effect 
Discovery of the PA effect predates even the discovery of X-rays, arguably 
making it one of the oldest medical imaging modalities. Alexander Graham Bell was the 
first to document the PA effect, in the late 19th century (Bell 1881). Bell conducted 
several experiments and devised an apparatus (see Figure 1) to make observations on the 
PA effect. Bell postulated that the modulated light caused “a wave of condensation… and 
                                                 
5 This appendix is adapted in part from a textbook chapter 'Overview of Photoacoustic Imaging' (Dana, 
Dumani, Cook and Emelianov, 2016). Nicholas Dana is the primary author of this textbook chapter. 
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a wave of rarefaction” (Bell 1881), recognizing what would later be formalized as a PA 
pressure wave (Tam 1986). Bell also observed that varying the material produced 
different sound intensities, as did altering the optical wavelength. Despite these initial 
discoveries, it would be nearly a century before the first medical applications utilizing PA 
phenomena would emerge. 
 
 
Figure A.1: Device developed by Bell to reflect sunlight via mirror (C), onto parabolic, 
reflective receiver containing sample (A). Light may be modulated by 
rotating disk (B) or by adjusting mirror angle (D). Adapted from (Bell 
1881). 
A.2.2 First studies applying photoacoustic methods to biological materials 
In order to efficiently generate a PA signal, a brief pulse of light is necessary 
(Tam 1986). Furthermore, accurate spectroscopic studies require a narrow optical 
emission band (i.e. high monochromaticity). For these reasons, advances in PA 
applications were forestalled until optical and laser technology had sufficiently matured. 
By the 1970’s technology was available to apply PA spectroscopy to the study of 
biological materials. Studies done by Rosencwaig and Pines (Rosencwaig and Pines 
1977) (Figure A.2) demonstrated the utility of PA spectroscopy as a means to estimate 




Figure A.2: Photoacoustic and optical absorption spectra of a poly(L-glutamic acid) 
membrane in the ultraviolet range. Adapted from (Rosencwaig and Pines 
1977). 
A.2.3 Experimental validation of theoretical models 
Early studies done by Diebold et al. (Diebold, Sun, and Khan 1991) (Figure A.3) 
using pulsed laser irradiation in conjunction with dyed methanol and benzaldehyde 
phantoms as tissue surrogates showed good agreement with theoretical predictions (Tam 
1986).  
A.2.4 Expanding the application of photoacoustic methods to biological materials 
During the early 1990’s work continued, showing that PA techniques were 
capable of measuring varying concentrations of glucose in whole blood, albeit using a 
mid-IR laser source (Christison and MacKenzie 1993), and later, using a gelatin tissue 
phantom and an NIR Nd:YAG laser source (Quan et al. 1993). NIR laser sources are 
desirable as they operate within the wavelength regime of low optical absorption by 
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Hemoglobin-variants, often referred to as the “biological window”, “optical window” or 
“NIR window”. Later Oraevsky et al. (Oraevsky, Jacques, and Tittel 1997) verified that 
PA measurements of absolute optical absorption using tissue samples were accurate when 
done in conjunction with diffuse reflectance to quantify optical fluence and estimate the 
amount of scattered light.  
 
 
Figure A.3: PA wave forms from short duration laser pulses. Left column: PA pressure 
(P, in arbitrary units) vs. dimensionless time (?̂?) for a fluid layer (A), a 
cylinder (B) and a sphere (C). Right column: Experimental wave forms 
obtained by irradiation of a 3-mm thick layer (A), a 150-µm-radius cylinder 
(B) and a 500-µm-radius droplet (C). Adapted from (Diebold, Sun, and 
Khan 1991). 
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A.2.5 Adaptation of photoacoustic methods to imaging applications 
These early studies had focused on using PA techniques to estimate optical 
properties (i.e. optical absorption) and characterize absorbers. Work by Kruger (Kruger 
1994) began to establish PA as an imaging technique by combining optical excitation 
with an US transducer and using US time-of-flight analysis to estimate absorber size. 
This led to formal photoacoustic tomography (PAT) methods, using techniques similar to 
those of X-ray tomography (Kruger et al. 1995).  
A.2.6 Early exploration of clinical applications of photoacoustic imaging 
As PA imaging and combined photoacoustic-ultrasound (PAUS) imaging became 
more prevalent, research began to focus on clinical applications of such imaging. Given 
that hemoglobin (Hb) and oxyhemoglobin (HbO2) are informative endogenous 
chromophores, studies began to focus on imaging Hb variants both ex vivo and in vivo. 
Work done by Viator et al. (Viator et al. 2002) demonstrated that, using a 532 nm laser, 
PA imaging could determine the depth of a port wine stain in vivo. Not long after, early 
three-dimensional (3D) PA images were acquired by Siphanto et al. (Siphanto et al. 
2004) visualizing rat mesenteric vasculature (Figure A.4). This latter study utilized an X-
Y two-dimensional (2D) motor stage to raster scan an optical fiber for PA, and used US 
time-of-flight to estimate the absorber axial position, achieving a 3D image space with 





Figure A.4: 3D volume-rendering of PA imaging of rat mesenteric vasculature. Part of 
the artery which is below the veins, (indicated by the arrows) becomes 
visible by rotating the three-dimensional image. Voxel size is (X-Y-Z) 
400x200x100 µm. Adapted from (Siphanto et al. 2004). 
A.2.7 Functional photoacoustic imaging 
Hb and HbO2 possess unique absorption spectra which are used to assess oxygen 
saturation percentage (SpO2), as is done with pulse oximetry. PA imaging contrast is 
absorption based, making it a good candidate for estimating SpO2. Wang et al. utilized 
PAT to assess tissue function and SpO2 using a whisker stimulation rat model (Wang et 
al. 2003). With image subtraction, they visualized hemodynamic changes using a single-
wavelength (532 nm, Figure A.5). Later, this same group demonstrated that spectroscopic 
PA (sPA) imaging could estimate tissue SpO2 non-invasively and transcranially using an 
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in vivo rat model (Wang et al. 2006). Similar techniques were used to visualize 
angiogenesis and vascular disruption associated with tumor growth in an in vivo rat brain 
tumor model (Ku et al. 2005). Investigations into intravascular photoacoustic (IVPA) 





Figure A.5: Functional imaging of cerebral hemodynamic changes in response to whisker 
stimulation. (A) Noninvasive PAT image of the vascular pattern in the 
superficial layer of the rat cortex (B, C). Functional PAT images 
corresponding to left-side and right-side whisker stimulation, respectively. 
These two maps of functional representations of whiskers are superimposed 
on the image of the vascular pattern in the superficial cortex shown in a. (D) 
Open-skull photograph of the rat cortical surface. B, bregma; L, lambda; M, 
midline; A, activated regions corresponding to whisker stimulation (4 mm × 
4 mm). (E) Histology of normal lamina IV cortical barrels, located in 
regions A, representing the large mystacial vibrissae of the rat 
somatosensory system (40× magnification). Adapted from (Wang et al. 
2003). 
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A.2.8 Evolution of photoacoustic imaging methods and reconstruction 
During this time, more research into image reconstruction methods were taking 
place.  A weighted delay-and-sum method was tested with a PA imaging phantom, 
achieving approximately a 20 x 200 µm (axial x lateral) field of view by scanning a high-
bandwidth hydrophone in an X-Y plane (Hoelen and de Mul 2000). Kruger, et al. 
(Kruger, Reinecke, and Kruger 1999), demonstrating thermoacoustic imaging (using 
microwave excitation) with a hemispherical array of detectors commonly called a bowl-
array. Bowl-arrays are particularly well suited to breast imaging, dubbed photoacoustic 
mammography, due to the geometry of the target tissue. Other PA imaging geometries 
include spiral-scanning (Kruger et al. 2013), rotating radial-scanning (Wang and 
Emelianov 2011) and cylindrical-scanning systems (Gamelin et al. 2008), to name a few. 
A.2.9 Maturation of hybrid photoacoustic imaging systems 
As PA imaging technology matured, the research focus shifted to combining PA 
imaging’s excellent molecular sensitivity with additional modalities for complementary 
structural, mechanical, elastic or optical property information. PA imaging is a hybrid 
optical-acoustic modality, making it well suited to integrate with similar modalities. 
Work to develop a combined PA, US and elastography imaging system was performed 
(Park et al. 2006). Additionally, magneto-photo-acoustic imaging was introduced by 
combining US and PA imaging with magneto-motive US (MMUS), which utilizes 
varying magnetic fields to acoustically excite contrast agents (Qu et al. 2011). PA 
imaging has also been integrated with an optical coherence tomography (OCT) system, 
which combines optical absorption sensitivity (PA) with optical scattering sensitivity 
(OCT), while sharing many optical components (Li et al. 2009). A combined PA and 
fluorescence tomography system was also explored, utilizing PA imaging to inform a 
finite element (FE) optical diffusion-based model for reconstructed fluorescence 
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(Razansky and Ntziachristos 2007). These represent just a few examples of combined 
multimodal PA imaging systems. 
A.2.10 Addition of photoacoustic contrast agents 
Developing PA imaging contrast agents has also been an active area of research. 
An ideal PA contrast agent is typified by strong, narrow-band optical absorption, high 
thermal- and optical-stability, high bio-compatibility and the potential for 
functionalization. Early work characterized the PA response from a solid sphere (Khan 
and Diebold 1995), which is commonly used as a contrast agent model. Gold 
nanoparticles (NPs), due to plasmon-resonance, demonstrate very high optical absorption 
(Jain et al. 2006) and low cytotoxicity, making them promising contrast agents. Dual-
contrast agents are also useful for combined imaging (Hannah et al. 2014; Yang et al. 
2013), while theranostic agents can help deliver or monitor therapy (Wang et al. 2013; 
Lee et al. 2013; Seungsoo et al. 2014). In addition to gold, other contrast agent materials 
include dyes, silver, iron oxide and graphene (Luke, Yeager, and Emelianov 2012), to 
name a few. Advances in contrast agent targeting and biocompatibility have also aided 
PA functional imaging (Nie and Chen 2014). 
A.3 CURRENT STATUS 
 With PA imaging firmly established as a molecularly sensitive pre-clinical 
imaging tool, much current research focuses on the translation of PA imaging to the 
clinical arena. Recent PA mammography studies using clinical systems have highlighted 
the utility of PA imaging for clinical (Kitai et al. 2014; Heijblom, Steenbergen, and 
Manohar 2015) tasks (Kitai et al. 2014; Heijblom, Steenbergen, and Manohar 2015), 
while progress continues in other applications. Current research focuses on translation of 
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contrast agents to the clinical environment, as well as the development of smart agents 
for targeted drug delivery or theranostic applications. 
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